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Preface
The studies detailed in this thesis were supported by a fellowship
from Family Health International. This funding was obtained on the condition
that at least a portion of the research would concentrate on applied aspects
of fertility control in the male, with special reference to the actions of
sulphasalazine, gossypol and propranalol, a diverse group of antifertility
agents known to affect sperm motility. The results of these investigations
have been detailed in section B of this thesis, entitled "Male Contraception".
In addition to these topics, a series of investigations into the
fundamental mechanisms involved in the cellular control of sperm motility
were performed. These studies are summarised in section A, "Fundamental
Biology of Sperm Movement" .
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Mammalian spermatozoa attain the ability to initiate progressive
motility during their passage through the epididymis. In many species the
movement characteristics of these cells are further modified in the female
tract to produce a state of "hyperactivation", which is believed to facilitate
penetration of the oocyte vestments, particularly the zona pellucida. The
exact biochemical mechanisms involved in the development and expression
of motility, and the way in which these processes are modified by potential
contraceptive agents, such as sulphasalazine, gossypol and propranolol,
remain unknown. Since published evidence implicates important roles for
prostaglandins and the intracellular messengers cyclic 3',5' adenosine
monophosphate (cAMP), calcium and pH in this context, this study
investigated the involvement and interplay of these factors in the aquisition
and expression of sperm movement.
In contradiction to previously published data in other species, cAMP
levels were found to be higher in immotile caput epididymal spermatozoa,
than in caudal epididymal spermatozoa, both in undiluted form and upon
release into appropriate media. Both cell types expressed a rapid calcium-
dependant, calmodulin-independ^nt increase in cAMP content upon dilution
to a concentration of 20 million spermatozoa/ml. This initial rise was
abolished by dilution to one million/ml. Further investigations revealed that
the rapid elevation of cAMP levels at the higher cell concentration was due
to a factor present in epididymal plasma which may be a phosphodiesterase
inhibitor. A more gradual increase in cAMP levels does occur in capacitating
caudal spermatozoa incubated at this lower density, whilst caput levels
remain low. This elevation precedes the appearance of hyperactivation,
which, in turn, precedes the induction of the acrosome reactii .i.
Both hyperactivation and the rise in cAMP levels are abolished by
incubation in medium with no added calcium (NAC). Neither phenomenon
restored by the addition of the phosphodiesterase inhibitor isobutyl methyl
xanthine (IBMX), although similar treatment of caudal spermatozoa in
medium MT-1 (containing 1.7mM calcium) increased cAMP levels,
stimulated percentage motility and advanced the appearance of
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hyperactivation. Addition of a membrane permeant analogue of cAMP to
caudal spermatozoa in NAC also failed to evoke hyperactivation, whereas it
mimicked the action of IBMX on caudal spermatozoa in MT-1
Incubation of caudal spermatozoa in MT-1 with the calmodulin
antagonist calmidazolium slightly reduced cAMP levels and totally
abolished coordinated sperm movement. Addition of IBMX in the presence
of calmidazolium increased cAMP content to levels higher than those
expressed in MT-1 alone, but did not restore coordinated motility.
To determine why caput spermatozoa failed to show an elevation of
cAMP levels during prolonged incubation, as well as the mechanisms
responsible for this increase in capacitating caudal spermatozoa,
intracellular calcium concentration and pH were determined for both cell
types. No overt difference in calcium content or internal pH exists between
caput and caudal spermatozoa, with both cell types exhibiting a rise in
calcium levels and a fall in pH over a time course of five hours. However,
calcium levels declined significantly in caudal spermatozoa at the time when
maximal levels of hyperactivation are being expressed.
In addition to these fundamental studies, suggesting a role for cAMP
in the expression of hyperactivation, the data published in this thesis also
shed light on the mechanisms by which the contraceptive agents
sulphasalazine, gossypol and propranolol influence sperm motility.
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Part A. Fundamental Biology of Sperm Movement
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Figure 1. Section through the adult human testis showing the structure.
(From Johnson M, Everitt B (eds): Essential Reproduction. Blackwell,
London, 1984)
The purpose of this introduction is to acquaint the reader with the
biological changes that spermatozoa undergo after they have completed
their development in the testis, with special reference to alterations in the
spermatozoa's capacity for movement. The changes which occur in the
epididymis are detailed first, followed by an account of the alterations
undergone by spermatozoa during their passage through the female genital
tract. The significance of these changes is then discussed, and the
biochemical mechanisms by which these alterations are thought to be
mediated is introduced.
A. Biology of the Epididymis
i. Background. The epididymis is a single duct which receives
spermatozoa from the vasa efferentia and transports them distally to the vas
deferens. Its origins lie in the mesonephric (Wolffian) duct; the so called
"primitive embryonic kidney" (Gier and Marion, 1970). This organ has
evolved in such a way that in mammals it has come to be utilised exclusively
for reproductive purposes.
The epididymal duct is highly convoluted in shape, and is tightly
packed within an extension of the testicular tunica albuginea to form the
epididymis proper (Fig 1). On the basis of its shape, this organ is
conventionally divided into three parts; the caput (head), which receives
spermatozoa from the efferent ducts of the testis, the corpus (body), a narrow
intermediate connection, and finally the cauda (tail), where spermatozoa are
stored prior to ejaculation. These gross anatomical divisions are, however,
misleading, as the exact regional boundaries are indistinct and vary from
species to species (Glover and Nicander, 1971). In the rat and hamster for
instance, the vasa efferentia occupies only the most proximal margin of the
caput epididymis, whereas in man, a large portion of the caput region is not
epididymal tissue at all, but is an extensive vasa efferentia (Baumgarten et
al, 1971; Fig 1). Thus, information concerning a particular epididymal region
from one species may not necessarily translate well to another.
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The first recorded observations on the epididymis were made by
Aristotle around 400BC (Thompson, 1910). This enterprising scholar
provided the first clear and detailed description of testicular anatomy and
function, and also produced suprisingly modern illustrations of the anatomy
of the testis, efferent ducts, epididymis and vas deferens. Indeed, the term
epididymis itself comes from the Greek, "didymi", meaning twins, which was
used by this race to describe the paired testes.
With the advent of the light microscope, Johan Ham, a medical
student at Leiden, brought a curious cell type in semen to the attention of the
distinguished Dutch microscopist Antony van Leeuwenhoek. He
subsequently established the existence of spermatozoa in the seminal fluid
of a variety of species, and presented his observations to the Royal Society
(Leeuwenhoek, 1679; Bodemer, 1973). The following year, an extensive
study of the anatomy of the testis was published by de Graaf (Jocelyn and
Setchell, 1972). By the nineteenth century, great advances had been made
in the understanding of male fertility, and especially of testicular physiology.
However, it appears that over this entire period the epididymis was regarded
solely as a canal which facilitated the passage of spermatozoa from the
testis to the penis. It was not until the very end of the nineteenth century that
some function was ascribed to this organ, when it was noted that patterns of
sperm motility changed within the epididymis (Hammar, 1897; Walker,
1899). Tournade (1913) confirmed these findings by showing that the
capacity of spermatozoa for sustained progressive motility increased during
their progression through the epididymis, and on the basis of this
observation he proposed that spermatozoa must undergo a "ripening"
process during their epididymal passage.
ii. Epididvmal development of the capacity for fertilization. The first
true evidence of functional maturation within the epididymis came from
studies by Young (1931), who obtained pregnancy rates of 68% in oestrous
guinea-pigs inseminated with spermatozoa collected from the distal part of
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the cauda epididymis, in comparison to a figure of 33% obtained with
equivalent samples from the proximal region. It has since been shown, using
both in vivo and in vitro techniques, that spermatozoa from the rabbit
(Nishikawa and Waide, 1952; Bedford, 1963a, 1966; Orgebin-Crist, 1967a;
Paufler and Foote, 1968; Igboeli and Foote, 1969), rat (Blandau and
Rumery, 1964; Dyson and Orgebin-Crist, 1973; Paz et al, 1978; Brackett et
al, 1978), Syrian hamster (Horan and Bedford, 1972; Cummins, 1976;
Gonzalez Echeverria et al, 1984), Chinese hamster (Dacheux and
Paquignon, 1980; Yanagimachi, 1985), mouse (Pavlok, 1974; Floppe,
1975), guinea pig (Young, 1931; Shilon et al, 1978; Williamson et al, 1980),
boar (Flunter et al, 1976; Holtz and Smidt, 1976), ram (Fournier-Delpech,
1977, 1979; Voglmayr et al, 1978), bull (Amann and Griel, 1974), marmoset
(Moore, 1981) and human (Flinrichsen and Blaquier, 1980; Schoysman,
1981; Moore et al, 1983) are infertile upon their exit from the testis, and only
gain the ability to fertilize eggs during their passage through the epididymis.
That the ability of the epididymis to support the maturation of spermatozoa
depends upon the presence of androgens was shown by the loss of this
capacity upon castration or hypophysectomy (Orgebin-Crist, 1973; Dyson
and Orgebin-Crist, 1973; Orgebin-Crist and Davies, 1974; Lubicz-Nawrocki
and Glover, 1974; Lubicz-Nawrocki, 1976). In vitro experiments have
subsequently confirmed the androgen dependance of sperm maturation
within the epididymis (Orgebin-Crist and Tichenor, 1973; Orgebin-Crist et al,
1976; Orgebin-Crist and Jahad, 1978).
iii. Epididvmal contribution to sperm maturation. There has been
much debate as to whether the maturation of spermatozoa within the
epididymis is reliant upon the activity of some specific region of this organ, or
whether spermatozoa possess an intrinsic capacity for maturation after
spermiation, and thus utilise the epididymal duct merely as a favourable but
nonspecific environment in which to develop their capacity for fertilization.
The consensus opinion amongst early workers was that the
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epididymal epithelium must play a specific role in inducing changes in
epididymal spermatozoa (Tournade 1913; Stigler, 1918; Benoit, 1921, 1926;
Redenz, 1924, 1926; Von Lanz, 1926). However, from experiments where
ligation of the caput epididymis produced an increase in the fertilization rate
achieved by spermatozoa trapped within this region, it was postulated that
the passage of time, rather than some specific property of epididymal
secretion, determined the functional state of spermatozoa, and that once
released from the Sertoli cell, the spermatozoon was committed to an
ageing process, during which functional competence was achieved (Young
1929a,b, 1931; Young and Simeone, 1930; Simeone and Young, 1931;
Simeone, 1933).
Subsequent studies appeared to provide support for this theory. In the
rabbit, where spermatozoa normally acquire the capacity for fertilization in
the distal corpus epididymis (Bedford, 1966), ligation of this region led to the
appearance of some fertile spermatozoa amongst those held in the distal
caput (Gaddum and Glover 1965; Bedford, 1967), or the proximal corpus
(Orgebin-Crist, 1967a; Paufler and Foote, 1968). Furthermore, recipients of
epididymovastostomies, a process by which epididymal blockage is
overcome by connection of the caput to the vas deferens (Young, 1951),
have been reported to subsequently father children (Young, 1970).
These studies would therefore appear to suggest that the corpus and
caudal regions of the epididymis are not required for the induction of normal
functional competence in spermatozoa from either the rabbit or human.
However, occlusion of the epididymal duct has been shown to drastically
alter the structure of the epididymal epithelium (Glover, 1962, 1969; Bedford,
1967; Orgebin-Crist, 1969). Thus, when the passage of spermatozoa
through the epididymis is halted by obstruction, the whole character of the
duct above the blockage becomes altered, and a completely abnormal
situation ensues. Hence conditions in a blocked epididymis are not
comparable to those prevailing in an intact organ. Subsequent studies on
patients who have undergone epididymovastostomy have revealed that the
likelihood of producing functionally competent spermatozoa is extremely low
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if the vas deferens is anastomosed to the proximal 7-1 Omm of the epididymis
(Silber, 1978; Schoysman, 1981). Furthermore, spermatozoa recovered
from the corpus epididymis of fertile men fail to fertilise ova in vitro
(Mahadevan and Trounson, 1985), and ligation of the epididymis does not
promote the fertilizing ability of spermatozoa recovered from the testis
(Cooper and Orgebin-Crist, 1975, 1977) or proximal caput epididymis
(Gaddum and Glover, 1965; Bedford, 1967; Orgebin-Crist, 1967a, 1969;
Cummins, 1976). The balance of evidence therefore indicates that the
maturation of spermatozoa within the epididymis is dependent upon some
component(s) of epididymal origin (Orgebin-Crist, 1969; Cummins and
Orgebin-Crist, 1971; Orgebin-Crist et al, 1975; Cummins, 1976; Holtz and
Smidt, 1976). This requirement cannot, however, be met simply by exposing
immature spermatozoa to the secretory products of the distal portion of the
epididymis (Cooper and Orgebin-Crist, 1975, 1977; Holtz and Smidt, 1976;
Hunter et al, 1978; Voglmayr and Gandhi, 1978; Voglmayr et al, 1978;
Peterson et al, 1984), and it is thus thought that sperm maturation involves a
complex interaction between the maturing spermatozoa and the luminal fluid
and epithelium of the epididymis (Orgebin-Crist and Jahad, 1978).
iv. Epididvmal development of the capacity for movement. The
acquisition of fertilizing ability within the epididymis runs parallel to an
increased potential for progressive movement, suggesting that a relationship
exists between these two factors (Dacheux and Paguignon, 1980). It is
known that spermatozoa from the rat (Blandau and Rumery, 1964; Gaddum,
1968; Fray et al, 1972; Burgos and Tovar, 1974; Wyker and Howards, 1977;
Morton et al, 1978; Hinton et al, 1979a; Turner and Giles, 1981), rabbit
(Orgebin-Crist, 1967a, 1969; Gaddum, 1968; Acott et al, 1979; Pholpramool
and Chaturapanich, 1979), hamster (Morton et al, 1978; Kann and Serres,
1980), mouse (Morton et al, 1978), ram (Fournier-Delpech et al, 1977;
Amann et al, 1982; Dacheux et al, 1983), boar (Acott et al, 1979; Dacheux et
al, 1983), bull (Cascieri et al, 1976; Morton et al, 1978; Acott et al, 1983; Carr
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and Acott, 1984), guinea pig (Shilon et al, 1978), cat, dog, monkey, bear,
elephant (Acott et al, 1979) and human (Belonoschkin, 1942; Mooney et al,
1972; Bedford et al, 1973, Morton et al, 1978) all acquire the potential for
movement during their passage through the epididymis, and it is assumed
that this phenomena occurs in every mammalian species (Bedford, 1975;
Hamilton, 1975; Orgebin-Crist, 1975; Bedford, 1979).
Although spermatozoa isolated from the seminiferous tubules of
mammals are completely immotile (Hinton et al, 1979a), caput epididymal
spermatozoa from rabbits (Orgebin-Crist, 1967a; Gaddum, 1968; Acott et al,
1979; Pholpramool and Chaturapanich, 1979), rats (Blandau and Rumery,
1964; Fray et al, 1972; Wyker and Howards, 1977;. Hinton et al, 1979a;
Turner and Giles, 1981) and hamsters (Kann and Serres, 1980) all exhibit a
tendency to move in circles. In contrast, spermatozoa from the human caput
epididymis exhibit only weak vibrations, and never express such circular
movements (Mooney et al, 1972; Bedford et al, 1973). However, as the fluid
environment within the lumen of the caput epididymis has a high osmolarity
(Levine and Marsh, 1971; Johnson and Howards, 1976; D'Addario et al,
1980) the movement patterns expressed by immature spermatozoa may
reflect artificially induced changes in the flagellum resulting from incubation
in culture medium which is hypo-osmotic with respect to their normal milieu
(Serres and Kann, 1984). In the rat, hamster and mouse, the movement of
immature cells is associated with an apparent "stiffness" of the mid-piece,
preventing the degree of rotation required for mature patterns of motility
(Fray, 1972; Kann and Serres, 1980; Saling, 1982). This contrasts with the
situation in bovine caput spermatozoa, in which the mid-piece appears to be
too flexible, resulting in the rotation rate in these cells occuring at a lesser
rate than in mature spermatozoa (Acott and Hoskins, 1983; Acott et al,
1983).
v. Epididvmal contribution to sperm movement. Investigations of the
involvement of the epididymis in the maturation of sperm motility have relied
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heavily upon the use of ligation techniques, which have been shown to
drastically alter the nature of the duct proximal to the site of ligation (Glover,
1962, 1969; Bedford, 1967; Orgebin-Crist, 1969). Although in vitro ageing of
ram and bull spermatozoa in rete testis (Voglmayr et al, 1967; Voglmayr et
al, 1970), or epididymal (Voglmayr et al, 1977) fluid has no stimulatory
effects upon any aspect of their motility, such studies have shown that
spermatozoa trapped by these means in the seminiferous tubules (Glover,
1962; Orgebin-Crist, 1967b), rete testis (O'Shea and Voglmayr, 1970;
Cooper and Orgebin-Crist, 1975, 1977), caput (Glover, 1962; Gaddum and
Glover, 1965; Bedford, 1967; Orgebin-Crist, 1967b; Gaddum, 1968; Burgos
and Tovar, 1974) or corpus (Horan and Bedford, 1972; Cummins, 1976)
epididymides do show an increase in flagellar beat rate. However,
spermatozoa treated in this manner never acquire the capacity for forward
motility, suggesting that this ability is conferred upon spermatozoa by some
component of epididymal origin, and is not simply due to an ageing process.
This theory is supported by castration and androgen replacement studies,
which alternately switch off and re-initiate epididymal function, respectively
preventing and maintaining the ability of the epididymis to induce forward
motility in spermatozoa trapped in the corpus region (Orgebin-Crist, 1973).
Lindholmer (1974) observed that human seminal plasma could
induce forward motility in caput epididymal spermatozoa recovered from
patients suffering from obstructive azoospermia. Subsequently it was shown
that progressive motility could be induced in immature spermatozoa from the
bull by incubation in the presence of bovine seminal plasma following
activation of the cells with phosphodiesterase inhibitors (Hoskins et al,
1975b; see below). This ability was subsequently shown to be due to a
37500 Dalton glycoprotein named forward motility protein (FMP) (Acott and
Hoskins, 1978; Hoskins et al, 1978), of epididymal origin (Brandt et al,
1978), which binds tightly to spermatozoa prior to their entrance into the
proximal portion of the cauda epididymis (Acott and Hoskins, 1981). Similar
effects have been attributed to a factor in the caudal fluid of the hamster
(Kann and Serres, 1980; Serres and Kann, 1984), although forward
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Connecting piece
Figure 2. Diagram of a primate spermatozoon with the cell membrane
removed to show the internal structure. (From D W Fawcett. Devel. Biol 44:
394 (1975))
- 11
progression in immotile spermatozoa from the ram (Amann et al, 1982), boar
(Dacheux and Paquignon, 1980) and rat (Turner and Giles, 1982) cannot be
induced by caudal plasma.
The binding of epididymal glycoproteins to the surface of developing
spermatozoa had previously been observed (Koehler, 1973; Gordon et al,
1975; Nicolson and Yanagimachi, 1974; Nicolson et al, 1977), and because
of the acidic properties of such molecules, such a process would account for
the increasingly negative charge found on the sperm tail during epididymal
transit (Bedford, 1963b; Cooper and Bedford, 1971; Yanagimachi et al,
1972). The ability of this FMP to increase beat frequency and power output is
not species specific (Acott et al, 1979), and although it has been shown that
part of this protein's action was due to a reduction of the binding of sperm
heads to the glass surfaces in the motility assessment chamber (Stephens et
al, 1981), this factor appears to act by reducing the flexibility of the flagellar
mid-piece (Acott and Hoskins, 1983; Acott et al, 1983; Serres and Kann,
1984).
In the hamster, anti-calmodulin drugs have been shown to mimic the
effects of FMP upon immature spermatozoa, and it has thus been proposed
that this protein's action may be mediated via this calcium-binding peptide
(Serres and Kann, 1984). Flowever, calmodulin inhibitors are known to have
completely opposite effects upon ejaculated dog spermatozoa, converting
mature motility patterns into movements reminiscent of those displayed by
caput spermatozoa (Tash and Means, 1982).
vi. Morphological changes in sperm during epididvmal transit.. The
mammalian spermatozoa is a small, elaborate, highly specialised and
condensed cell consisting of two major parts; the head and the tail (Fig 2).
The principal component of the head is the nucleus, which is covered
anteriorly by a characteristic cap-like structure, the acrosome, and
posteriorly by a cytoplasmic sheath, the post-nuclear region. The tail is a
long flagellum that is differentiated into four regions; the neck or connecting
piece, the mid-piece, which contains the mitochondrial sheath, the principal
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piece and the end piece.
Ultrastructurai modifications of spermatozoa are known to accompany
epididymal transit. Of these, the most noticeable change is the migration of
the cytoplasmic droplet, which gradually moves distally along the flagellum,
and is usually shed from the tail midpiece (Redenz, 1926). This droplet
represents a cytoplasmic remnant of the residual body from which the
spermatid was separated during spermiation (Fawcett and Phillips, 1969).
The role of this protoplasmic droplet is unknown. However, it has been
demonstrated that these droplets have close biochemical and strutural
similarities to lysosomes (Dott and Dingle, 1968; Garbers et al, 1970;
Moniem and Glover, 1972; Harrison and White, 1972), and it may be that this
structure interacts with the sperm membrane surrounding the mitochondria,
thus affecting the activity of this organelle.
The morphology of the acrosome also changes during epididymal
maturation. Originally reported as a shrinkage of the entire sperm head
(Mukherjee and Bhattacharya, 1949), this has now been shown to be
caused by a reduction in the size of the acrosome (Fawcett and Phillips,
1969; Jones, 1971; Bedford and Nicander, 1971; Bedford, 1963, 1965).
These changes are perhaps most dramatically illustrated in the guinea pig,
where the acrosome of testicular spermatozoa is flattened and large, whilst
in mature spermatozoa, it assumes a more rounded and smaller
appearance (Fawcett and Hollenberg, 1963).
However, the ultra-structure of the sperm tail does not appear to
change during epididymal maturation (Olson and Sammons, 1980), despite
the observation that the total disulphide bond content of the spermatozoan
tail increases concomitant with this process (Calvin and Bedford, 1971;
Calvin et al, 1973; Bedford and Calvin, 1974). Using demembranated sperm
models, in which flagellar beating can be re-initiated by treatment with ATP
(Bishop and Hoffman-Berling, 1959; Morton, 1973; Lindemann and Gibbons,
1975; Lindemann, 1978; Lindemann et al, 1980), it has been shown that
immature spermatozoa are capable of exhibiting coordinated flagellar
movement (Mohri and Yanagimachi, 1980; Treetipasatit and Chulavatnatol,
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1982; Yeung 1984, 1986; White and Voglmayr, 1986). Thus, although the
flagellar system of spermatozoa is thought to undergo some modification
during epididymal maturation (Mohri and Yanagimachi, 1980; Yeung 1984,
1986; White and Voglmayr, 1986), it would appear that the motor apparatus
of these cells is already functionally assembled upon their exit from the
testis.
vii. Epididymal storage of spermatozoa. Spermatozoa stored in the
cauda epididymis possess the full potential to express motility upon dilution.
However, as early as 1925 it was reported that mature guinea pig
spermatozoa remained immotile whilst still in their native fluid (Cody, 1925).
It is now known that spermatozoa are immotile whilst resident in the cauda
epididymis of rats (Jones, 1978; Morton et al, 1978; Turner and Howards,
1978; Usselman and Cone, 1983; Turner and Reich, 1985; Carr et al, 1985),
hamsters (Jones, 1978; Morton et al, 1978; Turner and Reich, 1985; Carr et
al, 1985), mice (Morton et al, 1978), guinea pigs (Turner and Reich, 1985;
Carr et al, 1985) and man (Turner and Reich, 1985). It is commonly assumed
that the storage of spermatozoa in a quiescent state during their sojourn in
the cauda epididymis allows energy stores to be conserved for the journey
through the female genital tract and for the fertilization process (Mann and
Lutwak-Mann, 1981; Zanaveld and Chatterton, 1982). However,
spermatozoa from rams (Jones, 1978), rabbits (Jones, 1978; Morton et al,
1978; Usselman and Cone, 1983; Turner and Reich, 1985) and rhesus
monkeys (Usselman and Cone, 1983) are motile in undiluted fluid from the
cauda epididymis. Bull spermatozoa also exhibit flagellar movement prior to
ejaculation (Cascieri et al, 1976; Morton et al, 1978; Carr and Acott, 1984;
Pholpramool et al, 1985). Although the extent of sperm movement within the
cauda epididymis evidently varies considerably between studies, it never
equals the levels expressed upon release into media. An explanation for
these differing strategies awaits elucidation
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B. Post ejaculatory modifications to spermatozoa.
i. Capacitation. Spermatozoa which have completed epididymal
maturation are still not competent to achieve fertilization immediately upon
ejaculation. CR Austin (1951) first reported that eggs recovered from rabbits
artificially inseminated prior to ovulation were mostly fertilized, whilst eggs
from females inseminated after ovulation rarely showed signs of penetration.
Although in the light of subsequent studies this may be interpreted as a
modification of the state of the oocyte, in view of this and a similar
observation (Chang, 1951), it was proposed that spermatozoa required a
period of maturation within the female genital tract before their potential for
fertilization can be realised, and the term "capacitation" was coined to
describe this phenomenon(Austin, 1952).
As spermatozoa recovered from the site of fertilization often lacked, or
at least possessed highly modified acrosomes (Austin and Bishop, 1958), it
was generally accepted that the process of capacitation included the loss of
the acrosome during the exocytotic acrosome reaction. However, following
the observation that capacitated spermatozoa could be "decapacitated"
(Chang, 1957; Bedford and Chang, 1962), it is now accepted that
capacitation includes acquisition of the ability to acrosome react and to
subsequently generate an altered area of plasma membrane around the
equatorial segment capable of fusing with the oolemma (Bedford, 1970;
Yanagimachi and Usui, 1974; Saling et al, 1978; Bedford, 1983), but does
not include the actual undertaking of these physiological changes (Bedford,
1970).
ii. Hvperactivated motility. In the 1960's, spermatozoa were shown to
exhibit a progressive increase in oxygen uptake and glycolytic activity during
capacitation (Hamner and Williams, 1963; Mounib and Chang, 1964;
Murdoch and White, 1967; Black et al, 1968; Iritani et al, 1969). It was
subsequently shown that the nature of the flagellar beat pattern also
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changed during the terminal stages of capacitation, accounting for the
increase in metabolic activity. These altered movement characteristics were
originally described for the hamster (Yanagamachi, 1969, 1970), and
subsequently shown to occur in the guinea pig (Yanagimachi, 1972; Barros
et al, 1973; Yanagamachi and Usui, 1974), dog (Mahi and Yanagamachi,
1976), mouse (Fraser, 1977), rabbit (Cooper et al, 1979; Suarez et al, 1983),
bat (Lambert, 1981), marmoset (Moore, 1981), bottlenosed dolphin
(Fleming, 1982), ram (Shams-Borhan and Harrison, 1981; Cummins, 1982),
rhesus monkey (Boatman and Bavister, 1984) and human (Gould et al,
1983; Burkman, 1984). Although originally termed activation (Yanagimachi,
1970), this beat pattern has since been renamed hyperactivation
(Yanagimachi, 1981) to avoid confusion with the initiation of motilty from
quiescence which occurs at ejaculation in many species (see above).
Hyperactivated motility is not an artifact generated in vitro, as similar
patterns of movement have been observed in spermatozoa both in situ and
upon recovery from the female tract after mating (Yanagimachi, 1970;
Fraser, 1977; Cooper et al, 1979; Katz and Yanagimachi, 1980; Overstreet et
al, 1980; Cummins, 1982) The movement characteristics of spermatozoa
exhibiting hyperactivated motilty differ dramatically from those of freshly
ejaculated cells. Whereas recently ejaculated spermatozoa propagate three
dimensional beats, and as a result swim in linear trajectories (Yeung and
Wooley, 1984), hyperactivating spermatozoa generate vigorous, large
amplitude planar beats (Yanagimachi, 1970; Yanagimachi and Usui, 1974;
Fraser, 1977; Cooper and Woolley, 1982; Ishijima and Mohri, 1985), which
are assymetrical, possibly as a result of the significantly one sided nature of
the flagellar bend (Katz et al, 1978). As a result, hyperactivating
spermatozoa move in a non-progressive, circular manner (Suarez et al,
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Figure 3. Posterior views of the human uterus and one oviduct: (a) intact; (b)
sectioned. (From Johnson M, Everitt B (eds): Essential Reproduction.
Blackwell, London, 1984)
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C. Requirement for motility.
What role does motility occupy in the fertilization process? Although
early workers believed that spermatozoa propelled themselves through the
epididymis (Redenz, 1926; Von Lanz, 1929), it is now clear that these cells
contribute little to their own passage. The requirement for motility is confined
to the spermatozoon's journey through the female tract (Fig 3 a, b). This
process is initiated by the deposition of semen at ejaculation. In the rabbit,
cow, sheep, goat and primate, the insemination site is intra-vaginal. Thus, in
these species, the cervix presents the first barrier to sperm transport in the
female (Mortimer, 1978). This is the case particularly in ruminants and
primates, where copious quantities of cervical mucus exist (Katz and
Overstreet, 1980). Passage of spermatozoa through this mucus appears to
depend entirely upon their capacity for movement (Mortimer, 1978, 1983;
Hunter 1980; Aitken et al, 1985, 1986) even in the rabbit (Noyes et al, 1959),
where only small amounts of cervical mucus are found (Katz and Overstreet,
1980). However, the subsequent progress of spermatozoa into and through
the uterus probably depends more upon myometrial contraction than upon
sperm motility (Mortimer, 1978).
In the pig, dog, horse and rodent, the passage of semen through the
cervix is achieved at ejaculation (Blandau, 1945), and spermatozoa are
deposited almost directly into the uterus (Bedford, 1971; Mortimer, 1978). In
these species, the uterotubual junction constitutes the major barrier to sperm
transport through the female tract (Gaddum-Rosse, 1981), as passage
through the uterus itself is facilitated by the thorough mixing of semen and
uterine contents which follows mating in these species (Yamanaka and
Soderwall, 1960). As immotile spematozoa from rams, rabbits and hamsters
are capable of traversing the uterotubal junction (Setchell et al, 1969;
Lambiase and Amann, 1973; Cooper and Orgebin-Crist, 1975; Cummins,
1976; Voglmayr et al, 1978), it is thought that in these species the passage
of spermatozoa through this region is facilitated by movements of the female
tract (Hunter et al, 1983). However as immotile spermatozoa appear to be
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less efficient in completing this journey than fully motile cells (Orgebin-Crist,
1967a, 1968; Baker and Degen, 1972; Mortimer, 1977), a requirement for
sperm motility must exist. The failure of non-motile spermatozoa from bulls
and rats to enter the oviduct (Blandau and Rumery, 1964; Amann and Griel,
1974; Gaddum-Rosse, 1981) suggests that in these species, sperm transport
into this area relies more heavily upon self propulsion.
The average length of time required for capacitation in the majority of
species appears to lie somewhere between three and four hours (Hunter,
1987). However, the time span from mating at oestrus to the onset of
ovulation can be up to forty hours (Hunter and Dziuk, 1968; Hunter, 1980).
Thus, spermatozoa acummulate in the isthmus of the oviduct far in advance
of the arrival of the oocyte in the ampulla (Harper, 1973; Hunter et al, 1980;
Cummins and Yanagimachi, 1982). In order to maximise the efficiency of
fertilization, it appears that the distal portion of the oviducal isthmus has
evolved as a reservoir for spermatozoa (Hunter and Nichol, 1983).
Spermatozoa are stored in this area in an arrested, pre-capacitated state
during the pre-ovulatory interval (Hunter and Nichol, 1983; Hunter, 1984).
Spermatozoa resident in the isthmus are practically immotile (Overstreet and
Cooper, 1975; Cooper et al, 1979; Johnson et al, 1981; Suarez, 1987),
although motility can be re-established by dilution and incubation in media
or ampullary fluid (Overstreet et al, 1980; Johnson et al, 1981).
The ascent of spermatozoa to the ampulla appears to occur in two
phases; the first, rapid-transport phase follows immediately after coitus, with
spermatozoa being passively transfered to this site within minutes of
insemination. However, such spermatozoa are non-motile, and pass into the
peritoneal cavity prior to ovulation (Overstreet and Cooper, 1978). The
second phase appears to be coordinated so as to coincide with the onset of
ovulation (Harper, 1973a,b; Yanagimachi and Mahi, 1976; Shalgi and
Kraicer, 1978; Overstreet et al, 1978; Overstreet and Cooper, 1979;
Cummins and Yanagimachi, 1982). Although isthmic spermatozoa rarely
express hyperactivation (Cooper et al, 1979; Cummins, 1982), a large
percentage of spermatozoa exhibit hyperactivation in the ampulla
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(Cummins, 1982; Cummins and Yanagimachi, 1982; Suarez et al, 1983).
Spermatozoa may require to display this pattern of movement in order to
progress from the isthmus to the ampulla of the oviduct (Overstreet and
Cooper, 1979; Cummins, 1982; Cummins and Yanagimachi, 1982).
However, the means by which sperm ascent is synchronised with ovulation
is thought to depend upon passive aid from oviductal contractions (Battalia
and Yanagimachi, 1979), which change in amplitude and frequency at
ovulation (Salomy and Harper, 1971; Talo, 1974; Spilman, 1974). These, in
turn, are probably regulated by the changes in ovarian steroid secretion
which precede ovulation (Waterston and Mills, 1976).
The number of spermatozoa which actually reach the ampulla is very
low, with a sperm/egg ratio of approximately unity appearing normal
(Zamboni, 1972; Thibault, 1973; Shalgi and Kraicer, 1978; Cummins and
Yanagimachi, 1982). It would thus appear that spermatozoa are much more
efficient at fertilizing eggs in vivo than in vitro, where the number of sperm
required to fertilize eggs is considerably higher (Fraser and Drury, 1975;
Tsunoda and Chang, 1975; Siddiquey and Cohen, 1982). The reason for
this difference is thought to be due to the existence of a positive selection
procedure which operates upon spermatozoa as they pass through the
various barriers of the female tract (Krzanowska, 1974; Mortimer, 1977).
The expression of hyperactivation is closely correlated with fertilizing
potential (Fraser, 1981; Fleming and Yanagimachi, 1982). Although this
pattern of movement may incidentally allow spermatozoa to resist
confinement within mucosal folds (Suarez et al, 1983; Suarez and Osman,
1987), aid sperm transport to the ampulla (see above), and maximise the
chance for contact between spermatozoa and the egg mass (Katz et al,
1978), it is thought that the primary function of hyperactivated motility is to
increase the thrust generated by the flagellar beat (Katz et al, 1978;
Dresdner and Katz, 1981; Johnson et al, 1981), facilitating the passage of
spermatozoa through both the cumulus oophorus and the zona pellucida
(Katz et al. 1986).
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D. Mechanisms by which spermatozoa acquire the capacity for
movement
As detailed above, during their normal life cycle, mammalian
spermatozoa may experience up to four transitional states with respect to
their capacity for movement; The acquisition during epididymal maturation of
the potential for coordinated, progressive movement, the expression of this
ability upon ejaculation in those species in which epididymal spermatozoa
are quiescent, the suppression of this motility during storage in the isthmus,
and the expression of hyperactivated motility in the female genital tract.
Elucidation of the mechanisms involved in these transformations, apart from
providing the answers to fundamental biological questions, would be an
important achievement for two diametrically opposed reasons. Firstly, this
information would provide insights into naturally occutfing
asthenozoospermia, allowing the development of rational forms of treatment
for such cases of male infertility. Secondly, knowledge of the mechanisms by
which spermatozoa acquire the capacity for movement should be of strategic
importance in the development of male contraceptive agents (Prasad et al,
1973; Hinton 1980; de Kretser, 1980; Fraser, 1982).
i. Energy metabolism in the epididymis. Sperm movement is
generated by the active sliding of the axonemal doublets, which are situated
longitudinally throughout the flagellum (Afzelius, 1959; Satir, 1968, 1974,
1979). The motility of demembranated spermatozoa depends upon the
presence of ATP in the reactivation media (Morton, 1973; Rikmenspoel et al,
1978; Mohri and Yanagimachi, 1980; Yeung 1984, 1986), and this
movement can be inhibited by selectively blocking dynein ATPase activity
(Kobayashi et al, 1978; Bouchard et al, 1981), implying that the power for
flagellar motion comes from the hydrolysis of adenosine triphosphate by
ATPases on the dynein arms (Gibbons and Rowe, 1965). The ATP required
for ATPase activity can be generated by both anaerobic glycolysis, utilizing
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either glucose or fructose as a substrate, or respiration coupled with
oxidative phosphorylation in the mitochondria (Rikmenspoel 1965;
Rikmenspoel et al, 1969; Mann, 1983). However, different species place
emphasis on different processes. For instance, glycolysis provides the major
energy source for human sperm motility (Peterson and Freund, 1968; Hong
et al, 1983), whereas motility in hamster and bull spermatozoa appears to
depend primarily upon respiration (Fischer-Fischbein et al, 1985; Inskeep
and Hammerstedt, 1985).
The rates of both glycolysis and respiration are lower in testicular than
in ejaculated spermatozoa from the boar and ram (Dacheux et al, 1979;
Dacheux and Paquignon, 1980; Hammerstedt, 1981; Inskeep and
Hammerstedt, 1982), as is glucose consumption in guinea pig and bovine
spermatozoa (Frenkel et al, 1973a, b; Hoskins et al, 1975a). However, the
consumption of this substrate by rat spermatozoa does not appear to change
during epididymal maturation (Paz et al, 1978). Levels of glyceraldehyde 3-
phosphate dehydrogenase (GPD), which may be the rate limiting enzyme in
sperm glycolysis (Hoskins et al, 1971; Hoskins et al, 1975a), increase in
guinea pig and mouse spermatozoa as they pass from the caput to the
corpus epididymis (Ford and Harrison, 1983), parallelling the acquisition of
the potential for fertility and motility (Shilon et al, 1978; Williamson et al,
1980). In contrast, GPD activity in rat and hamster spermatozoa has been
shown to decrease during epididymal maturation (Ford and Harrison, 1983).
However, this enzyme may not play such an important role in these species,
as glycolytic flux remains low when spermatozoa from these animals are
incubated under aerobic conditions (Ford et al, 1979). Measurements of the
other glycolytic enzymes have failed to reveal any clear patterns of change
accompanying epididymal maturation (Terner et al, 1975; Hammerstedt
1975; Mongkolsirikieat and Boonsaeng, 1980).
Of all the possible energy substrates for epididymal spermatozoa,
probably the most intensively studied has been carnitine. Increases in both
the luminal fluid (Brooks et al, 1973, 1974; Hinton et al, 1979b; Casillas et al,
1984; Besangon et al, 1985) and spermatozoal (Casillas, 1973; Casillas and
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Chaipayungpan, 1979; Inskeep and Hammerstedt, 1982) concentration of
carnitine accompany epididymal transit. Immotile spermatozoa from the
caput epididymis can be induced to express non-progressive movement if
incubated in the presence of concentrations of carnitine which are found in
the more distal portions of the epididymis (Hinton et al, 1981; Klinefelter and
Hamilton, 1984). Furthermore both carnitine and acetylcarnitine stimulate
sperm movement (Tanphaichitr, 1977), and the motility of mature
spermatozoa is related to their carnitine content (Johansen and Bohmer,
1979). As the motility of mature spermatozoa incubated in substrate free
media is reduced, in parallel with a decline in pyruvate oxidation, by high
concentrations of carnitine, but restored on the re-addition of substrate
(Turner and Giles, 1981), it has been suggested that the main role of
carnitine in spermatozoa is to provide substrate as acetylcarnitine.
Exogenously added acetylcarnitine can be metabolised by spermatozoa
(Storey and Keyhani, 1974; Hutson et al, 1977; Storey, 1980; Day-
Francesconi and Casillas, 1982), and it has been shown that the
acetylcarnitine/carnitine ratio is positively correlated with the motility of
human spermatozoa (Golan et al, 1984). However, exogenous carnitine
does not promote respiration in either immature (Casillas, 1973), or mature
(Casillas, 1973; Johansen and Bohmer, 1978) spermatozoa, nor does it
stimulate ATP production in caput cells from the ram, whilst it does so in
mature spermatozoa (Inskeep and Hammerstedt, 1982). It would thus seem
that carnitine, although related to the acquisition of motility within the
epididymis, is not a primary factor in this process.
Analysis of the literature reveals conflicting evidence concerning the
effects of epididymal transit on the ATP content of spermatozoa.
Concentrations of this nucleotide have been reported to increase
(Chulavatnatol et al, 1977), or to remain constant (Ke and Tso, 1982) in rat
spermatozoa; to rise in spermatozoa from the bull (Hoskins et al, 1975a), or
to fall in the guinea pig and ram (Frenkel et al, 1973; Voglymayr, 1976).
However, determination of the total cell content of ATP does not take into
account possible changes in the sub-cellular distribution of this molecule.
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The total ATPase activity expressed by spermatozoa has been found to
decrease during their epididymal transit in rats (Chulavatnatol and Yindepit,
1976; Chulavatnatol et al, 1977; Majumder, 1981). In contrast, ATPase
activity in both whole spermatozoa and isolated tails is known to increase
during epididymal maturation in the ram (Voglmayr et al, 1969). However,
the relationship between measurements of total ATPase activity and dynein
ATPase activity is unknown.
ii. Protein carboxvmethvlation in the epidivmis. Protein carboxyl-
methylase (PCM) transfers methyl groups from S-adenosyl-L-methionine to
the carboxyl groups of glutamate and aspartate residues in methyl acceptor
proteins (MAP) (Liss et al, 1969; Morin and Liss, 1973; Paik and Kim, 1980).
Protein methylesterase (PME) hydrolyses the methyl ester bonds formed by
PCM to yield methanol and the protein in its original, pre-methylation form
(Stock and Koshland, 1978; Gagnon, 1979). This process of carboxy-
methylation and demethylation is known to be involved in the control of
flagellar movement in bacteria (Kort et al, 1975). The observation that
carboxy-methylation of proteins was deficient in patients suffering from
asthenozoospermia (Gagnon et al, 1980a; 1982), and that inhibitors of PCM
activity, known to be localised in the sperm flagellum (Bouchard et al, 1980;
Purvis et al, 1982), blocked sperm motility (Bouchard et al, 1981; Goh and
Hoskins, 1985), suggest an involvement for this enzyme in the control of
sperm movement (Gagnon et al, 1979, 1982). The increase in PCM activity
and MAP capacity (Bouchard et al, 1980; Purvis et al, 1982), and the
decrease in PME activity (Gagnon et al, 1984) which accompany
epididymal maturation in the rat and bull further supports this theory.
However, the reason why an increase in the methyl ester content of sperm
proteins during epididymal maturation should increase motility is unkown,
although effects on membrane fluidity (Hirata and Axelrod, 1978; Gagnon
and Heisler, 1979) or calmodulin (Gagnon et al, 1980b) may be involved.
Protein carboxy-methylation also increases dramatically during the
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capacitation of hamster spermatozoa (Castaneda et al, 1983), and inhibition
of this process significantly depressed the expression of hyperactivation
(Llanos and Meizel, 1983), although without any apparent effect on
percentage motility (Meizel, 1981; Llanos and Meizel, 1983).
iii. Protein phosphorylation in the epididymis.
a. Effects on mature sperm motility. Of all the compounds which have
been linked with the spermatozoon's capacity for movement, possibly the
most intensively studied has been cyclic adenosine 3',5' monophosphate
(cAMP). The first evidence for an involvement of this agent in the control of
sperm movement came from experiments which utilized methyl xanthines,
particularly caffeine (1,3,7-trimethyl-2,6-dioxypurine), known to specifically
inhibit the enzyme responible for cAMP's degradation, cyclic nucleotide
phosphodiesterase (Butcher and Sutherland, 1962; Beavo et al, 1970).
Using this experimental approach, it was shown that caffeine could stimulate
the motility and respiration of caudal epididymal (Drevius, 1971, 1972;
Garbers et al, 1971a; Hoskins, 1973) and ejaculated (Garbers et al, 1971b)
spermatozoa from the bull, in association with the elevation of intracellular
cAMP levels (Garbers et al, 1973a). Ejaculated human spermatozoa were
also found to respond to caffeine in a similar manner (Bunge, 1973;
Haesungcharern and Chulavatnatol, 1973; Schoenfeld et al, 1973, 1975;
Homonnai et al, 1976; Chang and Boettcher, 1981). Other methylxanthine
phosphodieterase inhibitors such as theophylline, aminophylline and
pentoxifylline (Garbers et al, 1971a; Haesungcharern and Chulavatnatol,
1973; De Turner et al, 1978) and dibutryl cAMP (dbcAMP)(Garbers et al,
1971a), a membrane permeant analogue of cAMP, also increase the rates of
respiration and motility in spermatozoa. In addition to the bull and the
human, it has now been shown that the motility of spermatozoa from the pig
(Garbers et al, 1973b) guinea pig (Frenkel et al, 1973b), hamster (Morton et
al, 1974; Kann and Serres, 1980) and rat (Wyker and Howards, 1977; Paz et
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al, 1978) is enhanced by treatment with phosphodiesterase inhibitors.
As human sperm metabolism was known to rely predominantly upon
glycolysis (Peterson and Freund, 1968), and as this process was known to
be greatly affected by cAMP (Hicks et al, 1972), it was thought that the effect
of cAMP on motility may involve an increase in energy production by
accelerating glycolysis and the tricarboxylic acid cycle (Haesungcharern
and Chulavatnatol, 1973; Schoenfeld et al, 1975). However, since
compounds like caffeine and theophylline affect other enzymes in addition to
phosphodiesterase (Robison et al, 1971), it could not be conclusively
demonstrated that these reagents were stimulating sperm motility by
increasing cAMP content. Indeed, it has since been shown that caffeine
stimulated motility in detergent treated bovine spermatozoa is not
accompanied by an increase in cAMP dependant protein kinase activity
(Tamblyn and First, 1977), and that the concentration of caffeine required to
stimulate motility does not dramatically inhibit phosphodiesterase activity
(Levin et al, 1981). Such results suggest that this particular compound was
affecting sperm motility by means other than by the inhibition of
phosphodiesterase activity.
More conclusive evidence was required to unequivocally link cAMP to
sperm motility. To a certain extent, such evidence was provided by the
demonstration that reversible inhibition of sperm motility, such as is
produced upon slow cooling and rewarming, reversibly reduced the cAMP
content of spermatozoa (Tash and Mann, 1973), whereas conditions which
ireversibly inhibit motility, such as severe cold shock, produced irreversible
reductions in cAMP levels (Tash and Mann, 1973; Chaudhry and Anand,
1975; Cascieri et al, 1976). Better evidence was provided by experiments in
which cAMP was added to ATP reactivated, detergent lysed bovine sperm
models. Such treatment produced measurable increases in both beat
frequency and the proportion of motile cells (Lindemann, 1978), whilst
demembranated trout and rat spermatozoa failed to initiate motility in the
absence of cAMP (Morisawa and Okuno, 1982; Treetipasatit and
Chulavatnatol, 1982). Further proof for the involvement of cAMP in the
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capacity for movement were obtained from studies of the epididymal
development of sperm motility as detailed below.
b. Involvement with epididymal acquisition of the capacity for
movement. The acquisition of sperm motility in the epididymis was first
linked to cAMP when the amount of this nucleotide present in spermatozoa
was found to increase during epididymal transit (Hoskins et al, 1974). A
direct causal relationship was thought to exist between the cAMP content of
spermatozoa and their capacity for movement when it was found that
treatment with phosphodiesterase inhibitors induced non-progressive
flagellar movement in previously immotile spermatozoa from the bovine
caput epididymis (Hoskins et al, 1975b). This motion could be converted into
progressive motility by the addition of forward motility protein (see above).
However, testicular spermatozoa from the ram (Hammerstedt and Hay,
1980) and bull (Cascieri et al, 1976) did not show an increase in motility in
response to elevations of their cAMP content, implying that in these species
the ability to respond to cAMP also develops during epididymal maturation.
This may involve protein kinase activity, which is known to increase in
bovine spermatozoa as they progress through the epididymis (Hoskins et al,
1974; Pariset et al, 1985). A similar increase in cAMP content was reported
for ram spermatozoa (Amann et al, 1982), although a subsequent study has
failed to support this finding (Pariset et al, 1985). In the rat, however, a
decrease in cAMP content has been reported to accompany epididymal
maturation (Del Rio and Raisman, 1978).
E. Mechanisms for the suppression of sperm motility
Morton et al, (1974) reported that the initiation of hamster caudal
sperm motility in response to dilution was dependant upon the presence of
calcium within the media. Calcium's effects on motility were thought to be
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due to a stimulation of adenylate cyclase activity, as the cAMP content of
these spermatozoa rose rapidly in response to dilution. This group
postulated that these spermatozoa were maintained in an immotile condition
during storage in the cauda epididymis via the action of a
phosphodiesterase present in caudal epididymal fluid (CEF), which kept
their endogenous cAMP content low. A similar increase in cAMP content
was reported to accompany dilution of bovine spermatozoa and to precede
the expression of movement by these cells (Cascieri et al, 1976), although
motility initiation in this species did not require the presence of calcium. In
the light of this and a subsequent study which showed that the dilution of
rabbit caudal epididymal spermatozoa in aerated saline was sufficient to
initiate motility (Storey, 1975), Morton et al (1978) forwarded the hypothesis
that the degree of motility expressed within the epididymis of different
species was related to the free calcium content of the epididymal plasma,
and that an inverse relationship existed between the free calcium content of
CEF and the extent to which sperm motility could be induced by calcium.
However, it has since been shown that the induction of motility in
spermatozoa from rats (Turner and Howards, 1978; Chulavatnatol, 1982;
Usselman and Cone, 1983; Turner and Reich, 1985) and hamsters (Turner
and Reich, 1985), both of which should have the strongest calcium
requirement for motility initiation according to the theory of Morton et al
(1978), was not dependant upon the presence of this cation.
Following the observation that dilution of bovine CES in CEF was
sufficient to initiate progressive motility (Cascieri et al, 1976), this group
proposed that CEF from this species did not contain a motility inhibiting
factor, but that the partial quiescence enforced upon these cells whilst
resident in the male tract was due to cell/cell contact. However, later studies
did not confirm these findings (Carr and Acott, 1984; Acott and Carr, 1984).
Carnitine and glycerophosphorylcholine, both of which are present in
CEF (Brooks et al, 1974; Hinton and Setchell, 1980a,b; Casillas, 1973;
Frenkel et al, 1974), have also been implicated as the motility inhibitor in
epididymal fluid, although in these cases also, further investigations failed to
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substantiate these claims (Turner et al, 1978; Turner and Giles, 1981; Hinton
et al, 1981).
Two contrasting methods for maintaining sperm quiesence have been
identified and verified for spermatozoa of different species. Following the
demonstration that the dilution of rat CES in rat CEF did not result in the
induction of motility (Turner and Flowards, 1978), it was further shown that
the sperm-immobilising capacity of rat CEF was abolished following
treatment with proteases (Turner and Giles, 1982), indicating that an
epididymal protein was required for inhibition of motility. These findings
were confirmed and extended by Usselman and Cone (1983), who isolated
a high molecular weight, mucus-like glycoprotein from rat CEF, which they
named "Immobilin". They hypothesised that this molecule inhibited
epididymal sperm movement mechanically, via the creation of a highly
viscoelastic environment. A similar situation has been found to exist in the
hamster (Turner and Reich, 1985). However, in the bull, although vigorous
motility is initiated in a wide variety of ionic and non-ionic, osmotically-
balanced buffers (Carr and Acott, 1984), CEF from this species has a low
viscoelasticity. Following the observation that the pH of bovine CEF is 5.8
(Acott and Carr, 1984), it was proposed that the inhibition of CES motility in
this species was due to a pH-dependant factor present in CEF (Acott and
Carr, 1984). A similar mechanism appears to operate in the dog (Carr et al,
1985). However, CES from the guinea pig and the human, which have
neither viscoelastic nor acidic CEF, are immotile whilst in the cauda
epididymis and show no specific ionic requirement for the initiation of moility
(Turner and Reich, 1985; Carr et al, 1985). The mechanism by which
spermatozoa from these species are maintained in a quiesence^state
remains to be elucidated.
The quiescence of spematozoa in the isthmus of the oviduct may be
enforced by a putative molecular motility inhibitor (Suarez 1987), or by local
chemical or temperature differences in this region of the female tract (Hunter
and Nichol, 1986). The possibility exists that the storage function of the distal
Mullerian duct (oviduct isthmus, and the distal Wolffian. duct (cauda
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epididymis) may have a common physiological basis (Hunter and Nichol,
1983, 1986; Suarez, 1987).
F. Mechanisms for the generation of hyperactivated motility
Little is known of the mechanisms by which spermatozoa begin
hyperactivated motility. Lectin studies have revealed changes in the
exposed carbohydrates on the flagellar membrane during capacitation
(Kinsey and Koehler, 1978; Talbot and Chacon, 1981; Ahuja, 1984, 1985),
whilst Koehler and Gaddum-Rosse (1975) and Friend et al (1977) have
reported changes in the pattern of distribution of intramembranous particles
in the plasma membrane overlying the midpiece prior to the expression of
hyperactivated motility by guinea pig spermatozoa. The significance of these
changes are unknown, although they may indicate alterations in ion fluxes
across the membrane, as a specialised region of intramembranous particles
(the"zipper") is thought to be a site of ion exchange (Friend and Heuser,
1981). Furthermore, both sperm motility and particle dispersion are inhibited
by cyanide (Friend, 1977), although in view of the pernicious nature of this
compound, these effects may only be coincidental. The stimulation of
hyperactivation by membrane active agents (Yanagimachi, 1975) and
lysophospholipids (Fleming and Yanagimachi, 1981), and the inhibition of
this movement pattern by phospholipase blockers (Llanos and Meizel,
1983) further suggests the involvement of membrane changes in the
induction of hyperactivated motility.
The expression of hyperactivated motility by intact spermatozoa is
known to depend upon the presence of calcium (Yanagimachi and Usui,
1974, Fraser, 1977, Shams-Borhan and Harrison, 1981; Yanagimachi,
1982), and in the mouse at least, glucose (Fraser and Quinn, 1980; Cooper,
1984). Cyclic AMP has also been implicated in the induction of
hyperactivation, as both caffeine and dibutryl cAMP advance its onset in
mouse and hamster spermatozoa (Fraser, 1977, 1981; Mrsny and Meizel,
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1980)
The observation that detergent permeabilised hamster, guinea pig
and human spermatozoa express hyperactivated motility immediately upon
reactivation with ATP alone (Mohri and Yanagimachi, 1980), suggests that
the appearance of this flagellar waveform is actively suppressed in
uncapacitated spermatozoa. Furthermore, spermatozoa from the proximal
cauda epididymis of the hamster express hyperactivation immediately upon
dilution (S Suarez, personal communication), suggesting that some factor in
the plasma from the distal cauda epididymis prevents spermatozoa from
expressing hyperactivation.
G. Aim of this study
In view of the evidence sited above, it appears that cAMP may play a
pivotal role in the acquisition of the capacity for movement which occurs
during epididymal maturation, in the initiation of motility upon ejaculation,
and in the post-ejaculatory modifications of sperm-movement which occur
during capacitation in the female genital tract. This study sets out to
investigate the involvement of cAMP in these post-testicular modifications of
sperm movement using the hamster as an animal model.
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Chapter 2. The influence of epididymal maturation on the cAMP
levels in hamster and rat spermatozoa.
A. Introduction.
Mammalian spermatozoa isolated from the rete testis show only
uncoordinated twitching movements upon dilution. The ability to initiate
progressive motility is gradually attained during passage through the caput
and corpus epididymis, and spermatozoa which have completed epididymal
maturation are then stored in a quiescent state in the cauda epididymis prior
to release at ejaculation, at which time vigorous motility is expressed.
The exact biochemical mechanisms involved in the development and
expression of sperm motility remain unknown. However, a pivotal role has
been implicated for cyclic 3',5'-adenosine monophosphate (cAMP). The
motility of mature spermatozoa is enhanced by treatment with
phosphodiesterase inhibitors, membrane permeant analogues of cAMP and
stimulators of adenylate cyclase (Garbers and Kopf, 1980; Tash and Means,
1983; Vijayaraghavan and Hoskins, 1986; Aitken et al, 1986), whilst the
flagellar beat of both mature and immature detergent-permeabilized, ATP-
reactivated spermatozoa is stimulated by the addition of cAMP to the
reactivation medium (Lindemann, 1978; Mohri and Yanagimachi, 1980;
Treetipasatit and Chulavatnatol, 1982; Tash and Means, 1982; Yeung,
1984). In the bull (Hoskins et al, 1974), and the ram (Amann et al, 1982), the
development of the potential for movement which occurs during epididymal
passage is correlated with a rise in sperm cAMP levels. Furthermore,
coordinated flagellar movement can be induced in intact caput spermatozoa
by treatment with phosphodiesterase inhibitors (Hoskins et al, 1975b; Kann
and Serres, 1980). In addition, several groups have proposed that the
of
initiationYmotility which occurs upon dilution of caudal spermatozoa is
mediated by an increase in cAMP levels (Morton et al, 1974; Cascieri et al,
1976; Okumura et al, 1985). Coupled with the observation that the
expression of flagellar movement in a number of different motile systems is
known to require the cAMP-dependant phosphorylation of a 56 Kd
axonemal protein named axokinin (Tash et al, 1984), the hypothesis that an
increase in cAMP levels during epididymal maturation may be directly
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involved in the acquisition of sperm movement is attractive. However,
preliminary observations in the rat have shown that epididymal transit in this
species is accompanied by a decrease in sperm cAMP content (Del Rio and
Raisman, 1978). In the light of this discrepancy, this study has analysed the
effects of epididymal maturation on the cAMP content of rat and hamster
spermatozoa.
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B. Materials and Methods.
i. Media. The basic medium used throughout this study was a
modified Tyrodes solution (MT-1). This contained 125mM NaCI, 2.7mM KCI,
1,8mM CaCl2, 0.5mM MgCl2, 0.36mM NaH2P04, 11.9mM NaHCC>3, 4.5mM
glucose, 0.09mM pyruvate, 8.9mM sodium lactate, 0.5mM taurine, and
3mg/ml bovine serum albumin (BSA-RIA grade); 1.0ml penicillin
streptomycin (Difco laboratories, Detroit, Michigan, U.S.A.) was added to
each 100ml of media. Additional NaCI was added to MT-1 containing no
added calcium (NAC) in order to maintain constant osmolarity (approx. 290
mOsm). Under such circumstances, the free calcium concentration of this
medium was determined to be 10 pM (measured using a calibrated Orion
calcium-sensitive electrode).
Rat spermatozoa were incubated in the medium used by Toyoda and
Chang (1974). This contained 94.6mM NaCI, 4.78mM KCI, 1.71mM CaCI,
1.19mM KH2PO4, 1.19mM MgS04 and 25.07mM NaHC03, to which
21.58mM sodium lactate, 0.5mM sodium pyruvate, 5.56 mM glucose, 4mg/ml
BSA were added; Each 100ml of media was treated with 1.0ml penicillin-
streptomycin.
For media preparation, inorganic salts were dissolved in double
distilled water and stored in a refrigerator. Phenol red (100pl, 0.5% solution -
Flow laboratories, Irvine, Scotland) was added to these stock solutions as a
pH indicator. The other components were dissolved in this stock immediately
prior to use, with fresh media being made up each day. Medium MT-1 was
equilibrated by bubbling 5% CO2 in air through it prior to the addition of
BSA. All incubations were performed at 37°C in an atmosphere of 5%
CC>2:95% air. Unless otherwise indicated, biochemicals were obtained from
either Sigma (Dorset, UK) or BDH (Glasgow, UK).
ii. Isolation of Spermatozoa. Adult male Golden Syrian hamsters (<
100g) were asphyxiated using CO2 and killed by cervical dislocation. Their
- 35 -
epididymides were quickly excised and separated into caput and caudal
regions. These organs were then transferred to moist filter paper on a warm
stage maintained at 37°C, where adherent adipose tissue was removed.
Organs were blotted dry prior to isolation of spermatozoa. Caput
epididymides were punctured in the proximal portion (site 2 - Hinton et al,
1979a) by several passes of a #26 guage needle and spermatozoa isolated
by gentle compression using broad tipped forceps. Caudal epididymal
spermatozoa were extruded under positive pressure from the cut ends of 2
or 3 exposed tubules from the distal portion (site 7 - Hinton et al, 1979) of
this organ.
For experiments requiring undiluted cells (To determinations),
spermatozoa were drawn into 20|il microcapillary tubes (Drummond
Scientific, Pennsylvania, U.S.A.). These were plugged at one end with
critaseal (Hawksley & Sons LTD, Sussex, England) and centrifuged at 200g
for 5 mins. After centrifugation, the height of the sample within the tube was
carefully measured and compared to known values for packed sperm
density in these tubes. These values were pre-determined for the different
cell types by expressing measured "lengths" of spermatozoa into a known
volume of media and estimating the sperm density using an improved
Neubauer haemocytometer chamber. With the knowledge that a 1cm length
of these 20pl microcapillary tubes contains a volume of 2.94jil, the following
values were obtained:
Hamster caput fluid sperm density = 3.12 x 106/cm = 1.06 x 106/pl.
Hamster cauda fluid sperm density = 3.12 x 106/cm = 1.06 x 106/p.l.
Rat caput fluid sperm density = 1.59 x 106/cm = 5.41 x 105/pl.
Rat cauda fluid sperm density = 3.70 x 106/cm = 1.26 x 106/p.l.
These values are in close agreement with those determined in
previous studies for the hamster (Jesse and Howards, 1976) and rat (Turner
et al, 1977, 1984; Turner and Cesarini 1983; Turner, 1984).
For experiments performed on diluted spermatozoa, epididymides
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were prepared as above, then placed under pre-warmed and CO;
equilibrated liquid paraffin in plastic tissue culture dishes (60x15mm, Becton
Dickinson, NJ, USA) on a binocular microscope stage maintained at a
temperature of 37°C. The spermatozoa were extruded as detailed above,
then gently eased across the dish into a 0.5ml (caput) or 1.0ml (cauda)
droplet of medium, using a preformed hooked rod fashioned from an
extruded glass pasteur pipette. This dilution event was defined as To.
Spermatozoa were then dispersed by gentle agitation of the petri dish. After
even dispersion had occured (approx. 1 min), a 1 OjllI sample was removed
and counted using a haemocytometer chamber. The concentration of
spermatozoa was then adjusted to the required density by appropriate
dilution. The accuracy of this adjustment was checked by determining the
cell concentration after dilution. Preparations of caput spermatozoa were
determined to contain less than 1% contamination with other cell types,
whilst incubations of caudal spermatozoa were adjudged to be pure.
iii. Cyclic AMP Extraction.
a. Undiluted spermatozoa. For undiluted samples, the microcapillary
tubes containing the spermatozoa were broken at one end after mensuration
and the contents extruded into 500|il of ice cold ethanol (Aitken et al, 1986).
Spermatozoa treated in this manner tended to clump into globules rather
than to disperse freely throughout the liquid. In order to check whether
efficient extraction of cAMP was being achieved, especially from cells in the
centre of a clump, several samples were split and either extracted as normal,
or homogenised in a 0.1ml Uni-Form hand held homogeniser (Jencons Ltd,
Leighton Buzzard, UK). No significant difference was found between the
cAMP content measured by these different methods, and it was thus felt
unneccesary to homogenise undiluted spermatozoa during cAMP extraction.
Extraction procedures following immersion in ethanol were as detailed
below for diluted spermatozoa.
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b. Diluted spermatozoa. For incubations performed at 20x106/ml, two
50(il aliquots were removed at various time intervals and placed
immediately into 500pl of ice cold ethanol. For experiments utilising
spermatozoa at a density of 1x106/ml, three 1.0ml samples were removed
from the incubation and centrifuged at 250g for 5 min. After removal of the
supernatant, two of the pellets were resuspended in ethanol, whilst the third
was resuspended in 950pl of media. The density of spermatozoa in this tube
was then determined to account for losses during centrifugation.
After 20 mins in ethanol, cellular material was separated by
centrifugation (2000g, 10 min) and the supernatant decanted into flat
bottomed glass tubes and dried down under a stream of nitrogen at 40°C.
The residue was reconstituted in 500pl of the assay buffer {Phosphate
buffered saline (PBS), 0.01 mM, pH7.4} and stored at -17°c until assayed.
iv. Cyclic AMP Determination. The cAMP content of the extracted
samples was assessed according to the method of Steiner et al (1972) as
modified by Flarper & Brooker (1975). 100pJ duplicates from each sample
were treated with 5pl of freshly prepared acetylating reagents (2.7 parts
triethylamine: 1 part acetic anhydride), mixed and incubated at room
temperature for 1h. Subsequently, 10Opil antiserum (1:70 000 dilution made
up in assay buffer containing 0.3% bovine gamma globulin) raised against a
conjugate of human serum albumin and succinyl cyclic AMP (Steiner et al.,
1972), and 10Opil (30000 cpm) l25|-2'0-succinyl cAMP-tyrosine methyl ester
tracer (Sigma Chemical Co, St Louis, MO, U.S.A.) were added to each tube
and incubated for 16 h at 4°C; cAMP standards (0-2500 fmol) were treated in
precisely the same way. The bound complexes were precipitated by the
addition of 1.6ml of ice cold 17% (w/v) polyethylene glycol, separated by
centrifugation (2000g for 30 min at 4°C) and the radioactivity associated with
the pellets counted using a Nuclear Enterprises 1600 multihead gamma
counter. The amount of cAMP present in each sample was calculated by
computer, relative to a log-logit standard curve constructed for each assay,
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and expressed as pmol per 109 spermatozoa. The cross reactivities of the
antibody used in these assays are: cAMP, 100%; cGMP, 0.0035%; AMP,
0.0005%; ADP, 0.00045%; ATP, 0.00069%; GTP, 0.0005%; isobutyl methyl
xanthine, 0.00001%. Media blanks did not cross react in this assay. The intra
- and inter-assay coefficients of variation were 6.3% and 14.5% respectively.
v. Statistics. All statistical comparisons were made using the non-
parametric Mann-Whitney U test. Unless otherwise indicated, values shown




Figure 4. Cyclic AMP content (picomoles cAMP per 109 spermatozoa)
expressed by spermatozoa from the hamster caput (open squares) or cauda
(closed squares) epididymis incubated over a 3h period in medium MT-1 at
a density of 20x106/ml. Significance levels are: *, P<0.05; **,P<0.01. Values




a. Basal levels in undiluted spermatozoa. Whilst still in the fluid
environment of the epididymis, hamster caput spermatozoa were found to
contain significantly (P<0.01) greater amounts of cAMP than caudal
spermatozoa {597.4 ± 81.0 (n=9) vs 56.0 ± 6.2 (n=14) pmol cAMP/109
spermatozoa (mean ± s.e.m.)}. Similarly, spermatozoa isolated, without
dilution, from the caput epididymis of the rat were found to contain
significantly (P<0.01) greater amounts of cAMP than caudal cells {176.5 ±
26.0 (n=11) vs 44.1 ±11.3 (n=11) pmol cAMP/109 spermatozoa (mean ±
sem)}
b. Response to dilution at 20x106/ml.
1. In complete medium (MT-1).
A. Hamster. Spermatozoa from both the caput and cauda epididymis
exhibit an initial rapid increase in cyclic AMP content in response to dilution
in MT-1 at a density adjusted to 20x106/ml. However, this increase is not
identical for both cell types, as the cAMP content of caput spermatozoa is
elevated to significantly (P<0.01) higher levels than that of caudal
spermatozoa. The cAMP content of spermatozoa from both these regions of
the epididymis subsequently decayed over time, such that after 150min of
incubation, the cAMP content of caput and caudal cells was not significantly
different (Fig 4.)
B. Rat. Rat spermatozoa from both the caput and cauda epididymis
exhibited a rapid increase in cAMP content upon dilution into T&C at a
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Figure 5. Cyclic AMP content (picomoles cAMP per 109 spermatozoa)
expressed by spermatozoa from the rat caput (open squares) or cauda
(closed squares) epididymis incubated over a 60min period in medium T&C
at a density of 20x106/ml. Significance levels are: **, P<0.01. Values shown




Figure 6. Cyclic AMP content (picomoles cAMP per 109 spermatozoa)
expressed by spermatozoa from the hamster caput (a), or cauda (b)
epididymis incubated over a 60min period at a density of 20x106/ml in
medium MT-1 (open squares), or medium NAC (closed squares).
Significance levels are: *, P<0.05; **, P<0.01. Values shown are mean ±
standard error, n=6.
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spermatozoa from the hamster (see above). Caput spermatozoa expressed
significantly (P<0.01) higher levels of cAMP than spermatozoa from the
cauda epididymis (Fig 5). The cAMP content of both caput and caudal cells
subsequently decreased after this initial peak, but after 60mins of incubation,
caput levels were still significantly (P<0.01) greater than in caudal
spermatozoa. At this time point, the cAMP content of both cell types were
also still significantly (P<0.01) greater than in undiluted spermatozoa.
For further characterization of the increases in cAMP content detailed
above, it was decide to utilize the hamster as an animal model. The results
detailed hereafter thus refer only to spermatozoa from this species.
2. In medium NAC. Release of caput spermatozoa from the hamster
into medium MT-1 devoid of exogenously added calcium (NAC), at a cell
concentration adjusted to 20x106/ml, caused a significant inhibition (P<0.01)
of the rise in cAMP levels observed upon dilution into complete medium MT-
1 (Fig 6a). However, a statistically significant (P<0.05) increase in cAMP
content over the levels in undiluted spermatozoa was still apparent. In
contrast, the rise that accompanied dilution of caudal spermatozoa into MT-1
was completely abolished by release into NAC (Fig 6b).
The reduction of cAMP levels which resulted from the removal of
exogenously added calcium from the media could result from either an
inhibition of the synthesis, or enhancement of the degradation of cAMP. To
r
determine which of these possibilities was occuring, both caput and caudal
spermatozoa were incubated in either medium MT-1, or medium NAC in the
presence or absence of the phosphodiesterase inhibitor 3-isobutyl-1-methyl-
xanthine (IBMX) at a concentration of 0.2mM. This reagent caused a
significant (P<0.01) stimulation of the cAMP levels in both caput and caudal
spermatozoa, regardless of the calcium content of the media. However, the
levels expressed following this treatment with IBMX were significantly









































Figure 7. Cyclic AMP content (picomoles cAMP per 109 spermatozoa)
expressed by spermatozoa from the hamster caput (I), or cauda (II)
epididymis incubated for 20mins at a density of 20x106/ml in: medium MT-1
(open bars), medium MT-1 plus 0.2mM IBMX (lined bars), medium NAC
(dotted bars), or medium NAC plus 0.2mM IBMX (solid bars). Treatment
groups bearing the same letter are significantly (P<0.01) different. Values





Figure 8. Cyclic AMP content (picomoles cAMP per 109 spermatozoa)
expressed by spermatozoa from the hamster caput (a), or cauda (b)
epididymis incubated over a 60min period at a density of 20x106/ml in
medium MT-1 (open squares), or medium MT-1 plus 0.5pM calmidazolium
(closed squares). Significance levels are: *, P<0.05. Values shown are




Figure 9. Cyclic AMP content (picomoles cAMP per 109 spermatozoa)
expressed by spermatozoa from the hamster cauda epididymis, at a density
of 20x106/ml, pre-incubated (PI) for 10mins in either medium NAC (closed
squares), or medium NAC plus 0.5pM calmidzolium (open diamonds), then
centrifuged and resuspended (C&R) in; medium NAC (open squares),
medium MT-1 (closed squares), or medium MT-1 plus 0.5|iM calmidzolium
(open diamonds) for a final incubation (Fl) period of 30mins. Significance
levels are: *, P<0.05. Values shown are mean ± standard error, n=6.
- 47-
3. In the presence of calmodulin inhibitor. In view of previous
observations which reported that increases in the cAMP content of guinea
pig spermatozoa were dependant upon the action of calmodulin (Hyne and
Garbers, 1979a), it was decided to determine whether the calcium
dependant rise in cAMP levels observed upon dilution in spermatozoa from
the hamster caput and cauda epididymis was mediated by this calcium
binding protein. This was achieved using the calmodulin antagonist,
calmidazolium (CZ, compound R 24571), at a concentration of 0.5|iM, known
to be optimal for the inhibition of other calmodulin dependant enzymes
(Geitzen et al, 1982).
In contrast to our expectations, when calcium and CZ were presented
to spermatozoa simultaneously, by releasing the cells directly into MT-1,
both caput and caudal spermatozoa exhibited an increase in cAMP content,
although this rise was significant (P<0.05) only for caudal spermatozoa (Fig
8). Pre-incubation of caudal spermatozoa in NAC plus CZ, followed by
resuspension of these cells in MT-1 plus CZ similarly induced a significant
(P<0.05) increase in the cAMP content of caudal cells compared to the
levels of this nucleotide expressed by spermatozoa preincubated in NAC
and resuspended in MT-1 (Fig 9).
4. In the presence of phospholipase A2 inhibitor. As changes in
membrane phospholipid content are known to affect adenylate cyclase
activity (Houslay et al, 1976; Bakardjiera et al, 1979; Salesse and Gamier,
1984), and hamster spermatozoa have been shown to exhibit
phospholipase A2 activity (Llanos et al, 1982). the effects of the
phospholipase A2 inhibitor -p-dibromoacetophenone on the cAMP
content of caput and caudal spermatozoa were determined. At 20(iM, a
dose known to inhibit this enzymes activity in spermatozoa of other species
(J Crosby and RW Kelly, personal communication), this reagent had no























Figure 10. Cyclic AMP content (picomoles cAMP per 109 spermatozoa)
expressed by spermatozoa from the hamster caput (a), or cauda (b)
epididymis incubated over a 60min period at a density of 20x106/ml in
medium MT-1 (open squares), or medium MT-1 plus 20jiM -p-





















































Figure 11. Cyclic AMP content (picomoies cAMP per 109 spermatozoa)
expressed by spermatozoa from the hamster caput (a), or cauda (b)
epididymis incubated over a 3h period in medium MT-1 at a density of
20x106/ml (closed squares), or 1x106/ml (open squares). Significance levels
are: *, P<0.05; **, P<0.01. Values shown are mean ± standard error, n=6.
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c. Response to dilution at 1x10A6/ml. Caput and caudal spermatozoa
released into MT-1 and incubated at a density adjusted to 1x106/ml showed
completely different cAMP responses from those observed in incubations
performed at a cell concentration of 20x106/ml. The cAMP content of caput
spermatozoa fell from the basal undiluted level and remained low
throughout the incubation, in marked contrast to the dramatic increase in
cAMP levels seen at 20x106/ml (Fig 11a).
The initial rise in cAMP content expressed by caudal spermatozoa in
response to dilution at 20x106/ml was also significantly (P<0.01) reduced in
incubations performed at the lower density of 1x106/ml [1334 ± 147 vs 565 ±
110 pmol cAMP/ 109 spermatozoa, 15min after dilution]. However,
spermatozoa from this portion of the epididymis show a more gradual,
progressive, time-dependant increase in cAMP content, with the intracellular
concentration of this nucleotide reaching significantly (P<0.01) higher levels
than in undiluted spermatozoa after 15 min of incubation. At this lower
density, the cAMP content of caudal spermatozoa eventually reached levels
significantly higher than those shown at 20x106/ml (Fig 11b).
d. Epididvmal plasma effects on cAMP content of caput spermatozoa.
The dramatic fall in the cyclic AMP content of caput epididymal spermatozoa
on dilution from 20x106/ml to 1x106/ml may have been caused by the loss of
key factors in the epididymal fluid, which become diluted out when
spermatozoa are prepared at the lower density. To investigate this
possibility, the influence of conditioned media recovered from suspensions
of caput spermatozoa at a density of 20x106/ml on the cAMP content of the
same cell type at a concentration of 1x106/ml was determined.
The conditioned medium was prepared by releasing caput
spermatozoa into medium MT-1 at a cell density adjusted to 20x106/ml.
These spermatozoa were then pelleted by centrifugation at 250g for 5 min.






Figure 12. Cyclic AMP content (picomoles cAMP per 109 spermatozoa)
expressed by spermatozoa from the hamster caput epididymis incubated for
30min under the following conditions:
A. Open bar - At a density of 20x106/ml in medium MT-1,
B. Lined bar - At a density of 1 x106/ml in medium MT-1,
C. Dotted bar - At a density of 1x106/ml in the 250g supernatant from
incubation A. The closed bar represents the cAMP content of the
supernatant from incubation A alone.Significance levels are: *\ P<0.01.
Values shown are mean ± standard error, n=6.
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use, at which time it was thawed and rewarmed to 37°C. Aliquots of fresh MT
-1 were treated in the same manner to act as control media. Caput
spermatozoa released into this epididymal plasma conditioned media at a
density adjusted to 1x106/ml, expressed cAMP levels of 2671 ± 776 pmol
cAMP/109 cells after 30 mins of incubation, significantly (P<0.01) greater
than the cAMP content of these cells incubated at the same density in control
MT-1 (331 ± 58 pmol cAMP/109 spermatozoa). However, the cAMP content
of spermatozoa in conditioned media did not differ significantly from the
levels expressed by caput spermatozoa incubated in medium MT-1 at a
density of 20x106/ml (2018 ± 220 pmol cAMP/109 spermatozoa) (Fig 12).
The conditioned medium itself contained only a small amount of cAMP. This
was attributed to the presence of a small number of spermatozoa which had
not been removed by centrifugation.
e. Phosphodiesterase inhibitor effects on cAMP content of caput
spermatozoa. Caput spermatozoa incubated at a density of 1x106/ml do not
exhibit the rise in cAMP levels which is expressed by these cells upon
incubation at a concentration adjusted to 20x106/ml (Fig 11a). The results
presented above suggest that this may result from the dilution of some factor
present in epididymal plasma (Fig 12). To investigate the possibilty that such
a factor may be a phosphodiesterase inhibitor (Benau et al, 1986), caput
spermatozoa were incubated in MT-1 at a density of 1x106/ml in the
presence of the synthetic phosphodiesterase inhibitor, IBMX, at a
concentration of 0.2mM. This agent caused a significant (P<0.01) elevation
of cAMP content, with a temporal profile which closely resembled the




Figure 13. Cyclic AMP content (picomoles cAMP per 109 spermatozoa)
expressed by spermatozoa from the caput epididymis of the hamster
incubated for a 3h period under the following conditions:
Open squares - At a density of 20x106/ml in medium MT-1,
Closed squares - At a density of 1 x106/ml in medium MT-1,
Closed diamonds - At a density of 1x106/ml in medium MT-1 plus 0.2mM




Spermatozoa from the bull and ram exhibit an increase in cAMP
content as they mature in the epididymis (Hoskins et al, 1974; Amann et al,
1982), and non-progressive movement can be induced in immature
spermatozoa from the bull and hamster by artificially elevating their cAMP
content using phosphodiesterase inhibitors (Hoskins et al, 1975b; Kann and
Serres, 1980). In view of this, it has been postulated that the acquisition of
the potential for movement which occurs during epididymal maturation is
related to an increase in cAMP content (Garbers and Kopf, 1980; Tash and
Means, 1983). However, Del Rio and Raisman (1978) reported that the
cAMP levels of rat spermatozoa decreased during epididymal transit. This
study has confirmed and extended this observation by showing that immotile
spermatozoa from the caput epididymis of both the rat and the hamster
contain significantly higher levels of cAMP than spermatozoa which have
completed epididymal maturation, both in undiluted form and upon release
into media at a density adjusted to 20x106/ml. As the induction of
coordinated flagellar movement in a number of different motile systems has
been shown to require the cAMP-dependant phosphorylation of a 56kd
axonemal protein named axokinin (Tash, et al, 1984), these findings indicate
that the inability of caput spermatozoa from these species to express mature
motility patterns must be due to some block downstream from the
requirement for cAMP.
Spermatozoa from both the caput and cauda epididymis of the
hamster responded to release into medium MT-1 at an adjusted density of
20x106/ml with a sharp rise in cAMP content over basal, undiluted levels.
Rat spermatozoa from both these epididymal regions responded to dilution
at this density in a similar manner. Increases in the cAMP content of caudal
spermatozoa in response to dilution have previously been reported for the
hamster (Morton et al, 1974), bull (Cascieri et al, 1976), guinea pig (Hyne
and Garbers, 1979a) and mouse (Stein and Fraser, 1984).
In contrast to the situation seen when spermatozoa are diluted to a
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cell concentration of 20x106/ml, a rapid increase in cAMP levels is not seen
when incubations are performed at the lower cell density of 1x106/ml. It
would therefore appear that the initiation of caudal sperm motility which
occurs upon dilution does not involve an increase in cAMP levels as has
been previously suggested for the hamster (Morton et al, 1974), bull
(Cascieri et al, 1976), boar (Okamura and Sugita, 1983), and mouse
(Okumura et al, 1985).
Incubation of caput spermatozoa at 1x106/ml in the supernatant of
incubations performed at 20x106/ml caused a significant (P<0.01) elevation
of cAMP content to levels comparable with those seen upon dilution at the
higher density. This suggests that the stimulation of cAMP levels seen upon
dilution to 20x106/ml involves the mediation of a factor present in epididymal
plasma. As inhibitors of phosphodiesterase activity are known to be present
in the epididymis of the rat (Benau et al, 1986), the effects of incubating
caput spermatozoa at a density of 1x106/ml in the presence of the
phosphodiesterase inhibitor IBMX were determined. This agent elevated
cAMP to levels similar to, though significantly (P<0.01) greater than those
shown by caput sperm incubated at 20x106/ml in MT-1. These data are
therefore consistent with the hypothesis that the difference in cAMP levels
between incubations performed at 20x106/ml and 1x106/ml is due to the
dilution of a phosphodiesterase inhibitor present in epididymal plasma.
Closer analysis of previous studies which have reported increases in
cAMP content upon dilution revealed that those performed on the hamster,
bull and mouse (Morton et al, 1974; Cascieri et al, 1976; Stein and Fraser,
1984) had made no allowance for epididymal fluid contamination. Thus the
increases in cAMP content observed to accompany dilution in these species
may result from the action of some exogenous agent in these incubations.
The study which utilised the guinea pig as an animal model (Hyne and
Garbers, 1979a) did wash the spermatozoa once prior to incubation.
However, the relatively high cell concentration at which subsequent
incubations were performed may have potentiated the action of any
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remaining plasma factors.
Although Carr and Acott (1984) showed that the cAMP content of
caudal epididymal spermatozoa from the bull did not increase upon dilution,
eventhough epididymal plasma was not removed prior to incubation, the
buffer utilised by this group did not contain calcium, which has been shown
to be required for the expression of the increase in cAMP content (see
below).
The rise in cAMP levels which accompanied dilution of both caput
and caudal spermatozoa from the hamster at 20x106/ml was severely
inhibited by the removal of exogenously added calcium from the medium. As
the cAMP content of spermatozoa incubated in NAC in the presence of the
phosphodiesterase inhibitor IBMX is significantly (P<0.01) lower than the
identically treated spermatozoa in MT-1, it would appear that the synthesis of
cAMP has an obligatory requirement for this cation. A similar calcium
dependancy has been shown to exist in guinea pig caudal spermatozoa
(Hyne and Garbers, 1979a).
This group further reported that treatment of these spermatozoa with
the calmodulin antagonist trifluoperazine inhibited the calcium dependant
rise in cAMP levels associated with dilution. Extensions of their studies led
them to conclude that the sperm adenylate cyclase of this species is
calmodulin dependant, as 100|iM trifluoperazine inhibited the adenylate
cyclase activity of caudal sperm homogenates by 50% (Hyne and Garbers,
1979b). However, the dose of this reagent utilised is far in excess of the
concentration necessary to neutralise the activity of calmodulin dependant
enzymes such as the Ca2+-transport ATPase or brain phosphodiesterase
(Gietzen et al, 1982). Under these circumstances, the inhibitory action of this
lipophilic compound probably results from its ability to induce non-specific
perturbance of the plasma membrane, rather than a specific disruption of a
calmodulin dependant process. To determine whether the rise in cAMP
levels depended upon the action of calmodulin, both caput and caudal
hamster spermatozoa at a density of 20x106/ml in media MT-1, were
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challenged with calmidazolium (compound R 24571), a more efficient and
specific calmodulin inhibitor than trifluoperazine, at a dose (0.5pM) sufficient
to inhibit calmodulin-dependant enzyme activity (Gietzen et al, 1982). No
diminution in the cAMP content of either cell type was observed, either when
spermatozoa were simultaneously exposed to both calmidazolium and
calcium, or when caudal cells were preincubated in the presence of
calmidazolium and the absence of calcium. These results indicate a lack of
involvement for this calcium dependant modulator protein in cAMP synthesis
in this species. That a slight elevation of cAMP content resulted from
treatment with this reagent may indicate that the phosphodiesterase of these
cells is calmodulin dependant, as has been shown for rat spermatozoa
(Wasco and Orr, 1984).
As changes in membrane phospholipid content are known to affect
adenylate cyclase activity (Houslay et al, 1976; Bakardjiera et al, 1979;
Salesse and Gamier, 1984), and as hamster spermatozoa are known to
possess phospholipase A2 activity (Llanos et al, 1982), the effects of the
phospholipase A2 inhibitor, -p-dibromoacetophenone on the increase in
cAMP levels were determined. This agent had no significant effect on the
cAMP content of either cell type.
In conclusion, these experiments have shown that no direct
relationship exists between the cAMP content of hamster and rat
spermatozoa and their potential for motility. Also, although spermatozoa
incubated at a concentration of 20x106/ml show a rapid calcium, but not
calmodulin, dependant increase in cAMP levels upon dilution, this rise does
not appear to be involved in the initiation of motility upon dilution, as it is
absent in incubations performed at a density of 1x106/ml. The elevation of
cAMP content seen at the higher density may be due to a
phosphodiesterase inhibitor present in epididymal plasma.
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Chapter 3. The relationship between cAMP levels and the
expression of hyperactivated motility.
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A. Introduction.
Mammalian spermatozoa released at ejaculation require a period of
capacitation within the female genital tract before penetration of the oocyte
vestments and fertilization can be achieved (Chang, 1951; Austin, 1952).
Spermatozoa of many different species are known to express altered
patterns of motility concomitant with the terminal stages of this process (See
general introduction; Burkman, 1984; Boatmen and Bavister, 1984). These
changes, termed hyperactivation (Yanagimachi, 1981), are characterized by
vigorous, large amplitude, whiplash-like flagellar beats, with the sperm
heads tracing erratic trajectories (Katz and Yanagimachi, 1980). Such
modifications are thought to facilitate the passage of spermatozoa through
both the cumulus oophorus and the zona pellucida (Katz et al. 1986).
The exact biochemical mechanisms underlying this modulation of
sperm movement remain unknown. However, the expression of
hyperactivated motility is known to depend upon the presence of calcium in
the external medium (Yanagimachi and Usui, 1974; Fraser, 1977; Shams-
Borhan and Harrison, 1981; Yanagimachi, 1982). Indirect evidence further
suggests that capacitation in vitro is accompanied by a net uptake of calcium
(Singh et al, 1978; Triana et al, 1980; Singh et al, 1980). The adenylate
cyclase enzyme, which is known to be calcium (Kopf and Vacquier, 1985)
and possibly calmodulin (Hyne and Garbers, 1979a, b; Gordeladze et al,
1982) dependant in spermatozoa, has also been shown to increase in
activity during capacitation (Morton and Albagli, 1973; Stein and Fraser,
1984). These factors suggest that a calcium-dependant increase in the
intracellular levels of cyclic 3',5'-adenosine monophosphate (cAMP) should
occur during capacitation. Indeed, artificial elevation of sperm cAMP content
following treatment with membrane permeant analogues of cAMP or
phosphodiesterase inhibitors, has been found to induce hyperactivated
motility in rhesus monkey spermatozoa (Boatman and Bavister, 1984),
stimulate its incidence in both hamster (Mrsny and Meizel, 1980) and human
spermatozoa (Burkman, 1984), and accelerate its onset in spermatozoa from
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the mouse (Fraser, 1979; 1981), although a subsequent study (Cooper,
1984) has failed to confirm the latter observation.
However, until recently, direct measurements of the cAMP content of
capacitating spermatozoa have failed to relate changes in the level of this
nucleotide to the onset and expression of hyperactivated motility (Hyne and
Garbers, 1979a; Stein and Fraser, 1984). In the previous chapter it was
shown that caudal spermatozoa from the hamster, incubated at a density of
1x106/ml, exhibit a progressive increase in cAMP content which caput
spermatozoa incubated under identical conditions are unable to express.
The aim of the experiments detailed below was to determine whether this
increase in cAMP content is related to the expression of hyperactivated
motility during capacitation.
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B. Materials and Methods.
Both the media employed in this study and the techniques utilised for;
isolation of spermatozoa, extraction of cAMP, determination of cAMP levels
and statistics are as outlined in chapter 2.
i. Motility and acrosomal status assessment. Percentage motility and
the percentage of motile cells showing hyperactivated motility were
estimated using a microscope with a heated stage set at 37°C. At least 100
spermatozoa were counted for each separate determination with the aid of
an eyepiece graticule. These spermatozoa were also scored for the
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Figure 14. Percentage motility (open squares) and percentage
hyperactivated motility (closed squares) expressed by spermatozoa from the
hamster cauda epididymis incubated for a 7h period in medium MT-1 at a
density of 1x106/ml. Significance levels are: *, P<0.05; **, P<0.01. Values
shown are mean ± standard error, n=6.
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Figure 15. Percentage motility (a) and percentage hyperactivated motility (b)
expressed by spermatozoa from the hamster cauda epididymis incubated at
a density of 1x106/ml for a 7h period in either medium MT-1 (open squares),
or medium MT-1 plus 0.2mM IBMX (closed squares). Significance levels
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Figure 16. Percentage motility (a) and percentage hyperactivated motility (b)
expressed by spermatozoa from the hamster cauda epididymis incubated at
a density of 1x106/ml for a 7h period in either medium MT-1 (open squares),
or medium MT-1 plus 0.5mM dibutryl cAMP (closed squares). Significance
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Figure 17. Percentage motility (a) and percentage hyperactivated motility (b)
expressed by spermatozoa from the hamster cauda epididymis incubated at
a density of 1x106/ml for a 7h period in either medium MT-1 (open squares),
or medium NAC (closed squares). Significance levels are: *, P<0.05; **,
P<0.01. Values shown are mean ± standard error, n=6.
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C. Results.
i. Motility analysis - 1x10A6/ml.
a. In complete medium. After 30 min of incubation in medium MT-1,
75% of caudal spermatozoa were motile. Percentage motility then slowly
declined with time, reaching values of 61, 54 and 45 after 3, 5 and 7h
respectively (Fig 14). Significant (P<0.05) levels of hyperactivation were first
seen after two hours of incubation. Thereafter, percentage hyperactivated
motility steadily increased, reaching a maximum 5h after initial dilution, at
which time 58% of live spermatozoa expressed this pattern of motility.
Addition of 0.2mM of the phosphodiesterase inhibitor isobutyl methyl
xanthine (IBMX) to the incubations performed in MT-1 significantly (P<0.01)
stimulated the percentage motility (Fig 15a), and significantly (P<0.01)
advanced the onset of hyperactivated motility (Fig 15b).
Addition of 0.5mM of the membrane permeant analogue of cAMP,
dibutryI cAMP, to the incubations performed in MT-1 resulted in a significant
(P<0.01) stimulation of percentage motility between 150 and 360 mins after
dilution (Fig 16a). The percentage of spermatozoa exhibiting hyperactivation
was also significantly (P<0.01) increased after 120 mins of incubation
(Fig 16b), in a manner similar to, although less pronounced than that
produced by IBMX (see above).
b. In medium NAC. Incubation of caudal spermatozoa at a density of
1x106/ml in medium MT-1 devoid of exogenously added calcium (NAC)
caused a significant (P<0.01) stimulation of percentage motility over the first
half of the incubation period, but levels subsequently fell to become
significantly (P<0.01) lower than those expressed in complete MT-1 after 6h
of incubation (Fig 17a). Spermatozoa incubated in this medium, however,
exhibited a drastic reduction in percentage hyperactivation, significantly
(P<0.01) lower than the levels expressed in MT-1 (Fig 17b). In medium NAC,
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Figure 18. Percentage motility (a) and percentage hyperactivated motility (b)
expressed by spermatozoa from the hamster cauda epididymis incubated at
a density of 1x106/ml for a 7h period in either medium NAC (open squares),
or medium NAC plus 0.2mM IBMX (closed squares). Significance levels
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Figure 19. Percentage motility (a) and percentage hyperactivated motility (b)
expressed by spermatozoa from the hamster cauda epididymis incubated at
a density of 1x106/ml for a 7h period in either medium NAC (open squares),
or medium NAC plus 0.5mM dibutryl cAMP (closed squares). Significance
levels are: *, P<0.05; **, P<0.01. Values shown are mean ± standard error,
n=6
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Figure 20. Percentage motility (a) and percentage hyperactivated motility (b)
expressed by spermatozoa from the hamster cauda epididymis incubated at
a density of 1x106/ml for a 7h period in either medium MT-1 (open squares),
or medium MT-1 plus 0.5p.M calmidazolium (closed squares). Significance
levels are: *, P<0.05; **, P<0.01. Values shown are mean ± standard error,
n=6
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Figure 21. Percentage motility expressed by spermatozoa from the hamster
cauda epididymis incubated at a density of 1x106/ml for a 7h period in either
medium MT-1 plus 0.5pM calmidazolium (open squares), or medium MT-1
plus both 0.5pM calmidazolium and 0.2mM IBMX (closed squares). Values
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Figure 22. Percentage hyperactivated motility (closed bars) and a
representative fluoresence emission trace performed at 492nm (line graph)
for spermatozoa from the hamster cauda epididymis pre-incubated for 3h at
a density of 1x106/ml in medium MT-1, then treated with 0.5|iM
calmidazolium. Significance levels are: **, P<0.01. Values shown are mean
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Figure 23. Percentage acrosome reaction determined for spermatozoa from
the hamster cauda epididymis incubated for 7h at a density of 1x106/ml in
medium MT-1. Significance levels are: * P<0.05; **, P<0.01. Values shown
are mean ± standard error, n=6
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motile population, in comparison to peak levels of 58% in MT-1.
Addition of 0.2mM of the phosphodiesterase inhibitor isobutyl methyl
xanthine (IBMX) to the incubations performed in NAC significantly (P<0.01)
stimulated the percentage motility (Fig 18a), but caused only a slight,
insignificant increase in percentage hyperactivated motility (Fig 18b).
Addition of 0.5mM dibutryl cAMP to the incubations performed in NAC
also significantly (P<0.01) stimulated the percentage motility (Fig 19a), but
hyperactivation was never expressed in the presence of this reagent (19b),
the levels of hyperactivation actually being significantly (P<0.01) lower than
in medium NAC alone.
c. In the presence of calmodulin inhibitor. Addition of the calmodulin
antagonist calmidazolium (compound R24571) at a concentration of 0.5pM
(Gietzen et al, 1982) to incubations performed in MT-1 at a density of
1x106/ml caused severe disruption of coordinated motility, with levels being
significantly (P<0.01) lower than in MT-1 alone (Fig 20a). Flyperactivated
motility was never expressed in the presence of this reagent (Fig 20b).
Addition of IBMX to these incubations did not alleviate the effects of the
calmodulin antagonist on motility (Fig 21), despite a significant elevation of
intracellular cAMP levels (see figure 30).
Spermatozoa pre-loaded with Quin-2 (for loading protocol, see
materials and methods, chapter 4) showed no alteration in their
fluorescence emission either immediatley upon the addition of 0.5pM
calmidazolium or over the period of subsequent motility disruption (Fig 22).
ii. Acrosomal status. After 30 mins of incubation in medium MT-1, 9%
of caudal spermatozoa had lost their acrosomal caps. It was assumed that
this figure represented a background acrosomal loss secondary to a
reduction in cell viability, and not a physiological acrosome reaction. Levels
of acrosome reacted spermatozoa rose significantly (P<0.05) above this
basal level after 150 mins of incubation, when levels reached a value of













Figure 24. Percentage motility (open squares), percentage hyperactivated
motility (Closed squares) and percentage acrosome reaction (open
diamonds) determined for spermatozoa from the hamster cauda epididymis
incubated for 7h at a density of 1 x106/ml in medium MT-1. Values shown are




Figure25. Cyclic AMP content (picomoles cAMP per 109 spermatozoa)
expressed by spermatozoa from the hamster caput (open squares) or cauda
(closed squares) epididymis, incubated at a density of 1x106/ml over a 7h
period in medium MT-1. Significance levels are: *, P<0.05; **, P<0.01.
Values shown are mean ± standard error, n=6.
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Figure 26. Cyclic AMP content (picomoles cAMP per 109 spermatozoa)
expressed by spermatozoa from the hamster cauda epididymis, incubated
at a density of 1x106/ml over a 7h period in either medium MT-1 (open
squares), or medium MT-1 plus 0.2mM IBMX .(closed squares).
Significance levels are: **, P<0.01. Values shown are mean ± standard
error, n=6.
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Figure27. Cyclic AMP content (picomoles cAMP per 109 spermatozoa)
expressed by spermatozoa from the hamster cauda epididymis, incubated at
a density of 1x106/ml over a 7h period in either medium MT-1 (open
squares), or medium NAC (closed squares). Values differ significantly
(P<0.01) between the two treatment groups. Values shown are mean ±
standard error, n=6.
- 78 -
increased progressively, to reach levels of 31 and 52 % after 5 and 7 hours
respectively. It would thus appear that capacitating hamster spermatozoa
exhibit peak levels of hyperactivated motility prior to the maximal attainment
of the acrosome reaction (Fig 24).
iii Cyclic AMP levels - response to dilution at 1x106/ml.
a. In complete medium. In the chapter 2 it was shown that caudal
spermatozoa incubated for a 3h period at a density of 1x106/ml exhibited a
progressive increase in cAMP content which spermatozoa from the caput
epididymis were unable to express. By extending the incubation period to
7h, the cAMP content of caudal spermatozoa was shown to reach a plateau
of around 1875 pmols cAMP/109 spermatozoa between 3 and 4 h after initial
dilution (Fig 25). This rise in cAMP levels thus precedes the expression of
hyperactivated motility by these cells. After this time, cAMP levels
decreased slightly, although they remained significantly (P<0.01) elevated
over To values after 7h of incubation. Caput cAMP content remained low
throughout this extended incubation period.
Incubation of spermatozoa in MT-1 plus IBMX (0.2mM), conditions
which significantly accelerated the onset of hyperactivated motility (Fig 15b),
caused a dramatic increase in cAMP content, with levels being significantly
(P<0.01) higher than those expressed in MT-1 alone within 15min of dilution
(Fig 26).
P
b. In medium NAC. The supression of hyperactivated motility which
resulted from incubation in medium NAC was associated with a severely
attenuated rise in cAMP content, with levels never exceeding 400 pmol
cAMP/109 spermatozoa (Fig 27). Flowever, dilution in NAC was not
completely without effect, as a significant (P<0.01) increase in sperm cAMP
content over the basal levels was evoked, with levels reaching 228 pmol






















Figure 28. Cyclic AMP content (picomoles cAMP per 109 spermatozoa)
expressed by spermatozoa from the hamster cauda epididymis, incubated
at a density of 1x106/ml over a 7h period in; medium MT-1 (open diamonds),
medium NAC (open squares), or medium NAC plus 0.2mM IBMX (closed
squares). Significance levels are: *, P<0.05; *\ P<0.01. Values shown are
mean ± standard error, n=6.
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Figure 29. Cyclic AMP content (picomoles cAMP per 109 spermatozoa)
expressed by spermatozoa from the hamster cauda epididymis, incubated
at a density of 1x106/ml over a 7h period in either medium MT-1 (open
squares) or medium MT-1 plus 0.5p.M calmidazolium (closed squares).
Significance levels are: *, P<0.05; **, P<0.01. Values shown are mean ±
standard error, n=6.
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Figure 30. Cyclic AMP content (picomoles cAMP per 109 spermatozoa)
expressed by spermatozoa from the hamster cauda epididymis, incubated
at a density of 1x106/ml over a 7h period in either medium MT-1 plus 0.5jiM
calmidazolium (open squares) or medium MT-1 plus both 0.5|iM
calmidazolium and 0.2mM iBMX (closed squares). Significance levels are:
**, P<0.01. Values shown are mean ± standard error, n=6.
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cAMP/109 spermatozoa in undiluted ceils.
Addition of IBMX (0.2mM) to incubations performed in medium NAC
significantly (P<0.01) stimulated sperm cAMP content over a time course of
7h (Fig 28). However, these elevated levels were still significantly (P<0.01)
lower than those expressed in MT-1, and were not associated with a
stimulation of hyperactivated motility.
c. In the presence of calmodulin antagonist.. The disruption of
hyperactivated motility seen upon addition of calmidazolium to spermatozoa
incubated in MT-1 was associated with a significant (P<0.01) reduction in
cAMP content, with the disparity between treatment and control increasing
over the latter part of the incubation (Fig 29). Addition of 0.2mM IBMX to
these incubations caused a dramatic elevation of cAMP content to levels
significantly (p<0.01) higher than those expressed in MT-1 (Fig 30), although




It is widely accepted that increases in the cAMP content of
spermatozoa result in a stimulation of motility (see chapter 1; Garbers and
Kopf, 1980; Tash and Means, 1983). Indirect evidence from experiments
utilising phosphodiesterase inhibitors or membrane permeant analogues of
cAMP have also implicated a role for this nucleotide in the expression of
hyperactivated motility (Fraser, 1979, 1981; Mrsny and Meizel, 1980;
Burkman, 1984; Boatman and Bavister, 1984). However, previous studies
which have measured the cAMP content of capacitating spermatozoa have
failed to relate changes in the level of this nucleotide to the appearance of
hyperactivated motility (Hyne and Garbers, 1979a; Stein and Fraser, 1984).
The experiments detailed above have shown that capacitation of
hamster spermatozoa is associated with a progressive rise in cAMP levels,
and that this phenomenon precedes the expression of hyperactivation. In
turn, spermatozoa appear to display maximal levels of hyperactivation
before peak levels of acrosome reaction are attained. The observed timing
of these separate events is in agreement with the findings of previous
studies (Mahi and Yanagimachi, 1973; Fraser 1977, 1982).
These results also provide confirmation of the results published by
other groups who have reported that the expression of hyperactivated
motility depends upon the presence of calcium in the external media
(Yanagimachi and Usui, 1974; Fraser, 1977; Shams-Borhan and Harrison,
1981; Yanagimachi, 1982; Cooper, 1984). Furthermore, these observations
have been extended by demonstrating that the elevation of cAMP levels
which occurs during capacitation also depends upon the presence of
extracellular calcium.
Incubation of caudal spermatozoa in the absence of calcium, but in
the presence of the phosphodiesterase inhibitor IBMX, caused a significant
(P<0.01) increase in the cAMP content of these cells, although the level
attained did not reach that expressed by the same cell type in medium MT-1.
However, this elevation of cAMP levels was not associated with an increase
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in the proportion of cells exhibiting hyperactivated motility. Furthermore, the
addition of dibutryl cAMP to spermatozoa in medium NAC also failed to
cause the resumption of hyperactivation, despite presumably raising cAMP
levels. These results may indicate that calcium has multiple actions in the
induction of hyperactivation, stimulating the increase in cAMP, but also
fulfilling a more fundamental role, possibly at the level of the axoneme (see
below).
In keeping with the hypothesis that a causal relationship exists
between cAMP levels and hyperactivation, is the observation that treatment
of caudal spermatozoa in complete medium MT-1 with the
phosphodiesterase inhibitor IBMX accelerates the onset of hyperactivated
motility, as has been reported previously (Fraser, 1979; Mrsny and Meizel,
1980). Furthermore, this phenomena was associated with a substantially
augmented increase in cAMP levels. Similar treatment with the membrane
permeant analogue of cAMP, dbcAMP, produced effects analagous to,
although less pronounced than those achieved with IBMX.
The calcium requirement for the onset of hyperactivation does not
appear, however, to be the only action of this cation in the expression of
sperm movement. Caudal spermatozoa challenged with the calmodulin
antagonist calmidazolium suffer complete disruption of flagellar beat
patterns, and never express hyperactivated motility. These findings are in
agreement with those of Tash and Means (1982), who observed similar
disruption of dog sperm motility following treatment with the anti-calmodulin
drug W13, but contrast with the observations of both Peterson et al (1983),
who showed only a slight decrease in the motility of boar spermatozoa
following treatment with 4pM calmidazolium, and Serres and Kann (1984),
who showed that calmodulin antagonists induced mature motility patterns in
hamster caput spermatozoa. Peterson et al (1983) further reported that this
drug stimulated calcium uptake. However, this study has shown that the
influence of calmidazolium upon hamster sperm motility is not associated
with any changes of intracellular calcium concentration as determined using
the Quin-2 technique. The disparity between these observed effects of
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calmodulin antagonists upon sperm motility may either reflect species
differences or effects attributable to actions via mechanisms which do not
involve calmodulin. The influence of calmidazolium on caudal sperm motility
does not appear to be due to non-specific toxicity, as treated cells continued
to show twitching movements reminiscent of caput sperm over a 7h
incubation period.
This total inhibition of coordinated flagellar movement resulting from
calmidazolium treatment indicates a fundamental role for calmodulin in the
expression of sperm movement. The localization of calmodulin throughout
the sperm tail (Weinman et al, 1986; Feinberg et al, 1981, 1983; Gordon et
al, 1983; Jones et al, 1980) further implicates this protein in the regulation of
sperm motility. Such an action may involve the dynein ATPases located on
the outer doublet microtubules of the axoneme, as these enzymes are
known to be both essential for sperm motility and to be calcium-calmodulin
dependant (Blum et al, 1980; Hisanaga and Pratt, 1984).
The rise in cAMP content seen under normal capacitation conditions
at a sperm density of 1x106/ml is slightly reduced following treatment with
calmidazolium. This decrease may indicate that the adenylate cyclase
enzyme in hamster spermatozoa is calmodulin dependant, as has been
reported for spermatozoa of the guinea pig (Hyne and Garbers, 1979b).
However, this slight reduction may relate only to the lower percentage
motility seen under these conditions. Regardless of the mechanisms
involved, this reduction of cAMP content does not appear to be the primary
means by which calmidazolium affects sperm motility, as the addition of the
phosphodiesterase inhibitor IBMX to these incubations elevated cAMP
content to levels significantly higher than those seen in MT-1 alone, whilst
failing to elicit either the resumption of normal patterns of motility or the
appearance of hyperactivation.
In conclusion, these experiments have shown that in the hamster, the
calcium and calmodulin dependant expression of hyperactivated motility is
preceded by a calcium dependant elevation of cAMP levels. Furthermore,
the expression of coordinated sperm motility in this species appears to be
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dependant upon the mediation of calcium/calmodulin in a manner which is
independant of cAMP.
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Chapter 4. Mechanisms involved in the epididymal development
of the ability to express an increase in cAMP levels.
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A. Introduction.
The experiments detailed in chapters 2 and 3 have shown that
capacitation of spermatozoa from the cauda epididymis of the hamster is
associated with a progressive, calcium-dependant increase in cAMP content
which precedes the onset of hyperactivated motility. This rise in cAMP levels
is not, however, expressed by caput spermatozoa incubated under identical
conditions to capacitating caudal spermatozoa, despite the presence of
calcium in the external medium. In contrast to the rise expressed by caudal
spermatozoa, the cAMP content of caput spermatozoa decreases upon
dilution and remains low throughout a seven hour incubation period.
The increases in calcium content during capacitation which have
been implied from observed influxes of this cation (Singh et al, 1978; Triana
et al, 1980; Singh et al, 1980) could account for the elevation of cAMP levels
during capacitation, via an action upon the calcium-dependant adenylate
cyclase (Kopf and Vacquier, 1985). Furthermore, as the cAMP levels
expressed by caudal spermatozoa in NAC closely resemble the cAMP
content of caput spermatozoa in MT-1, the inability of immature cells to
express a rise in cAMP content may be due to insufficient calcium being
transported into the cells interior.
However, it has been reported that the capacity for calcium uptake is
in fact greater in immature spermatozoa from the caput epididymis (Hoskins
et al, 1983). It may then be that the calcium sensitivity of the adenylate
cyclase enzyme changes during epididymal transit. Determination of the
responsiveness of sperm adenylate cyclase to stimulation is complicated by
the fact that in this cell type, this enzyme does not respond to the usual
stimulators of adenylate cyclase activity such as, fluoride, guanyl
nucleotides, cholera toxin orforskolin (Braun and Dods, 1975; Herman et al,
1976; Chen and Boettcher, 1979; Garbers and Kopf, 1980; Stengel et al,
1982; Forte et al, 1983), as in spermatozoa, the adenylate cyclase system
diifers from that of somatic cells in that it appears to lack a regulatory subunit
(Stengel and Hanoune, 1984; Hildebrandt et al, 1985). However, it has
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recently been demonstrated that spermatozoal form of the adenylate cyclase
complex will respond to stimulation by artificial analogues of adenosine,
such as 2-chloro- and 2-deoxy- adenosine (Aitken et al, 1986;
Vijayaraghavan and Hoskins, 1986). Thus, the responsiveness of the
adenylate cyclase in caput spermatozoa can be probed using these
reagents.
The ATP content of spermatozoa from the rat and bull spermatozoa
has been reported to increase during epididymal transit (Chulavatnatol et al,
1977; Hoskins et al, 1975). Therefore, low substrate concentration in caput
spermatozoa could account for the inability of these cells to express the rise
in cAMP levels shown by capacitating caudal spermatozoa.
Another factor which may be involved in changes in the synthesis of
cAMP during epididymal transit is intracellular pH. Epididymal maturation in
the bull has been reported to be associated with an increase in intracellular
pH (Vijayaraghavan et al, 1985). As the adenylate cyclase enzyme in
spermatozoa has been reported to be stimulated by increases in
intracellular pH (Peterson et al, 1980), such a mechanism could account for
the low cAMP levels expressed by caput spermatozoa. Furthermore, motility
itself is enhanced by alkalinization of the sperm interior (Hansbrough and
Garbers, 1981; Christen et al, 1982; Babcock et al, 1983), presumably
through the activation of dynein ATPase. Thus an increase in internal pH
during capacitation could provide the primary signal for the onset and
development of hyperactivated motility, through effects upon both dynein
ATPase and adenylate cyclase.
Therefore, to determine the mechanisms involved in the generation of
the increase in cAMP content during capacitation, and the reasons why
spermatozoa from the caput epididymis are unable to exhibit a rise in cAMP
levels, four factors have been studied; intacellular calcium content, ATP - the
substrate for adenylate cyclase, intracellular pH, and the ability of the
adenylate cyclase enzyme to respond to stimulation.
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WAVELENGTH (nm)
Figure 31. Emission spectra (scanned from 380 to 550nm) of Quin-2
tetracetoxymethylester (fluoresence peak 429nm), and Quin-2 free acid
(fluoresence peak 492nm). Fluorescence intensity is plotted on an arbitrary
scale.
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B. Materials and Methods.
Both the media employed in this study and the techniques utilised for;
isolation of spermatozoa, extraction of cAMP, determination of cAMP levels
and statistics are as outlined in chapter 2. Motility assessment was
performed as outlined in chapter 3.
i. Intracellular Calcium Measurements. The intracellular concentration
of free extramitochondrial calcium was assessed using the fluorescent
calcium indicator Quin-2 (Tsien et al, 1982), using a modification of the
methodology outlined by Irvine and Aitken (1986).
Spermatozoa were released into medium MT-1, and adjusted to a cell
density of 4x106/ml. Twenty minutes after initial dilution, Quin-2-
tetracetoxymethylester [in dry dimethyl sulfoxide (DMSO)] was added at a
concentration of 50pM, whilst DMSO alone was added to controls. The
sperm suspensions were then incubated at 37°C (in 5% C02 in air) for 20
minutes, diluted 1:3 with fresh media, and subsequently incubated for a
further 60 minutes.
This incubation time was chosen as a result of monitoring the loading
and de-esterification of Quin-2 in caudal spermatozoa.This can be easily
quantified as the membrane permeant tetracetoxymethylester has a
characteristic emission spectrum with a fluorescence maximum at 429nm,
whilst the free acid (which is membrane impermeant, and is produced
intraceIlularly via hydrolysis by endogenous esterases) fluoresces
maximally at 492nm (Fig 31). Sperm cells were loaded with Quin-2 and
incubated in MT-1. At various time points, aliquots of the sperm suspension
were removed and the cells washed twice by centrifugation at 250g for
5mins, before being lysed with Triton X-100 to release the intracellular Quin-
2 into solution. The lysed cells were then removed from the solution by
centrifugation, and the supernatant, containing the Quin-2, was used to
assess the hydrolyzed state of the intracellular Quin by measurement of its
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Figure 32. Emission spectra (scanned from 380 to 550nm) of the 3000g
supernatant from triton x-100 lysed spermatozoa from the cauda epididymis
of the hamster, incubated in the presence of Quin-2 tetracetoxymethylester
for 20 (open squares), 40 (closed diamonds), 60 (closed squares), 80 (open
diamonds), or 100 (closed triangles) mins. Fluoresence intensity is plotted
on an arbitrary scale.
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WAVELENGTH (nm)
Figure 33. Emission spectra (scanned from 380 to 550nm) of spermatozoa
from the cauda epididymis of the hamster incubated in the presence of Quin-
2 tetracetoxymethyiester (1) or DMSO (2) for a total of 80 mins. Spectrum 3
has been produced by subtracting the control spectrum (2) from the Quin
spectrum (1). Fluoresence intensity is plotted on an arbitrary scale.
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emission spectrum. From from such determinations it was apparent that
complete hydrolysis has occured after a total incubation period of 80mins
(Fig 32).
For determination of free intracellular calcium content, spermatozoa
loaded with Quin according to the protocol outlined above were washed
twice by centrifugation at 250g for five mins to remove extracellular Quin and
finally resuspended in fresh medium at a concentration of 1.0x106/ml.
Fluorescence measurements were performed in either a Baird or a Perkin-
Elmer spectrofluorimeter, with the excitation wavelength set at 339nm and
the emission wavelength at 492nm. The sperm suspension was maintained
at 37°C in a quartz cuvette whilst the determinations were performed. The
entry of Quin-2 into the cells was checked by observing the shift in the
fluorescence maximum from 430 to 492nm. Intracellular calcium content was
determined by the addition of 0.5% v/v Triton X-100, followed by 10mM
EGTA (giving Fmax and Fmin respectively).
In contrast to the situation in the human (Irvine and Aitken, 1986),
hamster spermatozoa were found to emit significant levels of
autofluorescence. To compensate for this effect; the F, Fmax and Fmin values
measured in Quin loaded spermatozoa were adjusted by subtracting the
fluorescence signal produced by identically treated cells incubated in
D.M.S.O. alone (Fig 33). Calculation of intracellular calcium levels was
achieved using the equation: [Ca2+]j = Kd(F-Fmin)/(Fmax-F), where Kd =
115nM (Tsein et al, 1982).
ii. ATP Measurement. Extraction of ATP was achieved by mixing 25jil
of sperm suspension with an equal volume of 0.01% trichloroacetic acid
(TCA), followed by the addition of 850jil Tris-EDTA buffer (0.1M-Tris, 2mM-
EDTA, pH 7.75). Bioluminescence was measured with a Berthold
luminometer (Laboratory Impex Ltd, Twickenham, UK) after addition of 10Opil
luciferin-luciferase reagent (LKB-Wallace, Turku, Finland). Light emission
was calibrated using standard solutions of ATP (LKB-Wallace).
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iii. Intracellular pH Measurements. Intracellular pH was determined
using the fluorescent pH indicator 2,7-Biscarboxyethyl-5(6)-
carboxyfluorescein (BCECF - Research Development Corporation, Toronto,
Canada). Twenty minutes after initial dilution, BCECF-tetraacetoxymethyl
ester was added (5|ig/ml in DMSO) to spermatozoa at a density of 4x106/ml;
DMSO alone was added to control incubations. Cell suspensions were then
incubated at 37°C (in 5% C02/95% air) for 30 minutes to facilitate loading
and de-esterification. Loaded spermatozoa were then washed twice by
centrifugation at 250g for 5 mins to remove extracellular BCECF and finally
resuspended in fresh media at a concentration of 1.0x106/ml. Measurements
were performed in a Perkin-Elmer spectrofluorimeter, with the excitation
wavelength set at 500nM and the emission wavelength at 530nM. The
suspension of spermatozoa was maintained at 37°C in a quartz cuvette
whilst the determinations were performed. Fluorescence was calibrated by
releasing the dye into the medium using 0.5% v/v Triton X-100, then titrating
using 3.2% HCI (Rink et al, 1982; Grinstein et al 1984). Control incubations
showed negligible levels of autofluorescence. Red shift effects were minimal
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Figure 34. Percentage hyperactivated motility displayed by spermatozoa
from the cauda epididymis of the hamster incubated in either MT-1 alone
(closed squares), or in MT-1 plus 50pM Quin-2 (open squares) - see text for




Figure 35. Cyclic AMP content (picomoles cAMP per 109 spermatozoa),
expressed by spermatozoa from the hamster cauda epididymis incubated
over a 7h period in either medium MT-1 (open squares) or medium MT-1
plus 50(iM Quin-2 (closed squares) - see text for incubation details.





Figure 36. Free intracellular calcium content (nanomolar), determined at
various times throughout a 7h incubation period, of hamster spermatozoa
from the caput (open bars), or cauda (closed bars) epididymis incubated in
medium MT-1 - see text for incubation details. Significance levels are: *,




a. Effect upon hvperactivation. As Quin-2 is a calcium chelating agent,
and as the expression of hyperactivated motility is known to be affected by
alterations of intracellular calcium concentration, it was first determined
whether cells loaded with Quin-2 would display similar levels of
hyperactivated motility to spermatozoa incubated in MT-1 alone. Analysis of
this pattern of motility revealed that spermatozoa incubated in the presence
of Quin-2 expressed levels of hyperactivated motility which did not differ
significantly those displayed in medium MT-1 (Fig 34).
b. Effect upon cAMP levels. As the rise in cAMP levels expressed by
caudal spermatozoa has also been found to be affected by calcium
concentration, It was also determined whether spermatozoa loaded with
Quin-2 would exhibit similar rises in cAMP content to those cells incubated
in MT-1 alone. It was found that cAMP levels after 30mins of incubation were
significantly (P<0.01) lower in Quin loaded cells than in spermatozoa
incubated in medium MT-1 (Fig 35). This may be due to a lowering of
intracellular calcium levels. However, after this initial suppression,
spermatozoa incubated in the presence of Quin-2 proceded to exhibit a
progressive increase in cAMP content which did not differ significantly that
expressed by spermatozoa in medium MT-1.
c. Intracellular Calcium Determinations. Following the loading
protocol outlined above, the initial determination of cytosolic calcium
concentration was made after 135mins of incubation (Fig 36). At this time,
the internal calcium content of caudal spermatozoa was 66.8 ± 17.0nM,
significantly (P<0.05) lower that of caput spermatozoa (143.8 ± 26.6nM).
During the subsequent incubation of both cell types there was a significant
(P<0.01) increase in intracellular calcium levels. In the case of caput
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Figure 37. ATP content (picomoles per 106 spermatozoa) of hamster
spermatozoa from the caput (open squares), or cauda (closed squares)
epididymis. Incubations were performed in medium MT-1 over a 7h time
period, at a sperm density of 1x106/ml. Significance levels are: *, P<0.05; **,
P<0.01. Values shown are mean ± standard error, n=6.
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Figure 38. Percentage hyperactivated motility displayed by spermatozoa
from the cauda epididymis of the hamster incubated in either MT-1 alone
(closed squares), or in MT-1 plus 5p.g/ml BCECF (open squares) - see text




Figure 39. Intracellular pH, determined at various times throughout a 7h
incubation period, of hamster spermatozoa from the caput (open bars), or
cauda (closed bars) epididymis, incubated in medium MT-1. Significance
levels are: *, P<0.05; **, P<0.01. Values shown are mean ± standard error,
n=6.
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epididymal spermatozoa, this increase was progressive in nature, reaching
a peak after 390mins of incubation. Caudal epididymal spermatozoa
showed a transient fall in intracellular calcium levels between 210 and 300
mins of incubation, when peak levels of hyperactivation are being
expressed, such that at this time point the calcium levels in caput and caudal
spermatozoa differed significantly (P<0.05).
ii. ATP Content. After 30mins of incubation, ATP levels in caudal
spermatozoa are slightly, but insignificantly higher than in caput cells (30.0 ±
5.7 vs 18.4 ± 3.3). As the incubation proceded, the ATP content of caudal
spermatozoa progressively declined, whilst caput levels remained
unchanged (Fig 37). Thus, after 240mins of incubation, caudal ATP content
was significantly (P<0.05) lower than in caput spermatozoa (25.6 ± 5.4 vs
11.6 ± 1.7), and by 7h after dilution, caudal levels had dropped still further to
7.0 ± 1.5 (P<0.01).
iii. BCECF.
a. Effects upon hvperactivation. The effects of this reagent upon
various cell types have been quantified to a much greater extent than for
Quin-2. It has been shown that loading cells with BCECF does not alter
significantly their internal pH (Rink et al, 1982; Grinstein et al, 1984).
However, the percentage hyperactivation displayed by caudal spermatozoa
incubated in medium MT-1 containing BCECF was determined. When
compared to the levels of this motility pattern exhibited in MT-1 alone, no
significant difference was found (Fig 38).
b. Intracellular pH. Following the loading protocol outlined above, the
first determination of internal pH was made after 90 mins of incubation. At
this time, an internal pH of 6.937 ± 0.064 was measured in caudal
spermatozoa. Continuation of these measurements over the period of












Figure 40. Percentage motility (a) and percentage hyperactivated motility (b)
expressed by spermatozoa from the hamster cauda epididymis incubated at
a density of 1x106/ml for a 7h period in either medium MT-1 (open squares),
or medium MT-1 plus 75p.M 2-deoxyadenosine (closed squares).




Figure 41. Percentage motility (a) and percentage hyperactivated motility (b)
expressed by spermatozoa from the hamster cauda epididymis incubated at
a density of 1x106/ml for a 7h period in either medium MT-1 (open squares),
or medium MT-1 plus 2.5mM 2-deoxyadenosine (closed squares).
Significance levels are: *, P<0.05; **, P<0.01. Values shown are mean ±
standard error, n=6.
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Figure 42. Cyclic AMP content (picomoles cAMP per 109 spermatozoa)
expressed by spermatozoa from the hamster caput (a), or cauda (b)
epididymis, incubated at a density of 1x106/ml over a 7h period in either
medium MT-1 (open squares), or medium MT-1 plus 75p.M 2-
deoxyadenosine (closed squares). Significance levels are: **, P<0.01.
Values shown are mean ± standard error, n=6.
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[pH]i had occured after 4.5h of incubation, by which time values had
dropped to 6.769 ± 0.045 (Fig 39). Parallel analysis of caput spermatozoa
revealed that the intracellular pH of this cell type did not differ significantly
from the values determined for caudal spermatozoa. These immature cells
also expressed a significant (P<0.01) reduction in internal pH overtime.
iv. 2-deoxyadenosine.
a. Motility. Caudal spermatozoa incubated in medium MT-1 in the
presence of 75pM 2-deoxyadenosine (2-DA) showed a slight, but significant
(P<0.05) increase in percentage motility when compared to similar
spermatozoa incubated in MT-1 alone (Fig 40a). In contrast, this agent
caused a significant (P<0.05) decrease in the percentage of live
spermatozoa exhibiting hyperactivation (Fig 40b), despite having no effect
on the rise in cAMP (see below).
At the higher concentration of 2.5mM, 2-DA had no consistent effect
on percentage motility, levels being alternately significantly (P<0.05) lower
after 1 h of incubation, then significantly (P<0.05) enhanced after 5 h of
incubation (Fig 41a). However, at this dose, the percentage of spermatozoa
expressing hyperactivated motility was severly attenuated, with levels being
consistently significantly (P<0.01) lower than in MT-1 alone (Fig 41b).
b. Cyclic AMP. When added at a concentration of 75|iM, 2-DA
elevated the cAMP content of caput spermatozoa to levels significantly
(P<0.01) higher than those normally associated with this cell type (Fig 42a).
However, this reagent had no significant effect upon the characteristic
increase in cAMP levels expressed by caudal spermatozoa during
capacitation (Fig 42b).
When used at the higher concentration of 2.5mM, it was found that
sufficient quantities of this reagent were carried over with the spermatozoa
through the wash procedure to cross-react with the cAMP antisera. In order
to determine the effects of this dose of 2-DA on the cAMP content
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Figure 43. Cyclic AMP content (picomoles cAMP per 109 spermatozoa)
expressed by spermatozoa from the hamster caput (a), or cauda (b)
epididymis, incubated at a density of 1x106/ml over a 7h period in either
medium MT-1 (open squares), or medium MT-1 plus 2.5mM 2-
deoxyadenosine (closed squares). Significance levels are: **, P<0.01.
Values shown are mean ± standard error, n=6.
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Figure 44. Cyclic AMP content (picomoles cAMP per 109 spermatozoa)
expressed by spermatozoa from the hamster caput (a), or cauda (b)
epididymis, incubated at a density of 1x106/ml over a 7h period in medium
MT-1, undergoing either one (open squares), or two (closed squares)
rounds of centrifugation at 250g for 5 mins. Significance levels are: *,
P,0.05; **, P<0.01. Values shown are mean ± standard error, n=6.
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of spermatozoa, an additional wash step was included. The amount of 2-DA
remaining in the medium after two cycles of centrifugation did not cross-react
with the cAMP antiserum. When compared to the cAMP content of control
spermatozoa washed twice in MT-1, 2.5mM 2-DA was found to have no
effect upon the cAMP content of caput spermatozoa (Fig 43a), but caused a
significant (P<0.01) elevation of the cAMP levels in caudal spermatozoa
after 60 mins of incubation (Fig 43b).
v. Centrifugation effects. In the course of the previous experiment,
spermatozoa from both the caput and cauda epididymis were washed twice
prior to extraction of cAMP. This procedure involved a repetition of the
centrifugation step (250g, 5mins). Comparison of the cAMP content of
spermatozoa treated in this manner to the levels expressed by cells washed
with the normal single centrifugation revealed that the cAMP levels of caput
spermatozoa were significantly (P<0.01) stimulated by additional
centrifugation (44a), whilst this treatment caused a significant (P<0.01)
decrease in the cAMP content of by caudal spermatozoa (44b).
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D. Discussion.
The progressive elevation of cAMP levels which is expressed by
capacitating spermatozoa from the cauda epididymis of the hamster must
reflect a change in the ability of these cells to generate this nucleotide.
Capacitation in vitro is known to be accompanied by a net influx of calcium
(Singh et al, 1978; Triana et al, 1980; Singh et al, 1980) and an increase in
adenylate cyclase activity (Morton and Albagli, 1973; Stein and Fraser,
1984). Furthermore, increases in calcium content are known to activate
sperm adenylate cyclase (Kopf and Vacquier, 1985). As caudal
spermatozoa do not express this progressive rise in cAMP content when
incubated in calcium-free media, it is possible that the stimulus for an
increase in cAMP content may be an elevation of the levels of calcium
available for the use of the adenylate cyclase complex. Similarly, the
inability of caput spermatozoa to display a similar rise in cAMP levels,
despite the presence of calcium in the external media, might have been due
to a deficiency in their intracellular calcium concentration.
Using the fluorescent probe Quin-2, the intracellular calcium content
of both capacitating caudal and immature caput spermatozoa has been
directly quantified to determine whether; a) the calcium dependant rise in
cAMP levels observed during capacitation is associated with an increase in
free intracellular calcium content, and b) the low cAMP levels expressed by
caput spermatozoa reflect an inability on the part of these immature cells to
transport sufficient calcium across the plasma membrane.
Using this technique, it has been shown that the the rise in caudal
cAMP content is temporally related to an elevation of the free intracellular
calcium concentration in these cells. Furthemore, when cAMP levels reach a
plateau after three hours of incubation, a similar constancy is seen in the
calcium content of these cells. It can be concluded, therefore, that the rise in
cAMP levels which occurs during capacitation results from a progressive
stimulation of adenylate cyclase activity induced by increasing levels of
intracellular calcium.
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However, the free cytoplasmic calcium content of caput spermatozoa
incubated under identical conditions and over the same time period, is either
significantly (P<0.05) higher than, or not significantly different from the
calcium levels in caudal spermatozoa. These observations are in agreement
with the findings of Hoskins et al (1983), who showed that spermatozoa from
the caput epididymis of the bull have a greater capacity for calcium uptake
than caudal cells. Thus, as both cell types show an increase in intracellular
calcium concentration over time, some factor other than calcium availability
must prevent the elevation of cAMP levels in caput spermatozoa.
It is interesting to note that, when compared to the free calcium
content of caput spermatozoa, the levels of this cation in caudal
spermatozoa decrease significantly (P<0.05) after 5h of incubation,
concomitant with the expression of peak levels of hyperactivation. This
observation may indicate the activation of a cAMP-dependant calcium
extrusion mechanism in these mature cells (Feinstein et al, 1983; Zavioco
and Feinstein, 1984; Bradley and Forrester, 1985), compared to the
apparently passive rise in the calcium content of caput spermatozoa.
Analysis of the literature reveals conflicting evidence concerning the
effects of epididymal transit on the ATP content of spermatozoa.
Concentrations of this nucleotide have been reported to increase
(Chulavatnatol et al, 1977), or to remain constant (Ke and Tso, 1982) in rat
spermatozoa; to rise in spermatozoa from the bull (Hoskins et al, 1975), or to
fall in the guinea pig (Frenkel et al, 1973). However, none of these studies
were performed longitudinally. To determine whether lower substrate
concentration in caput spermatozoa could account for the inability of these
cells to express the rise in cAMP levels shown by capacitating spermatozoa,
the ATP content of both caput and caudal spermatozoa has been measured
over a 7h incubation period. These measurements have revealed that
although ATP levels are initially slightly, but insignificantly, higher in caudal
spermatozoa, the ATP content of these cells declines as the incubation
procedes, presumably reflecting the utilization of this nucleotide for the
expression of flagellar movement. Similar decreases in intracellular ATP
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content have previously been reported to occur in capacitating hamster
spermatozoa (Rogers and Morton, 1973). Eventually, the ATP content of
caudal spermatozoa fell to levels significantly (P<0.01) lower than those
shown by caput spermatozoa, in concert with the significant increase in
cAMP levels. Thus, lack of substrate availability does not account for the
inability of caput spermatozoa to express the rise in cAMP levels associated
with capacitation.
As both sperm adenylate cyclase activity (Peterson et al, 1980) and
sperm motility (Hansbrough and Garbers, 1981; Christen et al, 1982;
Babcock et al, 1983) are stimulated by increases in internal pH, a
longitudinal study of the steady state pH of caudal spermatozoa was
performed to investigate the possibility that the onset and development of
hyperactivated motility during capacitation may reflect an increase in
intracellular pH. Using the fluorescent probe BCECF, it has been shown that
intracellular pH does not increase during capacitation, suggesting that the
expression of hyperactivated motility is independant of this particular
intracellular control mechanism.
Furthermore, the intracellular pH of caput spermatozoa incubated
under identical conditions has been measured. In contrast to the situation in
the bull (Vijayaraghavan et al, 1985), no significant difference in internal pH
exists between these different cell types, implying that the inability of
hamster caput spermatozoa to express an increase in cAMP levels is not
due to differences in intracellular pH. This would also suggest that the
initiation of motility upon dilution does not involve an elevation of internal pH
as has been suggested for spermatozoa from the rat (Wong et al, 1981;
Treetipasatit and Chulavatnatol, 1982; Wong and Lee, 1983), bull (Acott
and Carr, 1984) and sea urchin (Schackman et al, 1981; Christen et al,
1982; Lee et al, 1983). The measured decrease of internal pH which
occured during the prolonged incubation of both caput and caudal
spermatozoa may be caused by acidification of the external media resulting
from extensive lactate production, as has been reported for bull
spermatozoa (Smith et al, 1985).
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Although the adenylate cyclase of caput spermatozoa appears not to
respond to the calcium present in the external media, this enzyme is not
totally unresponsive to stimulation in this cell type. The adenosine
analogue, 2-deoxyadenosine, one of the few reagents known to stimulate
the spermatozoal form of adenylate cyclase, when used at a concentration
known to increase the activity of this enzyme in spermatozoa from other
species (Vijayaraghavan and Hoskins, 1986), induced a significant (P<0.01)
increase in the cAMP content of caput spermatozoa. The inability of higher
concentrations of 2-DA to stimulate cAMP levels in caput spermatozoa may
be due desensitization of the adenylate cyclase complex (Aitken et al,
1986). The slight inhibition of hyperactivation which occurred at a
concentration of 75jiM may reflect an action upon the intracellular calcium
concentration as has been detailed for other cell types (Henon and McAffee,
1983; Dunwiddie, 1984). Such effects may also be responsible for the
severe inhibition of hyperactivated motility which resulted from treatment
with 2.5mM 2-DA. However, this suppression of motility was not due to an
inhibition of adenylate cyclase activity, as has been reported to occur when
spermatozoa from the bull are treated with this drug (Brown and Casillas,
1984).
Synthesis of cAMP in caudal spermatozoa may be r^ponsive to
stimulation by some agent, such as adenosine (Stein et al, 1986) which is
inactive with respect to caput cells. However, the only change in adenylate
cyclase activity documented to accompany epididymal maturation is the
apparent loss of sensitivity to forskolin exhibited by bovine spermatozoa
(Vijayaraghavan and Hoskins, 1985). In view of the conflicting reports of the
sensitivity of sperm adenylate cyclase activity to forskolin, the implications of
this observation are unclear. The gradual rise in cAMP levels expressed by
caudal spermatozoa does not, however, suggest an active stimulation. Such
an effect would be expected to produce a rapid response. Instead, the
dynamics of the rising nucleotide levels would appear to reflect a
progressive increase in activity.
It is interesting to note that the inclusion of an extra centrifugation
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step, a process known to destabilize membranes, caused a significant
(P<0.01) stimulation of the cAMP content of caput spermatozoa, whilst
significantly (P<0.01) decreasing the cAMP levels in caudal spermatozoa.
The loss of cholesterol from the plasma membrane of spermatozoa during
epididymal maturation (Scott et al, 1967; Lavon et al, 1970; Terner et al,
1975; Adams and Johnson, 1977) implies that the stability of these
membranes is decreasing (Johnson, 1975). As adenylate cyclase activity is
known to be intimately related to membrane fluidity and to be stimulated by
membrane perturbing agents (Salesse and Gamier, 1984), the stimulatory
effects of centrifugation upon the cAMP content of caput spermatozoa may
indicate that the inability of these immature cells to express a rise in cAMP
levels is due to an inhibition of adenylate cyclase activity as a result of the
lack of protein mobility within the plasma membrane
In conclusion, these experiments have shown that both the increase
in cAMP levels and the expression of hyperactivated motility by caudal
spermatozoa from the hamster epididymis appears to be controlled by an
elevation of cytoplasmic calcium concentration, which accompanies
capacitation in this species. However, the inability of caput spermatozoa to
express a similar rise in cAMP levels does not appear to be due to
deficiences in their calcium or ATP content, or to a difference in internal pH.
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Chapter 5. General Discussion
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A. Development of coordinated motility. Mammalian spermatozoa are
essentially immotile when they leave the testis, and are capable of
displaying only uncoordinated twitching movements upon dilution. The
ability to initiate both coordinated and progressive movement is gradually
attained as spermatozoa pass through the caput and corpus epididymis.
Functionally mature spermatozoa are then stored in a quiescent state in the
cauda epididymis, prior to ejaculation.
In the bull, acquisition by spermatozoa of the capacity for coordinated
progressive movement is correlated with an increase in their cAMP content
(Hoskins et al,1974). Furthemore, flagellar activity can be stimulated in caput
spermatozoa from this species by incubation in the presence of
phosphodiesterase inhibitors (Hoskins et al, 1975). Coupled with the large
body of evidence which relates artificial elevations of cAMP levels to an
enhancement of sperm motility (Drevius, 1971, 1972; Garbers et al, 1971a,
b, 1973b; Hoskins, 1973; Bunge, 1973; Haesungcharern and Chulavatnatol,
1973; Frenkel et al, 1973b; Schoenfeld et al, 1973, 1975; Morton et al, 1974;
Hommonnai et al, 1976; Wyker and Howards, 1977; De Turner et al, 1978;
Paz et al, 1978; Kann and Serres, 1980), a direct causal link has been
proposed to exist between the cAMP content of epididymal spermatozoa
and their capacity for movement (Garbers and Kopf, 1980; Tash and Means,
1983). In fact, in the light of the more recent demonstration that the cAMP
levels in ram spermatozoa also increase during epididymal transit (Amann
et al, 1982), and that the generation of flagellar movement in both
spermatozoa and a number of other motile systems requires the cAMP-
dependant phosphorylation of an axonemal protein (Tash et al, 1984), this
assumption has become a basic tenet of motility research.
However, in direct contradiction to the accepted model, it has been
demonstrated that intact spermatozoa from the cauda epididymis of the
hamster (this study) and rat (Del Rio and Raisman, 1978; this study) are
capable of expressing coordinated and progressive motility eventhough
their cAMP content is less than that of caput spermatozoa. It would thus
seem that the basal levels of cAMP present in the mature spermatozoa from
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these species are sufficient to fulfill the requirements of this nucleotide for
the induction of coordinated flagellar movement. The block which prevents
caput spermatozoa from expressing mature motility patterns must therefore
exist downstream from the requirement for cAMP. If the inability of
spermatozoa from the caput epididymis of the hamster to express mature
motility patterns is not due to low levels of cAMP, what other factors change
during epididymal transit to enable these cells to display coordinated
movement?
Although the flagellar system of spermatozoa is thought to undergo
some modification during epididymal maturation (Mohri and Yanagimachi,
1980; Yeung 1984, 1986; White and Voglmayr, 1986), spermatozoa from the
caput epididymis, which are immotile when intact, will exhibit coordinated
flagellar movement upon demembranation and reactivation in a suitable
medium (Mohri and Yanagimachi, 1980; Treetipasatit and Chulavatnatol,
1982; Yeung 1984, 1986; White and Voglmayr, 1986). These observations
imply that the motor apparatus of these spermatozoa is already functionally
assembled following spermatogenesis, and that some other factor must
therefore change during epididymal transit.
As the only known role for cAMP in eukaryotic cells is the stimulation
of protein phosphorylation via activation of protein kinase A (Rosen et al,
1975; Flockhart and Corbin, 1982), changes in the activity of this enzyme
could thus affect the acquisition of motility in the epididymis. Although
protein kinase activity has been found to increase during epididymal transit
in the bull (Hoskins et al, 1974), levels of this enzyme have been reported
both to rise (Pariset et al, 1985) and fall (Wooten et al, 1987) in the ram and
to remain unchanged in the rat (Atherton et al, 1985) during epididymal
maturation. However, care has to be exercised in the interpretation of these
findings, as although sufficient protein kinase activity may be demonstrated
in broken cell preparations of caput spermatoza, this enzyme may be
inactivated in vivo.
Analysis of the products of protein kinase activity have revealed two
phosphorylated proteins of 20 and 16Kd which appear exclusively in
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spermatozoa from the cauda epididymis of the ram (Wooten et al, 1987).
This contrasts with the situation in the rat, where five minor phosphorylated
proteins were associated only with the axonemes of caput spermatozoa
(Chulavatnatol et al, 1982). These conflicting reports emphasise the
difficulties encountered when data obtained from different mammals are
compared, as the factors which control the capacity for sperm movement
may vary between species. A system may operate in the ram whereby the
acquisition of motility during epididymal transit is initiated by the activation
(phosphorylation) of specific "motility" proteins, which occurs when the cAMP
content of spermatozoa reaches a level adequate to activate protein kinase
A. Conversely, the substrate for these kinases may be absent in caput
spermatozoa. The existence of such a situation is unlikely, however, as this
would imply that maturing spermatozoa are capable of active protein
synthesis, an ability which, it is generally accepted, spermatozoa do not
possess (Mann, 1983). By contrast, in the rat (and possibly the hamster),
where cAMP levels and protein kinase activity decrease during epididymal
maturation, the acquisition of motility may require the dephosphorylation of
certain proteins in caudal cells which inhibit the motility of caput
spermatozoa.
The roles of cAMP and calcium in the regulation of flagellar motion
are known to be closely related (Garbers and Kopf, 1980). Tash and Means
(1983) forwarded the hypothesis that cAMP and calcium exert opposing
actions in the regulation of sperm motility, respectively phosphorylating and
dephosphorylating specific axonemal proteins, such as dynein ATPase
(Tash and Means, 1982), with calcium negating the stimulatory effects of
cAMP. Although evidence does exist, from experiments utilizing both intact
and demembranated spermatozoa from a variety of species, that elevation of
cAMP levels results in a stimulation of motility (see above), the effects of
calcium on sperm motility vary widely, depending upon both the species
examined and the experimental approach adopted. Direct evidence for a
negative effect of calcium upon sperm motility comes from experiments
utilising both intact (Davis, 1978; Singh et al, 1980; Fraser, 1977) and
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demembranated (Mohri and Yanagimachi, 1980; Mohri and Yano, 1980,
1982; Gibbons and Gibbons, 1980; Tash and Means, 1982) spermatozoa.
However, results from both cell models relate high (and probably supra-
physiological) concentrations of calcium to reduced sperm viability.
Indirect evidence for an inhibitory role for calcium in the regulation of
sperm movement comes from experiments in which calcium was removed
from the external medium. In intact spermatozoa, Hong et al (1984) showed
that incubation of ejaculated human spermatozoa in media rendered
calcium free by the addition of either EDTA or EGTA, elicited a stimulation of
sperm motility. However, the baseline motility exhibited by these
spermatozoa when incubated in media containing normal levels of calcium
appears to be sub-standard. These low levels of motility may be due to the
inhibitory action of abnormally high levels of calcium within this population of
asthenozoospermic patients. The stimulation seen in response to incubation
in calcium free media may, therefore, be due to the normalizing effects of the
chelating agents on intracellular calcium levels, rather than by complete
removal of calcium from the spermatozoa.
Although the movement characteristics .of intact, ejaculated human
spermatozoa were shown not to differ between incubations performed in
medium containing either 1.7mM or 10|iM calcium, Aitken et al (1986)
showed that the stimulation of motility which resulted from the elevation of
cAMP levels following treatment with caffeine or 2-deoxyadenosine was
significantly diminished in the presence of normal (1.7mM) levels of calcium.
However, removal of calcium from the external medium severly inhibited the
motility of intact spermatozoa from the hamster (Morita and Chang, 1970;
Yanagimachi, 1982), rat (Miyamoto and Ishibashi, 1975; Davis, 1978) and
mouse (Miyamoto and Ishibashi, 1975; Heffner et al, 1980; Heffner and
Storey, 1981). Paradoxically, the reactivation of motility in demembranated
spermatozoa is unaffected by the absence of this cation (Morton, 1973;
Treetipasatit and Chulavatnatol, 1982, Mohri and Yanagimachi, 1980).
However, recent findings may provide an explanation for these
discrepancies. Flagellar dynein adenosine triphosphatase (ATPase)
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activity, known both to be essential for sperm motility and to be calcium-
calmodulin dependant (Blum et al, 1980; Hisanaga and Pratt, 1984), is
stimulated by Triton X-100 (Hisanaga and Pratt, 1984). Therefore, the
calcium dependancy of intact-sperm motility may be circumvented in
demembranated sperm models by the action of the detergent used to
permeabilise these cells. Thus, the only discernable actions of calcium on
the motility of these spermatozoa are the inhibitory effects caused by high
levels of this cation.
Results from this study indicate that the presence of 1.7mM calcium in
the external media is required for both the maintenance of sustained motility
and the appearance of hyperactivation. Part of this calcium requirement is to
stimulate the increased synthesis of cAMP during capacitation. Generation
of sufficient levels of this compound appears to be involved with the onset of
hyperactivation (see below). This study has also demonstrated that the free
internal calcium concentration of caput spermatozoa from this species is
neither too high, so that it inhibits sperm motility, nor too low to support
sperm movement. However, through the use of the calmodulin antagonist
calmidazolium, evidence has also been provided which suggests that the
expression of coordinated motility itself is dependant upon a calcium and
calmodulin dependant regulatory event downstream from the cAMP
requirement for motility.
Calmodulin has been detected throughout the sperm flagellum
(Jones et al, 1980; Feinberg et al, 1981, 1983; Gordon et al, 1983; Weinman
et al, 1986) and, in fact, comprises the major acidic glycoprotein of
spermatozoa (Brooks and Seigel, 1973). The demonstration that calmodulin
antagonists disrupt sperm movement (Levin et al, 1981b; Peterson et al,
1983), and induce patterns of motility in mature spermatozoa which
resemble those displayed by spermatozoa from the caput epididymis of the
dog (Tash and Means, 1982) and hamster (this study) may indicate a
primary involvement for this calcium-binding protein in the epididymal
acquisition of the capacity for sperm movement. However, the demonstration
that the intracellular concentration of calmodulin in ram spermatozoa
122 -
decreases as they pass through the epididymis (Pariset et al, 1985), may
indicate a different role for this compound in this species. The effect of
calmodulin on sperm motility may operate via activation of Mg2+ ATPases on
the outer doublet microtubules (Blum et al, 1980; Hisanaga and Pratt, 1984).
Unfortunately, no data is available on the calmodulin levels associated with
epididymal spermatozoa of the hamster.
Evidence from a variety of different species has shown that
substances secreted by the epididymal epithelium modify the plasma
membranes of spermatozoa as they pass through this organ (Hunter, 1969;
Barker and Amann, 1971; Killian and Amman, 1973; Lea et al, 1978; Faye
et al, 1980; Moore, 1980, 1981 b; Jones et al, 1981; Wong and Tsang, 1982;
Brooks and Tiver, 1983). Although many of these membrane alterations
occur over the acrosomal surface (Kohane et al, 1979, 1980; Yanagimachi,
1981; Brooks and Tiver, 1983), and are thought to be involved in the
development of the ability to recognize, bind to and penetrate the ovum
(Saling, 1982; Orgebin-Crist and Fournier-Delpech, 1982; Fournier-Delpech
et al, 1984; Cuasnicu et al, 1984), alterations of the flagellar membrane have
also been documented (Lea et al, 1978; Vernon et al, 1982; Brown et al,
1983; Zeheb and Orr, 1984; Ellis et al, 1985; Olson et al, 1987). These
changes are presumed to play some role in the epididymal development of
the capacity for sperm movement, but this remains to be demonstrated.
Forward motility protein, which is known to stimulate forward progression in
bovine spermatozoa (Acott and Hoskins, 1978; Hoskins et al, 1978), has not
been shown to bind specifically to the flagellum (Brandt et al, 1978; Acott
and Hoskins, 1981). However, a recent report has indicated that the forward
motility protein actually consists of two separate peptides. Although one
binds to the head, the other has been localised specifically on the principal
piece of the hamster sperm flagellum (Raynaud and Kann, 1986). This report
provides the first evidence for a direct link between events at the level of the
plasma membrane, and alterations of flagellar function. However, a causal
relationship between these phenomena remains to be demonstrated.
It is known that the induction of motility in bovine caput epididymal
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spermatozoa which results from treatment with either stimulators of
adenylate cyclase or phosphodiesterase inhibitors can be potentiated by
synchronous elevation of intracellular pH (Vijayaraghavan and Hoskins,
1985; Vijayaraghavan et al, 1985; Vijayaraghavan and Hoskins, 1986).
Furthermore, the internal pH of bovine spermatozoa has been shown to
increase during epididymal maturation (Vijayaraghavan et al, 1985). These
observations indicate that, in the bull at least, control of intracellular pH
represents a pivotal mechanism which governs the development of motility
during epididymal transit. Such a hypothesis has a sound theoretical basis,
in that sperm dynein ATPase activity, which is known to be essential for
axonemal motion, has an alkaline pH optimum (Gibbons and Gibbons,
1972). However, measurements of the intracellular pH of caput and caudal
spermatozoa from the hamster (see chapter 4) revealed no significant
difference between these two different cell types. Thus, regulation of internal
pH would not appear to occupy the same central position in the epididymal
development of motility in the hamster, as it does in the bull.
Treatment of spermatozoa from the bovine caput epididymis with high
concentrations of phosphodiesterase inhibitors (Hoskins et al, 1975; Acott et
al,1983), or lower doses of these reagents in the presence of weak bases
(Vijayaraghavan and Hoskins, 1985; Vijayaraghavan et al, 1985;
Vijayaraghavan and Hoskins, 1986) results in the induction of a degree of
coordinated motility not present in control cells. This stimulation of flagellar
movement results from an elevation of cAMP levels and an increase of
internal pH, both of which have been shown to be lower in bovine caput
spermatozoa (Hoskins et al, 1974; Vijayaraghavan et al, 1985). However,
reports that similar treatment of caput spermatozoa from the hamster also
results in the induction of coordinated motility (Kann and Serres, 1980;
Cornwall et al, 1986) are difficult to interpret in light of the findings in this
study which show that cAMP levels decrease during epididymal maturation
in the hamster, and that no significant difference exists between the internal
pH of spermatozoa from the proximal and distal portions of the epididymis.
Possibly the phosphodiesterase inhibitors utilized in these studies are
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operating via mechanisms other than the phosphodiesterase enzyme itself,
as has been implicated in other experimental situations employing these
compounds (Tamblyn and First, 1977). Such effects may be directed
towards altering the calcium homeostasis of the spermatozoa (Kopf et al,
1984).
Alterations in the ATP content of spermatozoa during epididymal
l
maturation have also been implicated as a mechanism controling the
acquisition of the capacity for coordinated movement, either as a result of
levels being so high in caput spermatozoa that they inhibit sperm movement
(Hoskins, 1973; Brokaw, 1984; Yeung, 1986, 1987), or being too low to
support the energy requirements imposed by the expression of sperm
movement (Hoskins et al, 1975; Chulavatnatol et al, 1977). However, the
measurements performed in this study demonstrated that caudal
spermatozoa from the hamster initially contain greater amounts of ATP than
caput spermatozoa, but subsequently express both coordinated and
hyperactivated motility when their ATP levels are significantly (P<0.01) lower
than those of immature cells. These results thus discount a direct effect of
ATP on the acquisition of motility in this species.
In conclusion, these experiments have shown that the epididymal
maturation of hamster spermatozoa is not accompanied by an increase in
cAMP levels, and that the acquisition of the capacity for movement which
accompanies this process does not appear to be due changes in ATP
content, intracellular calcium levels, or internal pH.
B. Development of hvperactivated motility. The shortening of
capacitation time (Rosado et al, 1974; Toyoda and Chang, 1974b; Fraser,
1981; Aitken et al, 1983) and the accelerated onset of hyperactivation
(Fraser, 1979; 1981; Mrsny and Meizel, 1980; Boatman and Bavister, 1984;
Burkman, 1984; this study) which results from treatments which artificially
elevate the cyclic AMP content of spermatozoa imply that in addition to its
obligatory requirement for the induction of coordinated movement (Tash et
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al, 1984), this nucleotide may play a more subtle, modulatory role in the
expression of sperm motility (Tash and Means, 1982). The observed
increase in adenylate cyclase (Morton and Albagli, 1973; Stein and Fraser,
1984), and the decrease in phosphodiesterase activity (Monks et al, 1986;
Monks and Fraser, 1987) during capacitation further implicate a role for this
nucleotide in the post ejaculatory modifications of sperm movement.
Although previous studies which measured the cAMP content of
spermatozoa during capacitation failed to link changes in cAMP levels to the
onset and expression of hyperactivated motility (Hyne and Garbers, 1979a;
Stein and Fraser, 1984), possibly as a result of the masking effect of
phosphodiesterase inhibitors present in epididymal plasma (this study), the
experiments detailed in this thesis have shown that caudal spermatozoa
from the hamster exhibit a rise in cAMP levels prior to displaying the
characteristic flagellar movements of hyperactivation. Two lines of evidence
for a causative association between cAMP and hyperactivation are:- 1)
acceleration of the onset of hyperactivation following treatment of
capacitating spermatozoa with phosphodiesterase inhibitors is associated
with an enhancement of the increase in cAMP content; and 2) the removal
of exogenously added calcium almost completely abolishes hyperactivation
and concomitantly reduces cAMP levels. These observations suggest that
cAMP is involved in the post-ejaculatory modification of sperm motility,
although they do not provide conclusive proof for this hypothesis. However,
assuming this theory is correct, by what means does cAMP manifest its
actions?
It has been suggested that capacitation involves the synthesis of a
critical level of cAMP (Fraser, 1981). As the only known action of this
nucleotide in eukaryotic cells is the stimulation of protein phosphorylation
via activation of protein kinase A (Rosen et al, 1975; Flockhart and Corbin,
1982), a certain concentration of cAMP may be required to trigger the
phosphorylation of key proteins present in either the plasma membrane or
the axoneme (Amann et al, 1982). However, although treatment with a
phosphodiesterase inhibitor advanced the onset of hyperactivation,
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spermatozoa incubated in the presence of such an agent did not express
significant levels of hyperactivated motility when their cAMP content
equalled that at which spermatozoa in MT-1 exhibited this movement
pattern. This implies that the action of cAMP in the induction of
hyperactivation may involve mechanisms other than those which occur in
the expression of coordinated movement, in which this nucleotide is thought
to operate directly upon the axoneme (Murofushi et al, 1986; Tash et al,
1986).
Increased levels of cAMP are known to antagonise calcium
mobilisation (Berridge, 1984) and to maintain low levels of this cation in the
cytoplasm of platelets, possibly through an action on ATP-dependant ion
pumps (Feinstein et al, 1983; Zavoico and Feinstein, 1984; Bradley and
Forrester, 1985). In view of the inhibitory influence of high levels of calcium
upon sperm motility (see above; Breibart et al, 1985), and the fall in calcium
content which occurs at the peak of hyperactivation, after cAMP levels have
reached their zenith (this study), the possibility exists that cAMP may exert
control over the cytoplasmic calcium content of these spermatozoa. Such an
action could be mediated by effects upon Ca2+/Mg2+ ATPases located in the
sperm plasma membrane (Feinstein et al, 1983; Zavoico and Feinstein,
1984; Bradley and Forrester, 1985), causing a decrease in the calcium
concentration of the cell. Whether the action of cAMP in the control of
hyperactivation is upon the motility apparatus itself or as a result of the
phosphorylation of proteins in the plasma membrane (Noland et al, 1984)
remains to be elucidated.
Through the use of the fluorescent probe Quin-2, these studies have
shown that the intracellular concentration of calcium increases at the time
when cAMP levels are rising, confirming the observations that a net influx of
calcium accompanies capacitation in this and other species (Singh et al,
1978; Triana et al, 1980; Singh et al, 1980). Increases in the levels of this
cation could provide the stimulus for the elevation of cAMP content via an
action upon the adenylate cyclase system, which is known to be calcium
dependant in spermatozoa (Kopf and Vacquier, 1985). Displacement of
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calcium from membrane bound sites has been implicated as the mechanism
by which a number of membrane active agents stimulate sperm movement
(Singh et al, 1980; 1983). Such an action would lead to an increase in
[Ca2+]j, which, in turn, could stimulate adenylate cyclase activity. The
intriguing but complex inter-relationship between cAMP, calcium and sperm
motility clearly requires further investigation.
As detailed above, the surface of spermatozoa undergoes changes
during epididymal maturation. In a similar manner, capacitation is also
associated with modifications of the plasma membrane. These alterations
include the loss of surface antigenic determinants (Oliphant and Brackett,
1973; Koehler, 1976) and decapacitation factors (Chang, 1957; Eng and
Oliphant, 1978), and changes in the patterns of lectin binding (Gordon et al,
1975; Talbot and Franklin, 1978; Kinsey and Koehler, 1978; Courtens and
Fournier-Delpech, 1979; Schwarz and Koehler, 1979; Lewin et al, 1979;
Byrd, 1981; Ahuja, 1984). Although the majority of these changes take place
over the acrosomal region, and are thought to faciliate the membrane fusion
events associated with the acrosome reaction and fertilization, some
alterations of the flagellar membrane have also been detailed (Talbot and
Chacon, 1978; Talbot and Franklin, 1978; Kinsey and Koeher, 1978;
Schwartz and Koehler, 1979). These have more recently been correlated
with the onset of hyperactivation in hamster spermatozoa (Ahuja, 1984),
implying that a relationship exists between intracellular and surface changes
in capacitating spermatozoa. The process by which forward motility protein
binds to the flagellum of bovine epididymal spermatozoa, acting in concert
with increasing levels of cAMP levels to facilitate the appearance of
coordinated motility, may be analagous to the membrane changes
demonstrated to occur in capacitating hamster spermatozoa, which coincide
with both increases in cAMP levels and alterations of movement
characteristics. Whether these changes reflect the increase in the
permeability of the membrane to calcium is unknown.
Catecholamines and the amino acids taurine and hypotaurine have
been implicated as "triggers" for the onset of hyperactivation (Cornett and
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Meizel, 1978; Bavister et al, 1979; Mmsy et al, 1979; Meizel et al, 1980;
Liebfreid and Bavister, 1981, 1982). Although the mechanisms by which
these agents operate have not been conclusively demonstrated, it seems
likely that non-specific inhibition of lipid peroxidation accounts for a large
proportion of their actions (Alvarez and Storey, 1983), although an action via
elevation of cAMP levels cannot be discounted (Cornett and Meizel, 1978;
Mrsny and Meizel, 1980). Furthermore, the inhibiton of hyperactivation which
resulted from treatment with the beta-blocker propranolol (Cornett and
Meizel, 1978), although interpreted as an implication of the involvement of
adrenergic receptors in the expression of this motility pattern, may actually
indicate the importance of membrane events in the induction of
hyperactivated motility, as propranolol is a membrane stabilizing agent
(Hong and Turner, 1982).
Spermatozoa from the caput epididymis of the hamster were found to
be unable to express an increase in cAMP levels upon prolonged
incubation, in contrast to the rise expressed by caudal cells. The reasons for
this inability did not appear to be due to deficiences in calcium levels, ATP
content, intracellular pH or responsiveness of the adenylate cyclase system.
However, the observation that repetitive centrifugation caused a stimulation
of caput cAMP levels, whilst depressing those of caudal cells, may indicate
that the membrane changes which occur during epididymal maturation are
involved in the development of the ability to express a rise in cAMP levels. In
this context, the recent observation that both invertebrate and mammalian
spermatozoa possess an inhibitory guanine nucleotide-binding regulatory
protein (Kopf et al, 1986) may be of importance. Changes in membrane
fluidity could affect the relationship between this sub-unit and the adenylate
cyclase enzyme. Such alterations could account for the epididymal
development of the capacity to express a rise in cAMP levels.
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Part B: Male Contraception
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Chapter 6. General Introduction.
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The purpose of this chapter is to acquaint the reader with the various
means which have been either proposed or employed as contraceptive
agents in the male; their mode of action, efficacy and drawbacks.
A. Background. Probably the oldest method of male contraception is
the practice of coitus interruptus (male withdrawal), which is mentioned in
the Bible, the Talmud and the Koran (Potts and Diggory, 1983). It remained
the most common single method in Europe until after World War II, and is
still the leading contraceptive used in Italy (Potts, 1985). However, records
extend for over 4000 years detailing the use of various pastes, gums and
gels as vaginal contraceptives (Sciarra, 1979). Vasectomy was begun in the
19th century, and is now such a simple operation that six million
vasectomies were performed in the United States in the 1970's (Stokes,
1980). Condoms were first described by the Italian anatomist Fallopius in
1564 (Forrest, 1984), who detailed the use of sheaths made of linen that
provided protection against syphilis. Animal intestines were also employed
for similar purposes. With the development of vulcanized rubber in the
1840's, the condom became the first mass-produced contraceptive aid.
The condom provides an ideal method of contraception in a
promiscuous society, being effective, easily available, socially acceptable,
and in addition offering the advantage of protection against venereal
diseases. In a more stable relationship however, the use of condoms is
frequently not acceptable to both partners. Since another potent, reversible
male antifertility agent is not available, the woman is again forced to bear
the contraceptive burden alone. Vasectomy may become an alternative
when the family has been completed, but psychological factors and the
desire to maintain potential fertility for unseen future events deter many men
from this, possibly irreversible, step. The development of a male analogue to
the female pill is thus required. It has been determined that 70% of American
men would accept such a method if it were available (Keith et al, 1975).
Attempts to develop a male contraceptive can be divided into two broad
areas; those whose mechanism of action operates via some aspect of the
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endocrine system in the male, and those which act directly upon the germ
cells themselves.
B. Approaches to male contraception,
i. The Endocrine approach.
a. GnRH analogues. Spermatogenesis in the human requires the
stimulatory actions of the gonadotropins secreted by the anterior pituitary;
namely follicle stimulating hormone (FSH) and luteinizing hormone (LH)
(Dizerega and Sherins, 1980). The production of these hormones is, in turn,
regulated by gonadotropin-releasing hormone (GnRH), which is produced
by the basal hypothalamus. In view of the central role played by GnRH,
analogues of this compound have been proposed as possible candidates
for a male contraceptive agent. Although treatment with GnRH agonists such
as buserelin (Berquist et al, 1979) was found to cause a reduction in the
numbers of spermatozoa present in the ejaculate (Linde et al, 1981; Rabin
et al, 1981), this action was accompanied by impotence and a loss of libido.
Similar undesirable side-effects resulted from treatment with GnRH
antagonists (Weinbauer et al, 1984). The reduction of testicular function
caused by these reagents thus requires androgen replacement if GnRH
analogues are to be made acceptable for male fertility regulation. However,
such treatment in turn presents a problem in that replacement testosterone
reduces the suppression of spermatogenesis, even when the replacement is
delayed as long as possible (Doelle et al, 1983; Schurmeyer et al, 1984;
Michel et al, 1985; Bhasin et al, 1985). Therefore, a contraceptive strategy
based upon the use of GnRH analogues plus testosterone replacement
would not currently appear to present a feasible means for regulating
fertility in the male.
b. Androgens. The secretion of FSH and LH are regulated by a
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negative feedback mechanism which operates via the gonadal steroids. It
should thus be possible to suppress spermatogenesis by the exogenous
administration of testosterone. The general validity of this basic concept was
demonstrated almost four decades ago (Heller et al, 1950). Since then,
several different forms of testosterone have been utilised in fertility studies.
Danazol (17 -pregn-4-en-20yno-(2,3-d) isoxazol-17-ol), a synthetic
analogue of ethinyl testosterone, was found to cause a moderate reduction
of sperm counts when administered on its own (Sherins et al, 1971;
Skolgund and Paulsen, 1973), but when presented in combination with
methyl testosterone, testosterone proprionate or testosterone enanthate, this
compound caused a severe reduction in sperm numbers (Sherins et al,
1971; Skolgund and Paulsen, 1973; Ulstein et al, 1975). However, the
relatively high doses required for these effects, and the lack of uniform
response in all subjects impeded the development of danazol as a male
contraceptive.
Treatment with testosterone propionate was found to induce complete
and fully reversible azoospermia in those injected daily with this compound
(Reddy and Rao, 1972). However, the need for high frequency intramuscular
injections precluded the use of this reagent as a male contraceptive and
consequently longer-acting testosterone esters were tested for male fertility
control. Testosterone enanthate (TE), again administered by injection, was
found to severly supress sperm production in rats (Walsh and Swerdloff,
1973; Flickinger, 1978; Kuhl et al, 1979), mice (Goldberg, 1984) and
humans (Mauss et al, 1974; Steinberger and Smith 1977; Paulsen et al,
1978; Swerdloff et al, 1979). However, difficulty in achieving complete
azoospermia, and the frequency of injection required (approximately one
per week) due to the relatively short half life of this ester, rendered this
compound unacceptable as a male contraceptive. The pharmacological
properties of testosterone cypionate and cyclohexanecarboxylate are similar
to those of TE (Schulte-Behrbuhl and Neischlag, 1980; Schurmeyer and
Neischlag, 1984), making these derivatives no more acceptable than those
previously tested. Administration of the orally effective testosterone ester,
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testosterone undecanoate had only limited suppressive effects on fertility
(Neischlag et al, 1978). However, studies employing 19-Nortestosterone
esters, which have a longer half-life than most other testosterone esters,
revealed that this group of compounds severely diminished sperm counts
without adversely affecting either libido or potence (Schurmeyer et al,
1984b; Knuth et al, 1985). Further investigation of this compound (Ziporyn,
1984), and the development of other novel, long-acting, testosterone esters
(Diczfalusy, 1986), such as tetosterone trans-4-n-butylcyclohexyl-
carboxylate (Weinbauer et al, 1986) may herald a breakthrough in this area
of male fertility control. Alternatively, the employement of new long-acting
contraceptive delivery systems such as polylactic and polyglycolic
microspheres (Lewis and Tice, 1984; Asch et al, 1986), may extend the
duration of action of extant testosterone esters. Preliminary studies utilizing
this method of drug presentation have already yielded encouraging results
(Turner and Kirkpatrick, 1982). However, it should be noted that long-term
use of androgens may result in liver damage and hepatic tumours (Farrell et
al, 1975; Westaby et al, 1977; Falk et al, 1979). Such side-effects would
presumably block the use of androgen therapy as a means to control male
fertility.
Although the use of the progestogenic anti-androgen, cyproterone
acetate, has been investigated as a potential male contraceptive agent
(Prasad et al, 1970; Morse et al, 1973; Roy et al, 1976; Moltz et al, 1980;
Wang and Yeung, 1980), the consequent drop in serum testosterone levels
and the resultant loss of potency and decrease in libido rendered these
agents of little more use than testosterone analogues when used at high
doses. Although the use of lower concentrations of this reagent were
reported to reversibly inhibit spermatogenesis without any apparent
detrimental effect on libido (Petry et al, 1972), subsequent studies detailed
only marginal reductions in sperm numbers (Fogh et al, 1979; Wang and
Yeung, 1980). It would thus appear that cyproterone acetate is unsuitable as
a male contraceptive agent.
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c. Gestagens and Estrogens. The administration of gestagens is
known to reduce testosterone levels , and for this reason they are used in
the treatment of prostatic cancer (Robinson and Thomas, 1971; Harper et al,
1976). As such treatment also brings spermatogenesis to a halt, the
possibility of developing a male contracepive based on an estrogen has
\T
been investigated (Briggs and Briggs, 1974). However, the occurence of
unacceptable side effects make this avenue of research unattractive.
In the late 1950's, progesterone and several synthetic analogues of
this hormone were shown to induce reversible azoospermia in men (Heller
et al, 1958, 1959). Since then, several combinations of steroids have been
investigated as possible male anti-fertility agents. Although combinations of
17-hydroxyprogesterone caproate with TE, medroxypregesterone acetate
with TE, and levonorgestrel with testosterone have been tested (Bain et al,
1980; Foegh et al, 1980a, b), depot medroxyprogesterone acetate (DMPA)
has yielded the best results so far, although due to diminished libido and
potency, this compound must also be administered with testosterone
replacement in the form of the testosterone esters, TE (Alvarez-Sanchez et
al, 1977; Brenner et al, 1977; Frick et al, 1977a, b; Melo and Coutinho, 1977;
Sanchez et al, 1979; Bain et al, 1980), testosterone propionate (Frick et al,
1977a), or testosterone cypionate (Friedl et al, 1985). However, DMPA only
induced consistent azoospermia in approximately 30% of the volunteers,
with the remainder exhibiting various degrees of oligozoospermia. Although
on the surface this would appear to make DMPA unnattractive as a anti-
fertility agent in the male, recent studies have shown that the spermatozoa
which remain after treatment with DMPA plus TE are unable to fuse with and
penetrate zona-free hamster ova (Wu and Aitken, unpublished
observations). These findings have thus renewed the interest in this
approach to male contraception.
d. Inhibin. Although, as stated above, the secretion of FSH and LH
are regulated by a negative feedback mechanism which operates via the
gonadal steroids, this process also appears to be controlled by a peptide of
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gonadal origin. This substance, termed inhibin, causes selective supression
of the secretion of FSH by the pituitary gland (Franchimont et al, 1978,
1979). In view of this ability to preferentially inhibit FSH production, which
should, in turn, lead to a reduction of germ cell production, inhibin has been
promoted as a potential male contraceptive agent (Franchimont et al, 1978).
However, some researchers believe that the specific inhibition of FSH
following inhibin administration would be unlikely to induce azoospermia, as
limited spermatogenesisis is known to persist even in the absence of FSH
(Matsumoto et al, 1984; Bremner and Matsumoto, 1986; Nieschlag, 1986). In
contrast to these views, however, active or passive immunisation of
monkeys against ovine FSH did result in azoospermia or severe
oligozoospermia (Murty et al, 1979; Wickings and Neischlag, 1980), and
suppression of fertility has been achieved following the administration of
impure inhibin preparations to male primates (Moudgal et al, 1985). Further
animal studies, preferably utilizing purified inhibin, are therefore required to
examine the contraceptive possibilities of this compound. However, even if
this compound does consistently induce reversible azoospermia, further
difficulties will surely be encountered, such as the problems of long term
administration of a polypeptide substance. Also, the cost of producing either
purified inhibin or a synthetic analogue is liable to be high, as such a
process would probably involve either recombinant DNA technology or
peptide synthesis, in addition to separation and purification procedures.
ii. The Direct approach.
a. Anti-sperm antibodies. Although it was shown in the early 1930's
that women injected with their husbands semen became temporally infertile
(Baskin, 1932), it was not until 1954 that two investigators separately and
independantly reported the existence of antibodies in the ejaculates of men
whose spermatozoa exhibited the phenomena of agglutination (Rumke,
1954; Wilson, 1954). The occurence of these antibodies in semen was
137
"to
subsequently correlated with an inability penetrate cervical mucus
(Fjallbrant, 1965) and to achieve pregnancy (Rumke et al, 1974; Fuchs and
Alexander, 1983). The exact cause of the infertility which results from the
presence of antibodies against spermatozoa appears to be due to either an
impedance of cervical mucus penetration (Fjallbrant, 1965; Kremer and
Jager, 1976; Alexander and Fulgham, 1978; Alexander 1981, 1984) and /or
an inhibition of sperm-egg interactions (Russo and Metz, 1974; Menge and
Black, 1979; Tzartos, 1979; Dor et al, 1981; Aitken et al, 1981; Bronson et al,
1983; Alexander, 1984).
Experimental studies have demonstrated that the active immunisation
of adult males with antigens derived from intact or extracted spermatozoa
can induce infertility in both rats and rabbits (Tung and Woodroffe, 1978;
Lipscomb et al, 1979). Such treatment results in the development over a 2-6
week period of aspermatogenic autoimmune orchitis, characterized by the
appearance of oedema in the intertubular spaces of the testis, and ultimately
by the complete sloughing of the germinal epithelium. These lesions appear
to be induced predominantly by a process of cell mediated immunity, as
thymectomy of adult mice prevents the induction of autoimmune orchitis
(Vojtiskova and Pokorna, 1964). However, due to the pain and inflammation,
as well as doubts over the reliability of such treatment, it is unlikely that the
intentional induction of auto-immune orchitis for contraceptive purposes
would be acceptable.
A more realistic approach to an immunological male contraceptive is
to identify sperm antigens which are capable of inducing a sustained form of
humoral immunity. In this context, encouraging results have been obtained
following the immunization of female baboons with the sperm specific
isozyme of lactate dehydrogenase (LDH-C4) isolated from mouse
spermatozoa (Goldberg et al, 1981). Furthermore, monoclonal antibodies
raised against certain components of the sperm membrane have been
shown to block fertilization both in vitro and in vivo (Saling et al, 1983; Naz
et al, 1984; O'Rand and Irons, 1984). However, worries exist over the
possibilty that anti-sperm antibodies may react with early embryos (Menge
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and Fleming, 1978; Koyoma et al, 1974), could exert an immunosuppressive
effect, or increase susceptibility to arterial disease (Aitken, 1982). It would
thus appear that the development of a vaccine against spermatozoa will
require a great deal of further basic research before this method of
contraception becomes a viable alternative to the means presently
available. The identification of a specific antigen is of paramount
importance, although combinations of anti-bodies, or anti-bodies which
interfere with, rather than directly block the cell recognition events of
fertilization may serve a contraceptive role just as efficiently.
b. Alkylating agents. In the late 1950's, several potent alkylating
agents (tretamine, triethylenephosphoramide, hexamethylphosphoramide
and hexamethylmelamine) were found to induce reversible infertility in male
rats (Jackson and Bock, 1955; Jackson et al, 1959). The antifertility effects of
these compounds apparently acted through effects on sperm DNA, causing
arrest of embryonic development. The toxicity of these compounds coupled
with fears for the production of genetically defective foetuses caused further
study of these compounds to be abandoned. However, bulsuphan, a less
cytotoxic alkylating agent than those previously tested, was also found to
exhibit antifertility effects in male rats (Jackson et al, 1961). This compound
appeared to interfere specifically with the developing spermatogonia, and
thus the onset of infertility was not apparent for a long period. Attempts to
synthesise more potent and less toxic derivatives of these compounds have
so far been unsuccessful (Jackson et al, 1961; Cooper and Jackson, 1970;
Hirsch et al, 1981).
c. 5-Thio-D-glucose. This chemical analogue of D-glucose was found
to cause complete, but reversible, inhibition of sperm development within
three weeks of administration to mice, without affecting libido (Zysk et al,
1975). Similar effects were demonstrated in rats (Homm et al, 1977).
Although the mechanism of action of this compound has not been
elucidated, it may interfere with testicular carbohydrate metabolism.
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However, persistent infertility after cessation of drug treatment (Homm et al,
1977; Lobl and Porteus, 1978) prevented the development of this compound
as a male contraceptive agent
d. a-chlorohvdrin. Experiments performed in the late 1960's revealed
several orally active agents which had rapidly acting antifertility effects upon
male rats (Ericsson and Youngdale, 1970). Of these, the most studied has
been 3-chloro-1,2-propranediol, perhaps better known as a-chlorohydrin.
This compound is known to cause reversible infertility in males of several
species (Ericsson and Baker, 1970; Kirton et al, 1970; Vickery et al, 1974;
Ford et al, 1979), and also to directly inhibit sperm motility (Hommonai et al,
1975; Mohri et al, 1975; Ford et al, 1979; Paz and Homonnai, 1982). a-
chlorohydrin's antifertility effects are thought to be mediated via the
glycolytic enzymes in spermatozoa, especially glyceraldehyde-3-phosphate
dehydrogenase (Mohri et al, 1975; Brown-Woodman et al, 1978; Ford and
Harrison, 1980). However, this compound will not inhibit glyceraldehyde-3-
phosphate dehydrogenase activity directly, and it is thought that an active
metabolite is formed within spermatozoa, most probably S_-oc-
chlorolactaldehyde, which has the same configuration as JR-glyceraldehyde-
3-phosphate, the substrate for glyceraldehyde-3-phosphate dehydrogenase
(Ford and Waites, 1986). However, an inhibitory action directed solely at this
enzyme would not be expected to completely account for the antifertility
effects of a-chlorohydrin, as spermatozoa could utilize lactate or pyruvate as
alternative substrates. Indeed, further investigation has revealed that the
inhibition of glyceraldehyde-3-phosphate dehydrogenase stimulates the
active dissipation of ATP through "futile substrate cycling" within the
glycolytic pathway (Ford and Harrison, 1985), leading to rapid cell death.
Interestingly, the disruption of fetility which resulted from a-chlorohydrin
treatment was not accompanied by a reduction of motility or sperm numbers
(Ericsson and Baker, 1970; Kirton et al, 1970) implying that the antifertility
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effects of this compound may operate via a more subtle disruption of sperm
function than by suppression of metabolism.
In view of the toxicity of a-chlorohydrin (Jackson et al, 1977), attempts
were made to develop more potent and less toxic analogues. Although
antifertility agents with reduced levels of toxicity were produced (Hirsch et al,
1975; James et al, 1978), none of these were deemed to be sufficiently
devoid of adverse side-effects to warrant further development.
However, the close structural similarity seen to exist between a-
chlorohydrin and the metabolites of glucose stimulated an investigation of
the antifertility effects of the chloro-derivatives of six carbon sugars. From the
many sugars tested, it appears that the substitution of a chlorine (Ford and
Waites, 1978), or fluorine (Ford, 1982a) group on the sixth carbon atom is
required for the expression of antifertility activity. Of these compounds, the
most potent is 6-deoxy-6-chloroglucose (Ford and Waites, 1978; Heifeld et
al, 1979; Warren et al, 1979). The readily reversible antifertility effects of this
reagent were thought to be due to an impairment of the oxidation of glucose
in spermatozoa (Ford et al, 1981; Ford and Harrison, 1981). Although this
avenue of male fertility control appeared promising, the demonstration that
the central nervous system of marmosets, mice and rats was adversely
affected by this compound (Jacobs and Duchin, 1980; Jacobs and Ford,
1981; Ford and Waites, 1981; Ford, 1982b) led to a decline in the interest in
these reagents as possible male contraceptive agents
e. Gossvpol. Gossypol (1,11,6,61,7,7i-hexahydroxy-5,5i-diisopropyl-
3,31-dimethyl (2,2i-binapthalene)-8,8i-dicarboxaldehyde) is a lipid soluble,
polyphenolic yellowish pigment isolated from the cottonseed plant (Family
Malavaciae, Genus Gossypium)(Edwards, 1958). In 1957, it was reported
that Wang village in Jiangsu, China had not had a single childbirth for as
long as ten years (Liu, 1957). It was subsequently found that during this time
the villagers had switched, for economic reasons, from using soybean oil to
crude cottonseed oil in the preparation of food. In view of this, Liu (1957)
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suggested that gossypol, the biologically active substance in cottonseed,
may cause infertility in females.
It was not until 1978 that gossypol was identified as being a male
contraceptive agent. In this year it was announced that 4000 healthy
Chinese men had been administered gossypol for a period of 6 months, and
that 99.98% of these had been rendered infertile on the basis of
conventional semen examination (National Coordinating Group on Male
Antifertility Agents, 1978). The oral administration of this drug was
conducted in two phases. The first, an inductive phase of 20mg/day, was
continued until oligozoospermia was achieved (defined as a sperm count of
below 4 million/ml). In most cases this took about two months. The second,
maintenance phase, consisted of single doses of 150-220 mg/month. This
treatment was reported to cause nuclear vacuolation and swelling of the
spermatozoa, whilst prolonged dosage caused almost complete exfoliation
of the germinal epithelium, with the exceptions of the Sertoli cells and the
spermatogonia (National Coordinating Group on Male Antifertility Agents,
1978). This group further reported similar lesions and morphological effects
in laboratory animals treated with gossypol. It has since been shown that in
addition to the human, gossypol is effective in inducing infertility in rats and
hamsters (Chang et al, 1980; Hadley et al, 1981; Hahn et al, 1981; Qixian
and Yuying, 1981; Waller et al, 1981; Weinbauer et al, 1982), although its
antifertility actions are less pronounced in monkeys and mice (Hahn et al,
1981; Shandilya et al, 1982).
A variety of mechanisms have been proposed for gossypol's
antifertility effects, including the disruption of testosterone biosynthesis (Lin
et al, 1981; Hadley et al, 1981), inhibition of germ cell differentiation
(National Coordinating Group on Male Antifertility Agents, 1978; Hadley et
al, 1981; Xue, 1981), disruption of Sertoli-Sertoli junctions, leading to a
breakdown of the blood-testis barrier (Pelletier and Friend, 1980) and the
induction of gonadal prostaglandin biosynthesis (Qian, 1981). In addition to
its testicular effects, gossypol has been shown to have a direct inhibitory
action upon the motility of mature spermatozoa both in vitro and in vivo
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(Waller et al, 1980; Poso et al, 1980; Ridley and Blasco, 1981; Tso and Lee,
1981; Cameron et al, 1982; Aitken et al, 1983; Chongthammakun et al,
1986). The mechanism by which gossypol disrupts motility may involve the
inhibition of glycolysis (Stephens et al, 1983; Wichmann et al, 1983), the
uncoupling of oxidative phosphorylation at the mitochondrial level (Abou-
Donai MB, Dieckert JW, 1974; Poso et al, 1980; Xue, 1981; Tso and Lee,
1982a), or the specific inhibition of the gonadal form of lactate
dehydrogenase, LDH-X (Tso and Lee, 1981, 1982b).
Although gossypol is an effective anti-fertility agent, reservations
about its use as a male contraceptive have arisen because of reports of
possible toxicity, side-effects and incomplete reversibility of
spermatogenesis after drug withdrawal (Prasad and Diczfalusy, 1982).
However, in view of the relatively small doses required to directly inhibit
sperm motility (Poso et al, 1980; Ridley and Blasco, 1981; Stephens et al,
1983; Waller et al, 1983), it has been suggested that gossypol has potential
as a topical, vaginal contraceptive (Waller et al, 1980; Poso et al, 1980; Tso
and Lee, 1981; Cameron et al, 1982; Waller et al, 1983; Ratsula et al, 1983).
Further investigation of the specific anti-fertility mechanism of this drug may
allow the distillation of a potent male contraceptive agent devoid of
deleterious side effects.
f. Sulphasalazine. Sulphasalazine (4-pyridyl-(2)-aminosulphonyl-3-
carboxy-41-hydroxybenzol - also known as Salicylazosulphapyridine,
Azulfidine and Salazopyrin) is an anti-inflammatory drug which has been
employed in the management of inflammatory bowel disease since the early
1940's (Baron et al, 1962). Although originally developed and introduced as
a therapy for rheumatoid arthritis (Svartz, 1942), Its use is now established
for the treatment of ulcerative colitis, and more recently it has been used to
combat the effects of colonic Crohn's disease (Summers et al, 1979). This
drug had been in constant daily use for almost forty years before two groups
separately and independantly reported an association between
sulphasalazine therapy and male infertility (Levi et al, 1979; Toth, 1979).
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Chronic administration of the drug was reported to cause a reduction in
sperm density and sperm motility, whilst increasing the numbers of
morphologically abnormal spermatozoa present in the semen. Several
independant studies have subsequently confirmed and enlarged upon
these original observations (Grieve, 1979; Traub et al, 1979; Birnie et al,
1981; Toovey et al, 1981; Mudge, 1982).
An analysis of the onset of seminal abnormalities in patients taking
sulphasalazine indicated that sperm motility was impaired before density
and morphology were affected (Toovey et al, 1981). Hence, seven men
treated for less than 2 months presented samples in which only 30 ± 1.5 %
of the spermatozoa were progressively motile , significantly different from the
normal range, which has a lower limit of 40%. In contrast, the concentration
of spermatozoa in these semen samples (82.5 ± 21.9 x 106/ml) was within
the normal range (>40 x 106/ml), as was the sperm morphology (70%
normal forms). However, when the duration of sulphasalazine treatment was
extended for more then two months in 17 patients, there was a significant
reduction in both the concentration of spermatozoa (20.9 ± 4.2 x 106/ml) and
in percentage motility (29.0 ± 4.2% progressively motile). Morphology was
also affected significantly after 2 months of sulphasalazine therapy, with 39
+ 4.5% abnormal forms being present. All three seminal parameters
measured tended to improve within two months of sulphasalazine
withdrawal, although none of these changes was statistically significant.
Thus, two months after the cessation of treatment, 11 out of 14 patients
possessed normal concentrations of spermatozoa in the ejaculates (53.6 ±
6.9 x 106/ml) and exhibited some improvement in sperm motility (45.1 ±
2.5% progressively motile), although defects in sperm morphology were still
evident.
Data from a number of centres indicated that upon cessation of
sulphasalazine therapy, normal fertility returns to patients before any
seminal characteristics have reverted to normal levels (Toovey et al, 1981;
Cann and Holdsworth, 1984; Cosentino et al, 1984). It would therefore seem
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that the primary antifertility action of this drug is occurring late in
spermatogenesis or during the epididymal maturation of spermatozoa.
These findings also indicate that the actual mechanism by which
sulphasalazine renders spermatozoa infertile may be by a much more
subtle alteration of sperm function than the gross changes detected in the
conventional semen profile. In contrast to the changes in both sperm
function and the semen profile, the circulating levels of LH, FSH,
testosterone, 5-a-dihydrotestosterone and prolactin show no changes
before, during or after sulphasalazine treatment (Toovey et al, 1981;
Cosentino et al, 1984a; Chodorge et al, 1986), suggesting that the
antifertility action of this drug does not have an overt endocrinological basis.
However, the exact mode of action of this drug remains unknown.
g. Spermicides. These agents act upon spermatozoa as they pass
through the female genital tract. The first commercial spermicide was
developed by an English pharmacist in 1885, who patented the Rendell
pessary. This contained soluble cocoa butter and quinine sulphate (Sciarra,
1979). Since then, many different compounds have been utilized as
spermicides, including mercury, quinine and boric acid. In the early 1950's,
the nonionic detergent nonoxynol-9 (nonylphenoxypolyethyleneoxyethanol)
was introduced, and this agent remains the spermicide in widespread use at
the moment. It is used on the spermicidal condom and in spermicidal foam,
creams, gels, suppositories and sponges. The basis of this compound's
spermicidal activity resides in its ability to solubilise the sperm plasma
membrane, causing rapid immobilization and cell death (Schill and Wolf,
1981; Wilborn et al, 1983).
As nonoxynol-9 is a surfactant, it may have problems contacting
spermatozoa, particularly when they are entrapped in the coagulum, or if
they rapidly enter cervical mucus (Sharman et al, 1986; Zanaveld et al,
1986). Thus, several other compounds have been investigated as potential
vaginal contraceptives. The spermicidal agent chlorohexidine overcomes
some of the problems of nonoxynol-9 by affecting sperm motility during its
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passage through cervical mucus (Sharman et al, 1986). However, this
compound is known to cause vaginal irritation in some people (E Chantler,
personal communication). Further development of this compound as a
spermicide awaits the results of toxicological studies.
Inhibitors of acrosin, implicated as the enzyme responsible for sperm
penetration of the zona pellucida (Stambaugh and Buckley, 1969), and
hyaluronidase, associated with the penetration of the cumulus oophorus
(McClean and Rowlands, 1942), will inhibit fertilization (Zanaveld et al,
1971; Meizel and Lui, 1976; Reddy et al, 1980; Burck and Zimmerman,
1980). Indeed tetradecyl sodium sulphate inhibits both of these enzymes
(Zimmerman et al, 1983). However, the acrosin inhibitors aryl 4-
guanidinobenzoates have attracted the most attention, with several of these
compounds exhibiting greater potency than nonoxynol-9 (Zanaveld et al,
1986). Further clinical testing will reveal whether these compounds present
viable alternatives to nonoxynol-9.
The widely used beta-blocking drug, propranolol, is known to inhibit
human sperm motility (Peterson and Freund, 1973, 1975; De Turner et al,
1978; Zipper et al, 1982). The basis of this compound's spermicidal action is
thought to depend upon its local anaesthetic properties, rather then its beta-
blocking ability, as the purified D-isomer has been found to be as effective
as the racemic mixture in supressing sperm motility, despite the fact that D-
propranolol does not possess the ability to block beta-receptors (Peterson
and Freund, 1973, Hong et al, 1981). This compound has also been
proposed as an alternative vaginal contraceptive (Chijioke et al, 1986).
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Chapter 7. Investigation of the mechanisms of action of
sulphasaiazine and gossypol.
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Figure 45. (a) The numbering of carbon atoms on the prostaglandin
skeleton, (b) The different molecular structure of the classical
prostaglandins. Redrawn from Ramwell et al (1980).
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Figure 46. The initial catabolism of PGE2. The oxidation of the hydroxyl
group of carbon 15 to a keto group is catalysed by 15-hydroxyprostaglandin
dehydrogenase (15-PGDH), whilst the reduction of the double bond
between carbons 13 and 14 to a single bond is catalysed by 15-keto-







^ ^~NHS02H^ ^-NH2 NH2H( jS •OH
SULPHAPYRIDINE 5-AMINOSALICYLIC
ACID
Figure 47. The azo-reduction of sulphasalzine to sulphapyridine and 5-
aminosalicylic acid. Redrawn from Hoult and Moore (1980).
-150-
A. Introduction.
The mechanism by which sulphasalazine causes infertility is
unknown. However, investigations into the mechanisms by which this drug
combats the effects of ulcerative colitis have shown that it is a potent
inhibitor of prostaglandin metabolism (Hoult and Moore, 1980).
Prostaglandins (PG's) are cyclic derivatives of certain unsaturated fatty acids
with 20 carbon atoms (Fig 45). They are found in many animal tissues and
have a variety of profound hormone-like, physiologic and pharmacologic
properties. PG levels within tissues are governed by the rates of their
production and degradation. They are not stored, and therefore their action
within a certain organ is controlled as much by metabolism as synthesis.
The initial catabolism of PGs involves oxidation of the hydroxyl group of
carbon 15 to a keto group, then reduction of the double bond between
carbons 13 and 14 to a single bond (Ramwell et al, 1980 - Fig 46). The
primary enzymes involved in this metabolic pathway are 15-
hydroxyprostaglandin dehydrogenase (15-PGDH), and 15-keto-
prostaglandin-13,14-reductase (13-PGR). Sulphasalazine is a potent
inhibitor of the initial catabolic step, catalysed by 15-PGDH, but not of the
second step, catalysed by 13-PGR (Moore et al, 1978; Hoult and Moore,
1978, 1980). Inactivation of PG breakdown is postulated to invoke the
cytoprotective and anti-ulcerative effects of PG's in the colonic mucosa
(Hoult et al, 1979; Hoult and Moore, 1980).
Of orally ingested sulphasalazine, approximately 33% is absorbed in
the small intestine, whence it undergoes entero-hepatic circulation.
Acetylated and free sulphasalazine subsequently appear in the urine. The
sulphasalazine that passes to the large bowel is azo-reduced by bacterial
action to form sulphapyridine and 5-aminosalicylic acid (Das et al, 1973a, b
- Fig 47). Neither of these metabolites has been found to inhibit 15-PGDH
activity in a manner similar to the parent molecule (Hoult and Moore, 1980).
Since the influence of sulphasalazine upon ulcerative colitis is thought to
involve the inhibition of prostaglandin catabolism, a rational approach to the
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investigation of its antifertility action was to examine the role that
prostaglandins play in the regulation of male reproductive function. Although
very little is known about the levels of PGs present in the human testis and
epididymis, the endocrine functions of both these organs have been shown
to include PG production (Buhrley and Ellis, 1975; Gerozissis and Dray,
1977). Furthermore, PGs have been shown to be present in both the testis
(Carpenter and Wiseman, 1970) and epididymis (Gerozissis and Dray,
1977) of the rat, and PG metabolising enzymes have also been located in
the reproductive tract of this animal (Nakano and Prancan, 1971; Nakano et
al, 1971; Ohuo-Obasiolu, 1983). PGs are known to have stimulatory effects
on both seminiferous and epididymal tubule contractions (Hunt and
Nicholson, 1972; Buhrley and Ellis, 1975; Poulos et al, 1975; Abbatiello et
al, 1976; Farr and Ellis, 1980), and are thought to bind to both human
(Mercado et al, 1978), and rabbit (Bartoszewitcz et al, 1975) spermatozoa. A
role for PG's in the maturation of spermatozoa in the epididymis has been
postulated (Glover and Nicander, 1971; Johnson and Ellis, 1977), and they
are known to have a profound effect upon the fertilizing potential of human
spermatozoa in vitro (Aitken and Kelly, 1985).- In addition, the exogenous
administration of PGs has been reported both to suppress spermatogenesis
and inhibit epididymal sperm motility in rats (Ericsson, 1973). In light of
these observations, it would seem reasonable to suppose that PGs are
involved in some way in the regulation of male reproductive function, and
that sulphasalazine and possibly gossypol exert their antifertility effects
through the disruption of PG catabolism. This study therefore investigates
this possibility by measuring the activity of the 15-PGDH enzyme, as well as
its regulation by sulphasalazine and gossypol, in the male reproductive tract
of the rat and and the human.
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B. Materials and Methods.
i. Reagents. 13,14-dihydro-15-keto [5,6,8,11,12,14(n)-3H] PGE;
(80Ci/mmol) was purchased from the radiochemical centre (Amersham,
England). Authentic PGs and PG metabolites were the gift of Dr J Pike
(Upjohn Co, Kalamazoo, Ml). Cofactors were obtained from Sigma (Poole,
England). Sulphasalazine, sulphapyridine and 5-aminosalicylic acid were
purchased from Pharmacia (Uppsala, Sweden). (±) Gossypol acetic acid
was obtained from the Beijing Family Planning Institute (Beijing, China). The
(+) and (-) enantiomers of gossypol were gifts from Dr S Matlin (City
University, London). An antiserum specific for the methoximated derivatives
of PGE2 metabolites was a gift from Dr RW Kelly (MRC Reproductive Biology
Unit, Edinburgh). Solvents (Analar grade) were purchased from BDH
(Glasgow).
ii. Tissue preparation. Human testicular and epididymal tissue was
removed from the cadavers of whole organ donors in the post-mortem room
of the Royal Infirmary of Edinburgh. Once excised, the tissue was placed on
ice for the short journey from the post-mortem room to the laboratory. Rats
(Rattus norveaicus L) CD strain (Sprague Dawley), housed in the MRC
Centre for Reproductive Biology's animal house under 12h daylight, with
free access to food and water, were suffocated with CO2 and killed by
cervical dislocation Tissue from both species were divided into testicular,
caput (rat, site 1-3 - Hinton et al, 1979a; human, region 1 b-1 d - Bedford et al,
1973), corpus (rat, site 4-5 - Hinton et al, 1979a; human, region 2a-4a -
Bedford et al, 1973), or caudal (rat, site 6-7 - Hinton et al, 1979a; human,
region 4b-5 - Bedford et al, 1973) epididymal regions. These were then
weighed, placed in ice-cold 0.05M tris/glycerol buffer, pH 7.4, and
homogenised in a polytron homogeniser (Brinkmann Instruments, Westbury,
New York) at full speed for 15 seconds. Cell debris was removed by
centrifugation at 1500g for 10 mins at 4°C. The supernatant was then
removed and stored at a tissue concentration of 100mg/ml at -18°C. The
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concentration of protein present in these tissue preparations was
determined using the method of Lowry et al (1951).
iii. Incubation conditions. Prior to use, each tissue extract was thawed
and diluted with ice-cold tris/glycerol buffer to a tissue concentration of
10mg/ml. 1.0ml of this solution was then pre-incubated in a shaking water
bath at 35°C for 5 mins with 1mM NAD+ (added in 40(il of tris buffer) and,
when appropriate, the test concentration of drug. After pre-incubation, 5pM
PGE2 was added as substrate in 20pl of ethanol/tris (4:1). Enzyme
characteristics were determined by incubation in the presence of varying
concentrations of substrate.
After a final incubation period of 15mins, the reaction was terminated
by the addition of 1ml of methoxymating solution (0.12mM methoxyamine
hydrochloride in 1.0M sodium acetate, pH 5.2). Methoxymation of the
prostaglandins present was achieved by heating the incubation at 60°C for
30mins.
iv. Derivatisation of prostaglandins. PGs and their metabolites will not
remain stable in aqueous solution. 13,14-dihydro-15-keto-PGE2 (EM2)
undergoes non-enzymic conversion to its bicyclic derivative, 13,14-dihydro-
15-keto-113,16 -cyclo-PGE2 via the intermediate 13,14-dihydro-15-keto-
PGA2. These compounds comigrate upon thin layer chromatography and
are collectively termed EM3. To avoid these and other non-enzymic
changes, measurements of the metabolites of PGs were performed upon
their methyl-oxime derivatives. Authentic PGs and their metabolites were
derivatised using the method of Kelly and Abel (1983). Antisera specific for
PGEM2 was raised against its methoxymated derivative coupled to human
serum albumin. PGs and their metabolites formed in incubations were
derivatised by the addition of methoxymating solution (see above). This
process stopped any enzymic reactions and furthermore prevented the
occurrence of non-enzymic destabilization.
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v. Determination of 15-PGDH activity. The activity of this enzyme in
different incubations was estimated by measuring the production of the first
metabolite of PGE2 catabolism, namely 15-keto PGE2 (PGEM1). These
measurements were performed using the radioimmunoassay procedure
described by Kelly et al (1986). The conversion of PGEM1 to PGEM2 was
prevented by cryostorage of the tissue extract, which denatures the co-factor
(NADPH) required for this step in the metabolic pathway (Abel and Kelly,
1983). Furthermore, the sole exogenous co-factor added to the incubation
mixtures was NAD+, which only catalyses the conversion of PGE2 to PGEM1.
For the assay of PGE2 metabolites, 0.1ml (0.01 pCi) of 3H PGEM1 in assay
buffer (tris 0.05mol/l, pH7.4, with 0.05% sodium azide and 0.03% EDTA,
plus 5% bovine gamma globulin) and 0.1ml of either unlabelled
methoxymated EM1 (4 - 2048 pg), or an aliquot from an incubation made to
0.1ml with assay buffer, were incubated with antisera specific for EM1 at a
dilution of 1:16000, in a 2ml capacity assay tube. Under these conditions,
approximately 35% of tritiated PG was bound in the absence of unlabelled
PG. The tubes were vortexed thoroughly and incubated for 1 h at 37°C,
followed by overnight storage at 4°C, allowing adequate time for
equilibration. The free fraction was then separated from the fraction bound to
the antibody using polyethylene glycol (PEG) with a molecular weight of
approximately 6000. 0.8ml PEG (300mg/ml in phosphate buffered saline, pH
7.0) was added to each tube. The mixture was then vortexed and centrifuged
at 1000g for 10 mins. The supernatant was removed and the pellet
resuspended in 1.0ml of cumene based scintillation fluid (Optiphase RIA,
Fisons, Crawley, England) using a multitube vortexer. The radioactivity
present in each tube was counted on an LKB liquid scintillation counter.
Standard curve plotting and analysis of unknowns was performed on an
apple benchtop computer linked to a Texas Instruments printer, pre¬
programmed to analyse radioimmunoassay data and perform spline fitting.
The antisera crossreacted with PGE1, PGE2, PGFM2 (13-14-dihydro-
15-keto PGF2a) at levels less than 1%, but cross reacted 100% with PGEM1
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and PGEM2. All solvents and chemicals used in the incubations were tested
for cross-reaction with the antisera. None inhibited or cross-reacted at the
concentrations used in these experiments. The inter- and intra-assay
coefficients of variation were 8.4% and 3.5% respectively.
vi. Statistical analysis. The statistical significance of the results was
assessed using analysis of variance (Winer, 1971). Differences between the
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Figure 48. A Lin ewe aver-Burke plot of the effect of increasing substrate
concentration on the conversion of PGE2 to 15-keto PGE2 by the NAD+
dependant 15-hydroxy prostaglandin dehydrogenase from the rat
epididymis. The line of best fit was obtained using weighted regression
analysis.
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Figure 49. 15-PGDH activity in the testis and caput, corpus and cauda













CONCENTRATION OF SULPHASALAZINE (pM)
Figure 50. Dose response curve for the effects of sulphasalazine on rat
epididymal 15-PGDH activity. Values shown are mean ± sem, n=6. -
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C. Results.
i. Enzvme characteristics. The characteristics of the enzyme are
shown as a Lineweaver-Burke plot (Fig 48). The Km value calculated from
this graph is 2.94 x 10-6mol/l, which compares with a value of 2.8 x 10-6mol/l
determined for the 15-PGDH enzyme from human myometrial tissue (Abel
and Kelly, 1983), indicating that the same enzyme is present in both studies.
ii. Basal enzvme levels. Appreciable levels of 15-PGDH activity were
measured in the reproductive tracts of both the rat and the human. In the
latter, the 15-PGDH activity (measured in terms of amount of first metabolite
of PG metabolism produced per mg protein per minute) was 3.90 ± 0.32
ng/mg/min in the testis and 3.7 ± 0.38 ng/mg/min in the caput region of the
epididymis. Significantly (P<0.01) higher levels of enzyme activity were
detected in the more distal regions of the epididymis, giving 7.39 ± 0.50
ng/mg/min in the corpus and 6.34 ± 0.52 ng/mg/min in the cauda (Fig 49a).
In the rat, the activity of the 15-PGDH enzyme in all regions of the
reproductive tract was significantly (P<0.01) greater than in the human,
although the relative distribution was similar. Hence in the rat testis and
caput epididymis, the levels were 18.7 ± 2.4 ng/mg/min and 7.0 ±1.5
ng/mg/min respectively, rising significantly (P<0.01) to 37.8 ± 5.0 and 67.9 ±
7.3 ng/mg/min in the corpus and cauda (Fig 49 b).
iii. Enzyme response to drug treatment.
a. Sulphasalazine and its metabolites. The effects of sulphasalazine
and its metabolites, sulphapyridine and 5-amino salicylate, on 15-PGDH
activity was assessed using enzyme obtained from homogenates of the
whole rat epididymis. A dose-dependant study revealed a biphasic
response to treatment with sulphasalazine, with a stimulation of enzyme
activity occurring at low levels, around 0.5 - 1.0 pM, followed by inhibition at
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Figure 51. Dose response curve for the effects of sulphapyridine on rat
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Figure 52. Dose response curve for the effects of 5-aminosalicylate on rat










CONCENTRATION OF GOSSYPOL (jjM)
Figure 53 Dose response curve for the effects of racemic gossypol on rat
epididymal 15-PGDH activity. Values shown are mean ± sem, n=6.
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TREATMENT ACTIVITY (ng/mg/min)
Control 7.17 ± 0.56
(-) Gossypol 0.5pM 9.71 ± 0.92*
(-) Gossypol 1.0pM 8.05 ±0.58
(+) Gossypol 0.5pM 7.45 ±0.52
(+) Gossypol I.OjiM 8.80 ±0.62
* F=4.52: P<0.05 [(-) gossypol vs control]
Dunnetts t=2.9: P<0.01 (0.5jiM vs control)
Table 1. Influence of the resolved enantiomers of gossypol on rat epididymal
15-PGDH activity. Values shown are mean ± sem, n=8.
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found to be statistically significant (P<0.05) and to represent a 30.0 ± 2.3%
increase over control levels at a dose of 0.5jiM. Sulphapyridine also tended
to increase the activity of this enzyme over a wide range of doses, although
in this case, the stimulation was not statistically significant (Fig 51). The
second metabolite of sulphasalazine, 5-amino salicylate, did induce a
significant increase in the activity of this enzyme, equivalent to a rise of 64.2
± 4.2% over control levels at a dose of 1pM (Fig 52).
b. Gossvpol. As shown in Fig 53, gossypol produced a dose response
curve which was very similar to sulphasalazine, incorporating the same
stimulation of activity at low doses of 0.5 - 1.0 pM, followed by an inhibitory
action at concentrations above 100pM. Furthermore, this activity appeared to
be confined largely to the (-) optical enantiomer of gossypol (Table 1), which
is thought to be responsible for the contraceptive properties of this
compound (Waller et al, 1983; Matlin et al, 1985). At a concentration of
0.5pM, (-) gossypol significantly (P<0.01) stimulated 15-PGDH activity, from
a control level of 7.17 ± 0.56 ng/mg/min to 9.71 ± 0.92, whilst at the same
dose, (+) gossypol produced no significant effect. Neither enantiomer
stimulated enzyme activity at a concentration of 1.0pM.
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D. Discussion.
These studies have demonstrated that the enzyme targeted by
sulphasalazine in the large intestine, 15-PGDH, is also present in the testis
and epididymis of both the rat and human. In both species, the activity of this
enzyme increases in the distal portions of the epididymis paralleling, in the
rat at least, the distribution of PGE2, which increases in concentration by a
factor of four during transit from the caput to the cauda epididymis
(Gerozissis and Dray, 1977).
The exact biological role of the PGE2 detected in the epididymis
remains unknown. However, PGs have been shown to affect the movement
of spermatozoa from both the rabbit (Schlegel et al, 1983) and the human
(Schlegel et al, 1981), and are known to stimulate the fertilizing potential of
human spermatozoa in a trans-species in vitro fertilization system (Aitken
and Kelly, 1985). Sperm motility has also been correlated with seminal PGE
levels (Isidori et al, 1980; Cosentino et al, 1984b).
The biochemical mechanisms by which PGEs influence sperm
motility and fertilizing potential is also unclear. However, these agents are
known to increase the cAMP content of spermatozoa (Heindel et al, 1978;
Cosentino et al, 1982; Kelly et al, 1984; Aitken et al, 1986), an action which
has been found to stimulate both the motility and fertilizing capacity of
mature spermatozoa (see chapter 1). Such an increase in cAMP content
may be achieved either directly by activation of the adenylate cyclase
(O'Donnel, 1974), or indirectly via the induction of a calcium influx, through
the ionophore-like activity of these compounds (Kirtland and Baum, 1972),
which consequently causes an increase in cAMP levels (Aitken et al, 1986).
The influence of sulphasalazine on ulcerative colitis appears to
involve the inhibition of PG catabolism, thus invoking the cytoprotective
effects of the PGs which subsequently accumulate in the intestine (Hoult and
Moore, 1980). However, the suppression of rat epididymal 15-PGDH by high
doses (>100p.M) of sulphasalazine is probably irrelevant in the context of
contraception, as although such levels may be achieved in the bowel, it is
- 166
extremely doubtful whether such concentrations would be attainable in the
peripheral circulation. Of greater interest in terms of male fertility control is
the significant increase in 15-PGDH activity observed at sulphasalazine
concentrations of around 0.5 - 1.0 jiM. Intriguingly, similar concentrations of
the male contraceptive agent gossypol also induced a corresponding
increase in the activity of this prostaglandin catabolizing enzyme.
Furthermore, when the resolved enantiomers of gossypol were examined for
their influence on 15-PGDH activity, only (-) - gossypol was found to possess
stimulatory activity. This is of significance because it is only the (-)
enantiomer which is thought to be capable of disrupting fertility (Waller et al,
1983; Matlin et al, 1985).
Stimulation of 15-PGDH activity in vivo would be expected to lower
the PG content of the epididymis. Some evidence that a reduction of PG
levels within the male reproductive tract might disrupt fertility has been
obtained from studies in which asprin (Biswas et al, 1978; Ratnasooriya and
Lionel, 1984) and fenclozic acid (Ratnasooriya and Wadsworth, 1979) have
been shown to exert a contraceptive action, presumably through the ability
of these reagents to disrupt PG synthetase activity. Furthermore, the addition
of exogenous 15-PGDH to the seminal plasma from rabbits (Schlegel et al,
1983) and man (Schlegel et al, 1981) has been shown to reduce sperm
motility.
However, direct evidence for a lowering of testicular or epididymal
prostaglandin levels following treatment with sulphasalazine or gossypol is,
at present, lacking. Analysis of the seminal prostaglandin levels in patients
receiving sulphasalazine treatment did not reveal any significant deviations
from those of normal fertile males (Cosentino et al, 1984a). However, the
prostaglandin content of seminal plasma is largely a reflection of the
synthetic capacity of the seminal vesicles (Kelly, 1981), and is unlikely to
reflect the levels obtained in the testis and epididymis.
Sulphasalazine undergoes azo-reduction in the intestine to produce
5-amino salicylic acid and sulphapyridine (Das et al, 1973a, b). The limited
studies that have been carried out on the rat have shown that
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sulphapyridine alone is capable of reducing fertility in this species (O'Morain
et al, 1982; Pholpramool and Srikhao, 1983). Furthermore, 5-
aminosalicylate has no effect on the fertility of either rats (O'Morain et al,
1982; Pholpramool and Srikhao, 1983) or humans (Cann and Holdsworth,
1984; Shafferet al, 1984). However, although the putative contraceptive
component of sulphasalzine, sulphapyridine, is capable of reducing the
fertility of rats (O'Morain et al, 1982; Pholpramool and Srikhao, 1983), it is
not as efficient in this respect as an equivalent dose of sulphasalazine. This
is difficult to equate with the claim that sulphapyridine is the active
metabolite, unless the bioavailabilty of the latter is a problem in the rat.
These results may indicate that the parent compound itself plays an active
role in the induction of temporary infertility. Whether sulphapyridine causes
infertility in humans is unknown. If this compound was found to be active in
man, it would obviously counteract the suggestion that the stimulation of 15-
PGDH activity is a significant factor in the contraceptive action of either
sulphasalazine or gossypol, since the in vitro studies described here
indicate that sulphapyridine does not exert a significant effect upon this
enzyme. In addition, the observation that 5-amino-salicylic acid stimulates
15-PGDH activity, whilst being ineffective in inducing infertility in man and
rats (O'Morain et al, 1982; Pholpramool and Srikhao, 1983; Cann and
Holdsworth, 1984; Shaffer et al, 1984) would also suggest that stimulation
of 15 PGDH activity is not involved in the induction of infertility.
Analysis of the literature reveals reports of other sulphonamide type
compounds causing infertility. Co-trimoxazole (a sulphonamide containing
mixture) (Murdia et al, 1978), and dapsone (a sulphonamide related
molecule) (Grieve, 1979) have both been found to reduce sperm numbers
and sperm motility. A subsequent study has confirmed and extended these
findings (Wong et al, 1987). Although the sulphonamide, sulphamethizole,
did not cause infertility in rats dosed orally with this compound (Levi et al,
1982), this may give a clue as to the pharmacological basis of
sulphasalazine's action, as sulphamethizole differs from sulphapyridine, the
putative anti-fertility portion of sulphasalazine, in that it has no pyridine ring
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in its structure. As sulphasalazine is known to inhibit both intestinal folate
transport and the enzymes dihydrofolate reductase, methylene-
tetrahydrofolate reductase and serine transhydroxymethylase (Franklin and
Rosenberg, 1973; Selhub et al, 1978), it is possible that this compounds anti-
fertility action may be mediated via effects on this vitamin. However the
demonstration that patients receiving sulphasalazine therapy showed no
improvement in their semen profile upon administration of large doses of
folate (O'Morain et al, 1984), and that seminal folate levels in sulphasalazine
treated patients were normal (O'Morain et al, 1985) suggest that these
compounds are not involved in the antifertility action of sulphasalazine.
Recent reports that sulphasalazine affects the production of reactive
oxygen species (Myachi et al, 1987), and that sperm membrane lipid
peroxidation increases after sulphasalazine treatment (Chodorge et al,
1986) are of interest in view of the inverse relationship shown to exist
between high levels of free oxygen radical production by human
spermatozoa and their ability to fuse with and penetrate zona-free hamster
eggs (Aitken and Clarkson, 1987). Although it has been stated that
sulphasalazine itself does not constitute an acceptable male contraceptive
(Giwercman and Skakkebaek, 1986) its action may provide clues for the
development of a target-specific, non-hormonal male contraceptive.
In conclusion, these studies have demonstrated that the first enzyme
of prostaglandin metabolism, 15-PGDH, is present in the testis and
epididymis of both the rat and the human. The concentration of this enzyme
was found to be greater in the corpus and caudal regions of the epididymis,
and its activity could be modulated by the male contraceptive agents
sulphasalzine and (-) gossypol. Available data suggests an important role
for prostaglandins in the control of male reproductive function, and that
agents which disrupt the synthesis or catabolism of this group of compounds
may have potential as male contraceptive agents. Whether these particular
contraceptive agents function through the disruption of PG metabolism is,
however, debatable.
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Chapter 8. Investigation of the mechanism of action of
propranolol, and its possible synergism with nonoxynol-9
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A. Introduction.
Spermicides exert an antifertility effect upon spermatozoa as these
cells pass through the female genital tract. Currently, the nonionic detergent
nonoxynol-9 (nonylphenoxy-polyethyleneoxyethanol) is the spermicide in
widespread use, being used on the spermicidal condom, in spermicidal
foam, creams, gels, suppositories and sponges. The basis of this
compound's spermicidal activity resides in its ability to solubilise the sperm
plasma membrane, causing rapid immobilization and cell death (Schill and
Wolf, 1981; Wilborn et al, 1983).
However, as nonoxynol-9 is a surfactant, it may have problems
contacting spermatozoa, particularly when they are entrapped in the
coagulum formed after ejaculation, or if they rapidly enter the cervical mucus
(Sharman et al, 1986; Zanaveld et al, 1986). Thus, several other compounds
have been investigated as potential vaginal contraceptives. These include
the widely used beta-blocking drug, propranolol, which is known to inhibit
human sperm motility (Peterson and Freund, 1973, 1975; De Turner et al,
1978; Zipper et al, 1982).
The basis of this compound's spermicidal action is thought to depend
upon its local anaesthetic properties, rather thejn its beta-blocking ability, as
the purified D-isomer has been found to be as effective as the racemic
mixture in supressing sperm motility, despite the fact that D-propranolol does
not possess the ability to block beta-receptors (Peterson and Freund, 1973,
Hong et al, 1981). Propranolol thus constitutes a potential candidate for
development as a novel spermicidal agent (Chijioke et al, 1986). The
possibility also exists that propranolol may interact synergistically with
nonoxynol-9 to produce a novel potent "cocktail" spermicide. At the request
of Family Health International, the sponsors of this Ph.D. fellowship, a study
was conducted into both the mode of action of propranolol and its interaction
with nonoxynol-9.
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B. Materials and Methods.
i. Sperm preparation. Semen samples were produced by
masturbation into sterile plastic containers by donors exhibiting normal
semen profiles (>20 x 106 spermatozoa/ml; >40% progressive motility and
>40% normal morphology - Aitken et al, 1982). The spermatozoa were
separated from the seminal plasma by 3 cycles of centrifugation at 500g for
5 min in 8 ml volumes of medium BWW (a modified Krebs-Ringer
bicarbonate buffer described by Biggers et al, 1971), and were finally
resuspended at a sperm concentration of 20 x 106 spermatozoa/ml and kept
at 37°C prior to use.
ii. Motility analysis. The concentration of motile cells in washed sperm
preparations was assessed by counting at least 100 cells in a 10pil aliquot at
x250, with the aid of a grid on an eye-piece graticule. The effects of drugs on
sperm motility in unwashed semen was determined using the Sander-
Cramer test (Sander and Cramer, 1941), whereby 200pl of freshly
ejaculated semen is mixed with 500pl of drug solution, and the percentage
of motile spermatozoa present 20 sees after drug addition is estimated.
iii. Sperm Function. The assessment of human sperm function was
carried out using the zona-free hamster oocyte assay introduced by
Yanagimachi et al (1976). The acrosome reaction was induced by pre
-incubating spermatozoa in the presence of the divalent cation ionophore
A23187, prepared as an aqueous suspension of the Ca2+/Mg2+ salt
(0.026mg/ml) (Aitken et al, 1984). Capacitated spermatozoa were then
washed free of A23187 at the end of the pre-incubation phase and
subsequently incubated with zona-free hamster oocytes for 3 h in fresh
BWW. In order to assess the incidence of sperm-oocyte fusion, the oocytes
were washed to remove loosely adherent spermatozoa and then
compressed to a depth of about 30pM before examination at x250 by phase
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contrast microscopy. The percentage of oocytes containing decondensed
sperm heads with an attached or closely associated tail, as well as the mean
number of penetrations per oocyte, were recorded. The number of oocytes
incorporated into each assay (20-30) was sufficient to ensure an adequate
sperm-oocyte collision frequency (Aitken and Elton, 1986). In addition,
corrections for small differences in the concentration of motile spermatozoa
were made using the formula, based on Poisson distribution theory, to
adjust all results for a constant concentration of motile spermatozoa (5 x
106/ml), where P2=1 - exp( - rm-i), in which P2 = the corrected penetration
rate for a motile sperm concentration of 5 x 106/ml, r = the ratio of the
theoretical concentration of motile spermatozoa (ie 5) to the actual
concentration recorded in the experiment, and mi = the observed outcome
of the pernetration test in terms of the mean number of spermatozoa
penetrating each oocyte (Aitken and Elton, 1984).
iv. Intracellular calcium measurements. The influence of propranolol
on the intracellular concentration of free, extramitochondrial Ca2+ was
assessed by monitoring the fluorescence signal emitted by the calcium
chelating agent, Quin-2, originally described by Tsien et al (1982), following
the methodology outlined by Irvine and Aitken (1986). Briefly, spermatozoa
were washed 3 times with medium BWW, and finally resuspended at a total
sperm concentration of 20 x 106/ml. Quin-2-tetracetoxymethyl ester was
added from a stock solution in dimethylsulphoxide to achieve a final
concentration of 50|iM, and the cell suspension was then incubated at 37°C
in 5% CO2 in air for 20 min. The cell suspension was then diluted 1:9 with
fresh BWW and the incubation continued for a further 100 min. The cells
were subsequently washed twice by centrifugation at 500g to remove
extracellular Quin-2, and finally resuspended in fresh medium BWW to a
concentration of 10 x 106/ml. Fluorescence measurements were performed
in a Perkin-Elmer spectrofluorimeter, with the excitation wavelength set at
339nm and the emission wavelength at 492 nm. The suspension of
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spermatozoa was maitained at 37°C in quartz cuvettes for the duration of
each series of measurements. The entry of Quin-2 into the cells was
checked by observing the shift in the fluoresence maximum from 430 to
492nm. The intracellular calcium content was calculated using the equation
[Ca2+]j = Kd(F-Fmin)/(Fmax-F), where Kd = 115nM (Tsein et al, 1982). Fmax
and Fmin were determined by the addition of 0.5% v/v triton X-100, followed
by 10mM EGTA.
v. Reagents. Purified D-propranolol was provided by Family Health
International (Research Triangle, North Carolina, USA). All other
biochemicals were obtained from either Sigma (Poole, England), or BDH
(Glasgow, Scotland) and were of the highest purity grade available.
vi. Statistics. All statistical comparisons were made using the non
-parametric Mann-Whitney U test.
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Figure 54. Percentage motility expressed by human spermatozoa incubated
in either medium BWW alone (open squares), or medium BWW plus DL
propranolol at a concentration of 5 (closed diamonds), 50 (open diamonds),
or 500 (closed squares) pM. Values shown are the mean ± sem of six
separate determinations. Significance levels are; *, P<0.05, **, P<0.0"1.
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Figure 55. Percentage motility expressed by two different human sperm
samples (hatched and closed squares) incubated in medium BWW plus DL
propranolol at a concentration of 500 pM. Control values (open squares) are
the mean of six separate determinations performed in medium BWW alone.
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Figure 56. Percentage motility expressed by human spermatozoa incubated
in either medium BWW alone (open squares), or medium BWW plus
nonoxynol-9 at a concentration of 5 (closed diamonds), 50 (open
diamonds), or 500 (closed squares) pg/ml. Values shown are the mean ±
sem of six separate determinations. Significance levels are; **, P<0.01.
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Figure 57. Percentage motility expressed by human spermatozoa incubated
in either medium BWW alone (open diamonds), or medium BWW plus
75pg/ml nonoxynol-9 (open squares), 500jiM DL propranolol (closed
squares), or both of these reagents at the doses already stated (closed
diamonds). Values shown are the mean ± sem of six separate
determination. Significance levels are; ** P<0.01.
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C. Results.
i. Motility analysis. Time and dose dependant studies utilising the
racemic mixture of propranolol revealed that, when added at the relatively
low dose of 5|iM, this reagent caused a transient stimulation of human
sperm motility, 30 mins after addition. When present at a concentration of
50jiM, this compound had no significant effects on sperm movement.
However, at the higher concentration of 500pM, DL propranolol caused a
significant (P<0.01) suppression of motility within 15 mins of addition, and
after 1 h of incubation, motility had been reduced to negligible levels (Fig
54). However, the response of different semen samples to this compound
varied greatly, as can be seen in Fig 55, with some samples showing
complete loss of motility within 10 min of the addition of 500pM DL
propranolol, whereas other samples continued to show low levels of motility
as long as 2 hours after the addition of this concentration of propranolol.
Time and dose dependant analysis of the effects of nonoxynol-9
revealed that at a concentration of 5pg/ml, this reagent had no significant
effect on human sperm motility over a period of 240 mins. However, at a
dose of 50 jig/ml, this drug caused a significant (P<0.01) reduction of motility
within 30mins of addition. At a concentration of 500|ig/ml, nonoxynol-9
completely abolished all sperm movement within 1 min of addition (Fig56).
To investigate the interaction of these two spermicidal agents, a
concentration of each compound was chosen which caused only a gradual
inhibition of sperm motility. When incubated in the presence of DL-
propranalol at a concentration of 500p.M, no significant effect upon motility
was seen after 30 mins of incubation. Nonoxynol-9 at a dose of 75pg/ml
caused a slight but significant (P<0.01) reduction in motility by 20 mins after
the addition of this reagent. However, when both compounds at these
concentrations were added to incubations of human spermatozoa, motility
was reduced by 50% within 1 min of addition, and was completely abolished
after 5 mins of incubation (Fig 57).
Dose and time dependant studies of the possible spermicidal effects
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Figure 58. Percentage motility expressed by human spermatozoa incubated
in the presence of 500|iM DL propranolol in either medium BWW (open
squares), or calcium free BWW (closed squares). Values shown are the
mean ± sem of six separate determination. Significance levels are; *,
P<0.01; **, P<0.01.
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Figure 59. Percentage motility expressed by human spermatozoa incubated
in either medium BWW alone (open squares), or medium BWW plus D
propranolol at a concentration of 5 (closed squares), 50 (open diamonds), or
500 (closed squares), or 5000 (closed triangles) pM. Values shown are the




Figure 60. Percentage motility expressed by human spermatozoa incubated
in either medium BWW alone (open squares), or medium BWW plus 75pg/ml
nonoxynol-9 (closed squares), 500|iM D propranolol (open diamonds), or
both of these reagents at the doses already stated (closed diamonds).
Values shown are the mean ± sem of six separate determination.
Significance levels are; **, P<0.01.
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of purified D propranolol were also investigated. As with racemic
propranolol, this resolved enantiomer caused a transient stimulation of
sperm motility soon after addition at a concentration of 5|iM, although this
increase was not statistically significant. However, in contrast to the effects of
the unresolved form of this drug, D propranolol at a concentration of 5jiM
caused a significant (P<0.01) reduction in percentage motility over an
incubation period of 120 mins. A similar response profile to that expressed in
the presence of 5pM D propranolol was found for 50jiM of this reagent. In
contrast to the effects of DL propranolol, when added at a concentration of
500|iM, D propranolol did not completely abolish sperm movement over a
120 min incubation period, although a significant (P<0.01) suppression of
sperm motility did occur. When added at a concentration of 5mM, D
propranolol caused a total inhibition of sperm movement within 1 min of
addition (Fig 59).
In view of the apparent synergism between DL propranolol and
nonoxynol 9 in the suppression of sperm movement, a study was
undertaken of the interaction between nonoxynol-9 and D propranolol in the
disruption of sperm motility. Incubation in the presence of nonoxynol-9 at a
dose of 75|ig/ml caused a slight but significant (P<0.01) suppression of
sperm movement. D propranolol at a concentration of 500pM caused a
significant (P<0.01) reduction in motility by 1 min after its addition. However,
when both these compounds at these concentrations were added to
incubations of human sperm, motility was almost completely abolished
within 1 min of addition, and was reduced to zero after 5 mins of incubation
(Fig 60).
To determine whether these drugs would interact positively to inhibit
sperm motility in a spermicidal context, their effects both alone and in
combination upon the movement of spermatozoa in unwashed semen were
determined. For this study, concentrations of the individual reagents were
chosen which had only a slight effect on sperm motility on their own. When
added at a concentration of 300 pg/ml, nonoxynol-9 had a slight, but
insignificant suppressive effect on seminal sperm motility within 20 sees of
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Figure 61. Percentage motility expressed by unwashed human spermatozoa
incubated for 20 sees in the presence of vehicle alone (medium BWW - open
bar), 300fig/ml nonoxynol-9 (lined bar), 850(iM D propranolol (dotted bar), or
both of these reagents at the doses already stated (closed bars). Values
shown are the mean ± sem of six separate determination. Significance
levels are; **, P<0.01.
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Figure 62. Free intracellular calcium content (closed squares) and
percentage motility (open squares) determined for human spermatozoa
































Figure 63. Free intracellular calcium content (closed squares) and
percentage motility (open squares) determined for human spermatozoa
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Figure 64. Corrected percentage penetration of zona-free hamster oocytes
(open bars) and percentage motility expressed by human spermatozoa
inubated in the presence of 0, 50, 100 and 200}iM DL propranolol. Values
shown are the mean ± sem of six separate determination. Significance
levels are; *, P<0.05; **, P<0.01.
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drug addition. D propranolol at a dose of 850p.M significantly (P<0.01)
inhibited sperm movement within 20 sees, although approximately 20% of
cells were still motile after this time. However, when both drugs were added
at these concentrations, motility was reduced almost to zero within this short
incubation period, and those which exhibited movement at this time showed
only feeble flagellar twitching (Fig 61).
ii. Intracellular calcium measurements. To investigate the mechanism
of action of DL propranolol, intracellular calcium levels were analysed using
the fluorescent probe quin-2. These measurements revealed that the
suppression of motility caused by a concentration of 500jiM of this reagent
was associated with a concomitant increase in the free calcium content of
these spermatozoa (Figs 62, 63).
To determine whether this calcium influx was a causative factor in the
induction of motility loss, experiments were conducted in which DL
propranolol was added to spermatozoa in the absence of exogenous
calcium. The suppression of motility resulting from treatment with 500|iM DL
propranolol was found to be significantly (P<0.01) enhanced by incubation
in calcium free medium BWW, with percentage motility in this medium being
reduced to zero within 20 mins of addition of propranolol (Fig 58).
iii. Analysis of sperm function. To determine whether low doses of
propranolol affected some aspect of sperm function other than motility, the
ability of spermatozoa to fuse with zona-free hamster oocytes in the
presence of different concentrations of DL propranolol was measured.
These experiments revealed that at a dose of 100p.M, this reagent
significantly (P<0.05) inhibited the ability to penetrate hamster oocytes,
whilst having no significant inhibitory affect on sperm motility. Although
200pM caused a significant (P<0.01 inhibition of sperm-oocyte fusion, this
concentration of DL propranolol also significantly (P<0.01) suppressed
sperm movement. (Fig 64). However, it should be noted that the reduction of
motility seen at this dose of DL propranolol was not the cause of the
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reduction in sperm-oocyte fusion, since the results presented in Fig 64 refer
to a fixed concentration of 5x106 motile cells per ml at all doses examined.
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4. Discussion.
Although a wide variety of vaginal contraceptives are currently in use,
all utilize the non-ionic surfactant nonoxynol-9 as their active ingredient. This
compound acts by disrupting the sperm plasma membrane, causing rapid
immobilization and cell death (Schill and Wolf, 1981; Wilborn et al, 1983).
However, the relatively short period of protection provided by nonoxynol-9
(John Hopkins University Population Report, 1984), and fears over the
possible teratogenic side-effects of this compound (Louis and Pearson,
1985) have stimulated the search for alternative spermicidal agents. In
addition to producing more effective vaginal contraceptives, the
development of alternatives to nonoxynol as a spermicidal agent is also of
importance for developing countries, where the importing of raw materials
makes the cost of widespread spermicide production prohibitively
expensive. In China, for instance, attempts are being made to utilize a by¬
product of the petroleum industry, agent 741[alkylphenoxy polyethoxy
ethanol (10)] as novel spermicidal agent (Xiao-Hui et al, 1986).
This study has confirmed the findings of other groups by showing that
the beta-blocking drug, propranolol, inhibits human sperm motility (Peterson
and Freund, 1973, 1975; De Turner et al, 1978; Zipper et al, 1982). In
addition, the purified D enantiomer was also found to suppress sperm
motility as has been previously reported (Peterson and Freund, 1973; Hong
et al, 1981). This observation implies that the basis of propranolol's
spermicidal action depends more upon its local anaesthetic properties,
rather than its beta-blocking potential, as D-propranolol does not possess
the ability to block beta-receptors (Barrett and Cullum, 1968). However,
these experiments have also shown racemic propranolol to be more
effective in supressing sperm motility than the purified dextro-isomer.
Incubations performed in the presence of 500p.M DL propranolol rendered
spermatozoa completely immotile within 120 mins of addition of this reagent.
Treatment with the same concentration of D propranolol did induce a
significant (P<0.01) reduction in the percentage of spermatozoa exhibiting
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flagellar movement, but after 120 mins of incubation, 17% of spermatozoa
were still motile, significantly (P<0.01) greater than in the presence of the
racemic mixture. Caution must be exercised in the interpretation of this
discrepancy, however, as a significant (P<0.01) variation in response to
propranolol was found to exist between different sperm samples.
Furthermore, at the lower concentrations of 5 and 50p.M, D propranolol
caused a significant (P<0.01) suppression of sperm motility, whilst at these
doses, the racemic mixture had no such inhibitory effects. Thus, the
difference between the effects of DL and D propranolol on sperm motility
may be due to the variation between different sperm samples, rather than to
the differing pharmacological properties of these compounds.
Spermatozoa incubated in the presence of 50|ig/ml nonoxynol-9
gradually lost the capacity for movement over a period of 60 mins, whereas
at a concentration of 500pg/ml, this reagent caused immediate and complete
loss of motility. To discern whether the anti-motility effects of propranolol and
nonoxynol-9 could interact in a synergistic manner, spermatozoa were
incubated in the presence of concentrations of these compounds which
separately had only slightly suppressive effects on sperm motility. When
added together, these compounds caused an immediate suppression of
motility, with sperm movement being inhibited completely within five minutes
of incubation. The combination of D propranolol and nonoxynol-9 also
appeared to suppress sperm movement to a greater extent than would be
expected if their effects were purely additive. These results thus show that
propranolol and nonoxynol-9 can interact synergistically in their ability to
inhibit sperm motility. Furthermore, this capacity was also expressed in a
more realistic contraceptive setting, when these compounds were presented
to spermatozoa still resident in seminal plasma. The basis for this synergism
is unknown. However, this capacity probably reflects the fact that these
compounds are affecting different aspects of membrane function. Possibly
propranolol's stabilising effects are causing the sperm membranes to
become more readily affected by the detergent properties of nonoxynol-9.
Measurement of the fluoresence signals emitted by human
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spermatozoa loaded with the calcium probe Quin-2 revealed that an
increase in free intracellular calcium content accompanied the inhibition of
motility which resulted from treatment with DL propranolol. In view of the fact
that high levels of calcium inhibit sperm motility (see chapter 5; Breitbart et
al, 1985), and that the ionophores A23187 and nigericin are more potent
than other membrane active agents in inducing immotility in human
spermatozoa (Hong et al, 1985, 1986), the possibility exists that the
alteration of membrane structure following treatment with membrane-
stabilising reagents influences sperm motility by either stimulating calcium
transport, or, more likely, inhibiting calcium efflux across the plasma
membrane.
To investigate whether the inhibition of sperm motility which results
from treatment with DL propranolol may be due to its ability to increase
internal calcium levels, the effects of this reagent on sperm motility were
tested both in the presence and the absence of extracellular calcium. The
addition of 500pM DL propranolol to spermatozoa incubated in calcium free
BWW (BWW with no added calcium and 100|iM EGTA) caused the complete
cessation of motility within 20 mins of addition, a significant (P<0.01)
enhancement of the spermicidal action of this compound over that
expressed in complete medium BWW. It would thus appear unlikely that the
ability of DL propranolol to inhibit sperm motility is mediated by an increase
in calcium levels. As the ability of DL propranolol to inhibit sperm movement
was potentiated by the removal of calcium from the medium, and as the
calcium concentration in BWW is probably far in excess of the levels of this
cation that spermatozoa encounter upon ejaculation (Mann, 1983),
propranolol may prove to be a more efficient spermicidal agent in vivo than
in vitro. It is unclear why propranolol's efficiency in suppressing sperm
movement should be increased in the absence of exogenous calcium
calcium. However, the exisitence of such an interaction raises the possibility
of utilizing combinations of propranolol and chelating agents as novel and
effective spermicidal agents.
Analysis of the effects of low doses of DL propranolol show that this
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agent also caused a significant inhibition of the penetration of zona-free
hamster eggs when present at concentrations which produced no visible
suppression of motility. This effect also probably reflects an action at the
level of the sperm membrane, reducing the capacity for membrane fusion as
a result of the membrane stabilising properties of propranolol. Such an
ability further increases the contraceptive potential of propranolol.
Recently, considerable interest has been expressed over the anti-aids
potential of nonoxynol-9. The capacity of this chemical to inactivate HTLV-III
(Hicks et al, 1985; Voeller, 1986) makes a strong case for the continued use
of this compound in spermicidal preparations. Thus the development of a
"cocktail" spermicide containing both propranolol with nonoxynol-9 is
attractive, as such a combination would have improved spermicidal efficacy,
whilst retaining the protection against possible viral infection. However, the
consequent reduction of the concentration of nonoxynol-9 required for
spermicidal purposes, due to the inclusion of propranolol, may enhance the
acceptability of this product through the reduction of side-effects. As clinical
trials of DL propranolol have revealed this agent to be both safe and
effective as a vaginal contraceptive (Zipper et al, 1983), the way would seem
open for the development of a new, "combination" spermicidal agent.
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Chapter 9. General Discussion.
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There are only three options currently available to the male who
wishes to regulate his fertility; coitus interruptus, condoms and vasectomy.
None of these methods provide the male equivalent of the effective,
convenient and reversible female pill. The development of a safe, reliable
and reversible male contraceptive would thus be a major breakthrough,
especially for those couples who wish to transfer the burden of contraception
from the female to the male, possibly as a result of contra-indications against
the use of the female pill.
The male reproductive process presents two separate areas open to
manipulation in a contraceptive context. The first, the formation of
spermatozoa in the testes, is a continuous and complex process of cell
division and differentiation, regulated by pituitary gonadotropins and
gonadal peptides (Dizerega and Sherins, 1980). The second involves the
maturation of spermatozoa within the epididymis, the biochemical
complexities of which are only now being fully comprehended (see part A).
The passage of spermatozoa through the female tract, and ultimately the
fertilization of the oocyte present further opportunities for the artificial
inhibition of sperm function.
Attempts to inhibit spermatogenesis have been hampered by the
almost inevitable interference with testicular steroid secretion that results
from this approach to male contraception. To compensate for the loss of
libido, potence and secondary sexual characteristics which results from the
decrease in testosterone secretion, androgen substitution therapy is
required. This, in turn, presents its own problems, as such treatment tends to
counteract the original anti-spermatogenic effects. Furthermore, inhibition of
spermatogenesis rarely induces complete azoospermia; more often only
severe oligozoospermia is achieved. It would thus appear that the
development of methods which interfere with the maturation of spermatozoa
in the epididymis represents the most attractive approach to the
development of novel forms of male contraception. A chemical attack
centred upon spermatozoa maturing in the epididymis would minimise the
risk of damage to the genetic material, as cell divisions have been
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completed by this stage of development, and the DNA is in a highly
condensed state. Furthermore, such a site of action would ensure a rapid
onset of infertility, requiring a relatively short period of treatment before
unprotected intercourse became safe.
a-chlorohydrin, 6-chloro-6-deoxysugars, gossypol and
sulphasalazine all have an antifertility action in the male which appears to
act either partially or completely at the level of the epididymis. However, In
view of the toxicity of a-chlorohydrin (Jackson et al, 1977), the demonstration
that the central nervous system of marmosets, mice and rats is adversely
affected by 6-chloro-6-deoxysugars (Jacobs and Duchin, 1980; Jacobs and
Ford, 1981; Ford and Waites, 1981; Ford, 1982b), the incomplete
reversibility of the anti-spermatogenic effects of gossypol (Prasad and
Diczfalusy, 1982), and the numerous side effects associated with
sulphasalzine treatment, such as nausea, vomiting, headaches, fever,
reticulocytosis, arthralgia, blood dyscrasia, bronchospasm, pulmonary
eosinophilia and peripheral neuropathy (Toth, 1979), none of these
compounds have been introduced as novel male contraceptive agents.
However, all these reagents provide valuable clues, not only for the
development of target specific, non-steroidal male contraceptives, but also
for the identification of those lesions responsible for naturally occurring male
infertility.
As over 40% of cases of male infertility have no demonstrable cause
(Diczfalusy, 1986), research aimed at defining the causative mechanisms of
such ailments may, in turn, reveal fundamental processes open to disruption
in fertile spermatozoa. In this context, the correlation shown to exist between
free oxygen radical production, lipid peroxidation and the ability to fuse with
and penetrate zona-free hamster eggs (Aitken and Clarkson, 1987) is an
exciting observation, especially in the light of the knowledge that
sulphasalazine affects the production of reactive oxygen species (Myachi et
al, 1987), and that sperm membrane lipid peroxidation increases after
sulphasalazine treatment (Chodorge et al, 1986). Spermatozoa are highly
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susceptible to damage by reactive oxygen species because of the high
levels of unsaturated fatty acids, particularly docosahexanoic acid, present
in this cell type (Jones et al, 1979), and because they are unable to protect
themselves against peroxidative damage (Aitken and Clarkson, 1987). The
observation that eight other sulphonamide compounds cause infertility in
male rats (Wong et al, 1987) is of great interest. Further research is required
to determine whether this class of substances also induce lipid peroxidation
in spermatozoa, thus possibly creating a unifying hypothesis for the
development of a new antifertility agent for the male.
The search for a biochemical male contraceptive agent continues.
Novel anti-fertility agents are constantly being evaluated, many from plants
used as traditional herbal medicines. Tripteriaium wildfordii. a Chinese herb
medicine (Zheng et al, 1983, 1985; Qian et al, 1986a) and Allitridum, the
active principle of garlic (Qian et al, 1986b) both possess antifertility activity,
and as shown in chapter 8, propranolol may soon be utilized as a new
spermicide, either on its own, or more probably in combination with
nonoxynol-9. New approaches to contraception are also being adopted.
ORF 13904, a long-chain, sulfonated polystyrene polymer, is not a
surfactant, nor does it possess spermicidal properties, yet it exhibits potent
vaginal contraceptive activity by inhibiting the penetration of cervical mucus
(Homm et al, 1985), in addition to inhibiting acrosin activity (Foldesy et al,
1986). 1,2,3-trihydroxypropane has been found to cause long-term
cessation of spermatogenesis upon injection into the rat testis, without
apparently affecting leydig cell function, libido, secondary sexual
characteristics, potency or serum hormone levels (Weibe and Barr, 1984).
Certain 1-substituted imidazoles are effective spermicidal agents which can
be administered orally (Eliasson and Dornbusch, 1980; Vickery et al, 1983).
Compounds which prevent the spontaneous liquefaction of the coagulum
formed by semen upon ejaculation may also have potential as novel vaginal
contraceptives (Mandal and Bhattacharyya, 1986). Reducing the transit time
for the passage of spermatozoa through the epididymis by treatment with
sympathomimetic drugs (Hib, 1976; Ratnasooriya et al, 1980) may also
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provide a new approach to fertility control in the male.
New analogues of contracepive agents previously discarded because
of insufficient antifertility activity, or deleterious side-effects, are also being
developed. For instance, the 1H-indazole-3-carboxylic acids, known to exert
antispermatogenic activity (Corsi et al, 1976), were discarded as potential
male contraceptive agents because of their nephrotoxicity in monkeys
(Barcellona et al, 1986). However, interest has recently been rekindled with
the testing of tolnidamine (1-[(4-chloro-2-methylphenyl)methyl]-1 H-indazole-
3-carboxylic acid), which apparently possesses the antispermatogenic
effects, but not the toxicity, of its parent compound (Barcellona et al, 1986).
Although treatment with depot medroxyprogesterone acetate and
testosterone enanthate was found to cause a severe suppression of sperm
numbers (Alvarez-Sanchez et al, 1977; Brenner et al, 1977; Frick et al,
1977a, b; Melo and Coutinho, 1977; Sanchez et al, 1979; Bain et al, 1980),
the inability of this combination of compounds to induce complete
azoospermia caused this approach to male contraception to be temporarily
abandoned. However, the recent demonstration that the spermatozoa which
remain after such treatment are unable to fuse with zona-free hamster ova
(Wu and Aitken, unpublished observations) has reinitiated interest in this
area of male contraceptive research. Similar studies in progress using
testosterone enanthate alone may reveal actions of this anti-fertility agent
overlooked using conventional semen analysis (J Aitken, personal
communication).
The demonstration that spermatozoa from sub-fertile donors express
lower levels of hyperactivated motility (Burkman, 1984; Robertson et al,
1987) indicates that inhibition of this pattern of movement may provide a
subtle approach to male contraception. In this context, the demonstration in
this study of the relationship between cAMP and hyperactivated motility
suggests that the inhibition of this nucleotide could present new means of
suppressing sperm function. The adenylate cyclase in spermatozoa exhibits
many unique characteristics, in that it does not respond to the usual
stimulators of adenylate cyclase activity, such as fluoride, guanyl
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nucleotides, cholera toxin orforskolin (Braun and Dods, 1975; Herman et al,
1976; Chen and Boettcher, 1979; Garbers and Kopf, 1980; Stengel et al,
1982; Forte et al, 1983). It is thought that this discrepancy is due to the lack
of a stimulatory subunit in this cell type (Stengel and Hanoune, 1984;
Hildebrandt et al, 1985). Due to the unique nature of the spermatozoal form
of adenylate cyclase, this enzyme constitutes an attractive potential target for
a new antifertility agent.
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